10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2011

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to                

Commission File Number: 1-12718

HEALTH NET, INC.

(Exact name of registrant as specified in its charter)

Delaware	95-4288333
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
21650 Oxnard Street, Woodland Hills, CA	91367
(Address of principal executive offices)	(Zip Code)

(818) 676-6000

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x  Yes    ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

x  Large accelerated filer    ¨  Accelerated filer    ¨  Non-accelerated filer    ¨  Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    x  No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date:

The number of shares outstanding of the registrant’s Common Stock as of August 3, 2011 was 89,083,967 (excluding 57,634,331 shares held as treasury stock).

HEALTH NET, INC.

INDEX TO FORM 10-Q

	Page
Part I—FINANCIAL INFORMATION
Item 1—Financial Statements (Unaudited)		3
Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2011 and 2010		3
Consolidated Balance Sheets as of June 30, 2011 and December 31, 2010		4
Consolidated Statements of Stockholders’ Equity for the Six Months Ended June 30, 2011 and 2010		5
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2011 and 2010		6
Condensed Notes to Consolidated Financial Statements		7
Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations		28
Item 3—Quantitative and Qualitative Disclosures About Market Risk		52
Item 4—Controls and Procedures		53
Part II—OTHER INFORMATION
Item 1—Legal Proceedings		54
Item 1A—Risk Factors		54
Item 2—Unregistered Sales of Equity Securities and Use of Proceeds		54
Item 3—Defaults Upon Senior Securities		54
Item 4—(Removed and Reserved)		54
Item 5—Other Information		54
Item 6—Exhibits		55
Signatures		56

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

HEALTH NET, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share data)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
Revenues
Health plan services premiums	$	2,566,719		$	2,507,318		$	5,179,103		$	5,034,825
Government contracts		171,015			851,939			1,046,142			1,661,398
Net investment income		25,091			16,567			48,926			36,489
Administrative services fees and other income		2,084			1,837			4,805			10,693
Northeast administrative services fees and other		11,021			59,301			23,470			109,661
Total revenues		2,775,930			3,436,962			6,302,446			6,853,066
Expenses
Health plan services (excluding depreciation and amortization)		2,231,278			2,163,191			4,513,612			4,374,447
Government contracts		130,828			811,386			952,980			1,583,288
General and administrative		219,029			237,378			645,390			484,474
Selling		57,571			56,574			118,262			115,405
Depreciation and amortization		8,953			8,466			17,781			17,129
Interest		8,238			8,761			15,858			18,645
Northeast administrative services expenses		37,825			71,951			90,080			153,829
Adjustment to loss on sale of Northeast health plan subsidiaries		(6,283	)		(8,171	)		(41,137	)		(8,171	)
Asset impairment		0			6,000			0			6,000
Early debt extinguishment charge		0			3,532			0			3,532
Total expenses		2,687,439			3,359,068			6,312,826			6,748,578
Income (loss) from operations before income taxes		88,491			77,894			(10,380	)		104,488
Income tax provision		30,191			32,828			39,515			43,332
Net income (loss)	$	58,300		$	45,066		$	(49,895	)	$	61,156
Net income (loss) per share:
Basic	$	0.64		$	0.46		$	(0.54	)	$	0.61
Diluted	$	0.63		$	0.45		$	(0.54	)	$	0.61
Weighted average shares outstanding:
Basic		90,539			98,896			91,907			99,965
Diluted		92,046			99,687			91,907			100,894

See accompanying condensed notes to consolidated financial statements.

3

HEALTH NET, INC.

CONSOLIDATED BALANCE SHEETS

(Amounts in thousands, except per share data)

	June 30, 2011			December 31, 2010
	(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	166,503		$	350,138
Investments-available-for-sale (amortized cost: 2011-$1,566,673, 2010-$1,653,502)		1,576,132			1,663,218
Premiums receivable, net of allowance for doubtful accounts (2011-$3,408, 2010-$6,613)		348,567			298,892
Amounts receivable under government contracts		334,868			266,456
Incurred but not reported (IBNR) health care costs receivable under TRICARE North contract		52,373			284,247
Other receivables		93,868			136,323
Deferred taxes		16,990			45,769
Other assets		232,636			182,252
Total current assets		2,821,937			3,227,295
Property and equipment, net		122,713			123,137
Goodwill		605,886			605,886
Other intangible assets, net		22,413			24,217
Deferred taxes		41,886			50,648
Investments-available-for-sale-noncurrent (amortized cost: 2011-$0, 2010-$10,447)		0			8,756
Other noncurrent assets		120,535			91,754
Total Assets	$	3,735,370		$	4,131,693
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Reserves for claims and other settlements	$	900,724		$	942,024
Health care and other costs payable under government contracts		94,219			113,865
IBNR health care costs payable under TRICARE North contract		52,373			284,247
Unearned premiums		160,613			158,493
Borrowings under revolving credit facility		185,000			0
Accounts payable and other liabilities		229,735			402,024
Total current liabilities		1,622,664			1,900,653
Senior notes payable		398,788			398,685
Other noncurrent liabilities		223,962			137,939
Total Liabilities		2,245,414			2,437,277
Commitments and contingencies
Stockholders’ Equity:
Preferred stock ($0.001 par value, 10,000 shares authorized, none issued and outstanding)		0			0
Common stock ($0.001 par value, 350,000 shares authorized; issued 2011-146,707 shares; 2010-145,121 shares )		147			145
Additional paid-in capital		1,265,061			1,221,301
Treasury common stock, at cost (2011-57,002 shares of common stock; 2010-50,474 shares of common stock)		(1,826,076	)		(1,626,856	)
Retained earnings		2,049,444			2,099,339
Accumulated other comprehensive income		1,380			487
Total Stockholders’ Equity		1,489,956			1,694,416
Total Liabilities and Stockholders’ Equity	$	3,735,370		$	4,131,693

See accompanying condensed notes to consolidated financial statements.

4

HEALTH NET, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in thousands)

(Unaudited)

	Common Stock					Additional Paid-In Capital			Common Stock Held in Treasury						Retained Earnings			Accumulated Other Comprehensive Income		Total
	Shares		Amount						Shares			Amount
Balance as of January 1, 2010		144,175	$	154		$	1,190,203			(41,020	)	$	(1,389,722	)	$	1,895,096		$	52	$	1,695,783
Comprehensive income:
Net income																61,156					61,156
Change in unrealized gain on investments, net of tax impact of $10,007																			16,196		16,196
Defined benefit pension plans:
Prior service cost and net loss																			131		131
Total comprehensive income																					77,483
Exercise of stock options and vesting of restricted stock units		782		(9	)		1,055														1,046
Share-based compensation expense							23,121														23,121
Tax detriment related to equity compensation plans							(5,249	)													(5,249	)
Repurchases of common stock										(6,514	)		(158,444	)							(158,444	)
Balance as of June 30, 2010		144,957	$	145		$	1,209,130			(47,534	)	$	(1,548,166	)	$	1,956,252		$	16,379	$	1,633,740
Balance as of January 1, 2011		145,121	$	145		$	1,221,301			(50,474	)	$	(1,626,856	)	$	2,099,339		$	487	$	1,694,416
Comprehensive (loss) income:
Net loss																(49,895	)				(49,895	)
Change in unrealized gain on investments, net of tax impact of $735																			701		701
Defined benefit pension plans:
Prior service cost and net loss																			192		192
Total comprehensive loss																					(49,002	)
Exercise of stock options and vesting of restricted stock units		1,586		2			26,979														26,981
Share-based compensation expense							15,295														15,295
Tax benefit related to equity compensation plans							1,486														1,486
Repurchases of common stock										(6,528	)		(199,220	)							(199,220	)
Balance as of June 30, 2011		146,707	$	147		$	1,265,061			(57,002	)	$	(1,826,076	)	$	2,049,444		$	1,380	$	1,489,956

See accompanying condensed notes to consolidated financial statements.

5

HEALTH NET, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(Unaudited)

	Six Months Ended June 30,
	2011			2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$	(49,895	)	$	61,156
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Amortization and depreciation		17,781			17,129
Adjustment to loss on sale of business		(41,137	)		(8,171	)
Share-based compensation expense		15,295			23,121
Deferred income taxes		36,806			3,378
Excess tax benefit on share-based compensation		(1,277	)		(473	)
Asset impairment charges		0			6,000
Net realized (gain) loss on investments		(26,951	)		(10,881	)
Other changes		6,781			(9,768	)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Premiums receivable and unearned premiums		(47,555	)		(53,416	)
Other current assets, receivables and noncurrent assets		(22,892	)		9,435
Amounts receivable/payable under government contracts		(88,058	)		(5,540	)
Reserves for claims and other settlements		(41,300	)		(16,776	)
Accounts payable and other liabilities		(53,398	)		95,950
Net cash (used in) provided by operating activities		(295,800	)		111,144
CASH FLOWS FROM INVESTING ACTIVITIES:
Sales of investments		1,197,801			660,070
Maturities of investments		117,897			108,958
Purchases of investments		(1,210,617	)		(835,625	)
Sales of property and equipment		0			19
Purchases of property and equipment		(21,012	)		(9,009	)
Purchase price adjustment on sale of Northeast Health Plans		41,036			(8,415	)
(Purchases) sales of restricted investments and other		(12,267	)		4,464
Net cash provided by (used in) investing activities		112,838			(79,538	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options and employee stock purchases		11,796			1,046
Excess tax benefit on share-based compensation		1,277			473
Repurchases of common stock		(189,889	)		(173,494	)
Borrowings under revolving credit facility		467,500			100,000
Repayment of borrowings under financing arrangements		(282,500	)		(216,771	)
Net decrease in checks outstanding, net of deposits		(8,857	)		0
Net cash used in financing activities		(673	)		(288,746	)
Net decrease in cash and cash equivalents		(183,635	)		(257,140	)
Cash and cash equivalents, beginning of year		350,138			682,803
Cash and cash equivalents, end of period	$	166,503		$	425,663
SUPPLEMENTAL CASH FLOWS DISCLOSURE:
Interest paid	$	15,285		$	14,620
Income taxes paid		27,809			49,279

See accompanying condensed notes to consolidated financial statements.

6

HEALTH NET, INC.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.    BASIS OF PRESENTATION

Health Net, Inc. prepared the accompanying unaudited consolidated financial statements following the rules and regulations of the Securities and Exchange Commission (SEC) for interim reporting. In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Company,” “Health Net,” “we,” “us,” and “our” refer to Health Net, Inc. and its subsidiaries. As permitted under those rules and regulations, certain notes or other financial information that are normally required by accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted if they substantially duplicate the disclosures contained in the annual audited financial statements. The accompanying unaudited consolidated financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2010 (Form 10-K).

We are responsible for the accompanying unaudited consolidated financial statements. These consolidated financial statements include all normal and recurring adjustments that are considered necessary for the fair presentation of our financial position and operating results in accordance with GAAP. In accordance with GAAP, we make certain estimates and assumptions that affect the reported amounts. Actual results could differ from those estimates and assumptions. In addition, revenues, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these interim financial statements may not be indicative of those for the full year.

Certain items presented in the operating cash flow section of the consolidated statements of cash flows for the six months ended June 30, 2010 have been reclassified within the operating cash flow section. This reclassification had no impact on our operating cash flows, net earnings or balance sheets as previously reported.

2.    SIGNIFICANT ACCOUNTING POLICIES

Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with maturity of three months or less when purchased. We had checks outstanding, net of deposits, of $37.1 million as of June 30, 2011 and $45.9 million as of December 31, 2010. These amounts were classified as accounts payable and other liabilities in the consolidated balance sheets, and the changes in these amounts have been reflected in the line item net decrease in checks outstanding, net of deposits within the cash flows from financing activities in the consolidated statements of cash flows.

Investments

Investments classified as available-for-sale, which consist primarily of debt securities, are stated at fair value. Unrealized gains and losses are excluded from earnings and reported as other comprehensive income, net of income tax effects. The cost of investments sold is determined in accordance with the specific identification method, and realized gains and losses are included in net investment income. The Company analyzes all debt investments that have unrealized losses for impairment consideration and assesses the intent to sell such securities. If such intent exists, impaired securities are considered other-than-temporarily impaired. Management also assesses if the Company may be required to sell the debt investments prior to the recovery of amortized cost, which may also trigger an impairment charge. If securities are considered other-than-temporarily impaired based on intent or ability, management assesses whether the amortized costs of the securities can be recovered. If management anticipates recovering an amount less than its amortized cost, an impairment charge is calculated based on the expected discounted cash flows of the securities. Any deficit between the amortized cost and the expected cash flows is recorded through earnings as a charge. All other temporary impairment changes are

7

recorded through other comprehensive income. During the three and six months ended June 30, 2011 and 2010, we did not recognize any losses from other-than-temporary impairments. See Note 4 to our consolidated financial statements for additional information regarding our investments.

Fair Value of Financial Instruments

The estimated fair value amounts of cash equivalents, investments available-for-sale, premiums and other receivables, notes receivable and notes payable have been determined by using available market information and appropriate valuation methodologies. The carrying amounts of cash equivalents approximate fair value due to the short maturity of those instruments. Fair values for debt and equity securities are generally based upon quoted market prices. Where quoted market prices were not readily available, fair values were estimated using valuation methodologies based on available and observable market information. Such valuation methodologies include reviewing the value ascribed to the most recent financing, comparing the security with securities of publicly traded companies in a similar line of business, and reviewing the underlying financial performance including estimating discounted cash flows. The carrying value of premiums and other receivables, long-term notes receivable and nonmarketable securities approximates the fair value of such financial instruments. The fair value of notes payable is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt with the same remaining maturities. The fair value of our fixed rate borrowings was $414.0 million and $401.2 million as of June 30, 2011 and December 31, 2010, respectively. The fair value of our variable rate borrowings under our revolving credit facility was $185.0 million as of June 30, 2011, which was equal to the carrying value because the interest rates paid on these borrowings were based on prevailing market rates. There were no borrowings outstanding under our revolving credit facility as of December 31, 2010. See Note 6 for additional information regarding our financing arrangements.

Concentrations of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments and premiums receivable. All cash equivalents and investments are managed within established guidelines, which provide us diversity among issuers. Concentrations of credit risk with respect to premiums receivable are limited due to the large number of payers comprising our customer base. The federal government is the primary customer of our Government Contracts segment (Government Contracts) with premiums and fees associated with this customer and, to a much lesser extent, state and local government contracts, accounting for 100% of our Government Contracts revenue. In addition, the federal government is a significant customer of our Western Region Operations segment (Western Region Operations) as a result of our contracts with the Centers for Medicare & Medicaid Services (CMS) for coverage of Medicare-eligible individuals.

Comprehensive Income

Comprehensive income includes all changes in stockholders’ equity (except those arising from transactions with stockholders) and includes net income, net unrealized appreciation (depreciation) after tax on investments available-for-sale, and prior service cost and net loss related to our defined benefit pension plan.

8

Accumulated other comprehensive income are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in millions)
Investments:
Unrealized (losses) gains on investments available-for-sale as of April 1 and January 1	$	(1.5	)	$	3.5		$	5.3		$	1.0
Net change in unrealized gains on investments available-for-sale		17.0			16.3			18.2			23.3
Reclassification of unrealized gains to earnings		(9.5	)		(2.6	)		(17.5	)		(7.1	)
Unrealized gains on investments available for sale as of June 30		6.0			17.2			6.0			17.2
Defined benefit pension plans:
Prior service cost and net loss amortization as of April 1 and January 1		(4.7	)		(0.9	)		(4.8	)		(0.9	)
Net change in prior service cost and net loss amortization		0.1			0.1			0.2			0.1
Prior service cost and net loss amortization as of June 30		(4.6	)		(0.8	)		(4.6	)		(0.8	)
Accumulated other comprehensive income	$	1.4		$	16.4		$	1.4		$	16.4

Earnings Per Share

Basic earnings per share excludes dilution and reflects net income divided by the weighted average shares of common stock outstanding during the periods presented. Diluted earnings per share is based upon the weighted average shares of common stock and dilutive common stock equivalents (this reflects the potential dilution that could occur if stock options were exercised and restricted stock units (RSUs) and performance share units (PSUs) were vested) outstanding during the periods presented.

Common stock equivalents arising from dilutive stock options, RSUs and PSUs are computed using the treasury stock method. For the three months ended June 30, 2011, 1,507,000 shares of dilutive common stock equivalents were outstanding. For the six months ended June 30, 2011, 1,530,000 shares were excluded from the computation of loss per share due to their anti-dilutive effect. There were 791,000 and 929,000 shares of dilutive common stock equivalents outstanding for the three and six months ended June 30, 2010, respectively.

Options, RSUs and PSUs to purchase an aggregate of 1,328,000 shares of common stock, during the three months ended June 30, 2011, and 2,712,000 and 2,700,000, during the three and six months ended June 30, 2010, respectively, were considered anti-dilutive and were not included in the computation of diluted earnings per share. Outstanding options expire at various times through April 2019.

In March 2010, our Board of Directors authorized a $300 million stock repurchase program (2010 stock repurchase program). We completed our 2010 stock repurchase program in April 2011. In May 2011, our Board of Directors authorized a new stock repurchase program for the repurchase of up to $300 million of our outstanding common stock (2011 stock repurchase program). The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. See Note 5 for more information regarding our 2010 and 2011 stock repurchase programs.

Goodwill and Other Intangible Assets

The carrying amount of goodwill by reporting unit is as follows:

	Western Region Operations		Total
	(Dollars in millions)
Balance as of June 30, 2011 and December 31, 2010	$	605.9	$	605.9

9

The intangible assets that continue to be subject to amortization using the straight-line method over their estimated lives are as follows:

	Gross Carrying Amount		Accumulated Amortization			Net Balance		Weighted Average Life (in years)
	(Dollars in millions)
As of June 30, 2011:
Provider networks	$	40.5	$	(33.1	)	$	7.4		19.4
Customer relationships and other		29.5		(14.5	)		15.0		11.1
	$	70.0	$	(47.6	)	$	22.4
As of December 31, 2010:
Provider networks	$	40.5	$	(32.6	)	$	7.9		19.4
Customer relationships and other		29.5		(13.2	)		16.3		11.1
	$	70.0	$	(45.8	)	$	24.2

We performed our annual impairment test on our goodwill and other intangible assets as of June 30, 2011 for our Western Region Operations reporting unit, and no impairment was identified. We also re-evaluated the useful lives of our other intangible assets and determined that the current estimated useful lives were properly reflected.

During the three months ended June 30, 2010, we performed our annual impairment test and determined that the implied value of the Northeast Operations reporting unit’s goodwill was zero. As a result, we recorded an impairment charge of $6 million for the total carrying value of the Northeast Operations’ goodwill during the three months ended June 30, 2010.

Estimated annual pretax amortization expense for other intangible assets for the current year and each of the next four years ending December 31 is as follows (dollars in millions):

Year	Amount
2011	$	3.5
2012		3.4
2013		3.4
2014		2.8
2015		2.6

Restricted Assets

We and our consolidated subsidiaries are required to set aside certain funds which may only be used for certain purposes pursuant to state regulatory requirements. We have discretion as to whether we invest such funds in cash and cash equivalents or other investments. As of June 30, 2011 and December 31, 2010, the restricted cash and cash equivalents balances totaled $0.3 million and $0.4 million, respectively, and are included in other noncurrent assets. Investment securities held by trustees or agencies were $25.7 million and $25.8 million as of June 30, 2011 and December 31, 2010, respectively, and are included in investments available-for-sale.

Subsequent Accounting for the Northeast Sale

On December 11, 2009, we completed the sale (the Northeast Sale) of all of the outstanding shares of capital stock of our health plan subsidiaries that were domiciled in Connecticut, New Jersey, New York and Bermuda (Acquired Companies) that had conducted businesses in our Northeast Operations segment (see Note 3) to UnitedHealth Group Incorporated (United). The sale was made pursuant to a Stock Purchase Agreement (Stock

10

Purchase Agreement), dated as of July 20, 2009, by and among the Company, Health Net of the Northeast, Inc., Oxford Health Plans, LLC (Buyer) and, solely for the purposes of guaranteeing Buyer’s obligations thereunder, United. At the closing of the Northeast Sale, affiliates of United also acquired membership renewal rights for certain commercial health care business conducted by our subsidiary, Health Net Life Insurance Company (Health Net Life) in the states of Connecticut and New Jersey (the Transitioning HNL Members). We were required to continue to serve the members of the Acquired Companies under United Administrative Services Agreements we entered into with United and certain of its affiliates (the United Administrative Services Agreements) until all members are either transitioned to a legacy United entity or non-renewed, which occurred on July 1, 2011. As part of the Northeast Sale, we retained certain financial responsibilities for the profits and losses of the Acquired Companies, subject to specified adjustments, for the period beginning on the closing date and ending on the earlier of the second anniversary of the closing date and the date that the last United Administrative Services Agreement was terminated. Accordingly, subsequent to the Northeast Sale, our Northeast Operations reportable segment (Northeast Operations) includes the operations of the businesses that provided administrative services pursuant to the United Administrative Services Agreements prior to the termination of the United Administrative Services Agreements on July 1, 2011, as well as the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Subsequent accounting for the Northeast Sale is reported as part of our Northeast Operations reportable segment (see Note 3).

Under the United Administrative Services Agreements, we provided claims processing, customer services, medical management, provider network access and other administrative services to United and certain of its affiliates. We recognized the revenue that we earned from providing these administrative services in the period these services were provided, and we reported such revenue in the line item, Northeast administrative services fees and other income, in our consolidated statements of operations. Also included in Northeast administrative services fees and other income was the amortization of the value of services provided under the United Administrative Services Agreements. In connection with the Northeast Sale, the United Administrative Services Agreements were fair valued at $48 million and recorded as deferred revenue. The deferred revenue was amortized and recorded as Northeast administrative services fees and other income using a level of effort approach. During the three months ended June 30, 2011 and 2010, $0.5 million and $24.6 million, respectively, and during the six months ended June 30, 2011 and 2010, $2.7 million and $27.1 million, respectively, were amortized from deferred revenue and recorded as Northeast administrative services fees and other income.

In addition, we were entitled to 50% of the profits or losses associated with the Acquired Companies’ Medicare business for the year ended December 31, 2010 (subject to a cap of $10 million of profit or loss), and in the first quarter of 2011, we received $7 million related to our share of the profit associated with the Acquired Companies’ Medicare business. The Medicare business was transferred to a United affiliate on January 1, 2011. As part of the Northeast Sale, we also retained certain financial responsibilities for the Acquired Companies, subject to specified adjustments for the period beginning on the closing date of the transaction and ending on the date that the last United Administrative Services Agreement was terminated. Accordingly, the Northeast administrative services fees and other income included a quarterly net payment (QNP) paid to United in accordance with the terms of the Stock Purchase Agreement. The QNP is a defined term in the Stock Purchase Agreement and represented the net profit or loss from the wind-down of the Acquired Companies, as adjusted in accordance with the Stock Purchase Agreement. We reported expenses we incurred in providing these administrative services as a separate line item, Northeast administrative services expenses, in our consolidated statements of operations.

Under the Stock Purchase Agreement, United is required to pay us additional consideration for the value of the Transitioning HNL Members and the members of the Acquired Companies that transitioned to other United products based upon a formula set forth in the Stock Purchase Agreement to the extent such amounts exceed the initial minimum payment of $60 million that United made to us at closing (referred to as contingent membership renewals). This membership transition was completed on July 1, 2011. In connection with contingent membership renewals, we recorded as an adjustment to the loss on sale of the Northeast health plan subsidiaries

11

$6.3 million and $41.1 million in the three and six months ended June 30, 2011, respectively, and $8.2 million in the three and six months ended June 30, 2010. As of June 30, 2011, $41.3 million was due from United in connection with contingent membership renewals.

With the termination of the United Administrative Services Agreements on July 1, 2011, we have estimated and recorded the final QNP of $19.7 million in the second quarter of 2011. This estimated amount is subject to review by United, and the final QNP after such a review may be materially different than the amount recorded. At this time, we expect to complete the QNP review process with United by December 31, 2011. Upon the termination of the United Administrative Services Agreements, we entered into Claims Servicing Agreements with United and certain of its affiliates pursuant to which we will continue to adjudicate run out claims and perform limited other administrative services. The Claims Servicing Agreements will be in effect until the last run out claim under the applicable Claims Servicing Agreement has been adjudicated.

T-3 TRICARE Contract

On April 1, 2011, we began delivering administrative services under the new Managed Care Support Contract (T-3) for the TRICARE North Region. The T-3 contract was awarded to us on May 13, 2010. We were the managed care contractor for the United States Department of Defense’s (DoD) previous TRICARE contract in the North Region, which ended on March 31, 2011.

The T-3 contract has five one-year option periods; however, on March 15, 2011, the DoD exercised option period 2 (without exercising option period 1), due to a delay of approximately one year in the government’s initial award of the T-3 contract. Accordingly, option period 2 commenced on April 1, 2011, and if all remaining option periods are exercised, the T-3 contract would conclude on March 31, 2015.

We provide various types of administrative services under the contract, including: provider network management, referral management, medical management, disease management, enrollment, customer service, clinical support service, and claims processing. We also provide assistance in the transition into and out of the T-3 contract. These services are structured similar to administrative services only (ASO) arrangements with fees received in the form of cost plus fixed price, and fixed unit price, and contingent fees and payments based on various incentives and penalties.

In accordance with GAAP, we evaluate, at the inception of the contract and as services are delivered, all deliverables in the service arrangement to determine whether they represent separate units of accounting. The delivered items are considered separate units of accounting if the delivered items have value to the customer on a standalone basis (i.e., they are sold separately by any vendor) and no general right of return exists relative to the delivered item. While we identified two separate units of accounting within the T-3 contract, no determination of estimated selling price was performed because both units of accounting are performed ratably over the option periods and, accordingly, the same methodology of revenue recognition applies to both units of accounting.

We recognize revenue related to administrative services on a straight line basis over the option period, when the fees become fixed and determinable.

The contract includes various performance-based incentives and penalties. For each of the incentives or penalties, we adjust revenue accordingly based on the amount that we have earned or incurred at each interim date and are legally entitled to in the event of a contract termination.

The transition-in process for the T-3 contract began in the second quarter of 2010. As of June 30, 2011, revenue in the amount of $52.5 million related to the transition-in activities has been recognized as an upfront fee, and amortized over the four-year customer relationship period on a straight-line basis. We have also deferred $43.8 million of costs related to the transition-in activities as of June 30, 2011. These deferred transition-in costs began amortizing on April 1, 2011 on a straight-line basis with the related deferred revenue over the customer relationship period. Fulfillment costs associated with the T-3 contract are expensed as incurred.

12

Revenues and expenses associated with the T-3 contract are reported as part of Government Contracts revenues and Government Contracts expenses in the consolidated statements of operations and included in the Government Contracts reportable segment.

The TRICARE members are served by our network and out-of-network providers in accordance with the T-3 contract. We pay health care costs related to these services to the providers and are later reimbursed by the DoD for such payments. Under the terms of the T-3 contract, we are not the primary obligor for health care services and accordingly, we do not include health care costs and related reimbursements in our consolidated statement of operations. Health care costs for the T-3 contract that are paid and reimbursable amounted to $421.6 million for the three and six months ended June 30, 2011.

Recently Issued Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-05, Comprehensive Income (Topic 220), Presentation of Comprehensive Income. The amendments in this update affect all entities that report items of other comprehensive income (OCI). Under the new guidance, the entities will no longer be allowed to present OCI in the statement of stockholders’ equity. The entities are required to report components of comprehensive income in either a continuous statement of comprehensive income or two separate but consecutive statements. Under either method, entities must display adjustments for items that are reclassified from OCI to net income in both net income and OCI. Reclassification adjustments between OCI and net income have to be presented separately on the face of the financial statements. The amendments in this update do not change the items that must be reported in OCI or when an item of OCI must be reclassified to net income. Also, this ASU does not change the current option for entities to present components of OCI gross or net of the effect of income taxes as long as such tax effects are presented in the statement in which OCI is presented, or disclosed in the notes to the financial statements. This ASU does not affect how earnings per share is calculated or presented. The amendments in this update should be applied retrospectively and will become effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We do not expect the adoption of ASU No. 2011-05 to have a material effect on our financial condition or results of operations.

In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820), Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U. S. GAAP and IFRSs. The amendments in this ASU result in common fair value measurement and disclosure requirements in GAAP and International Financial Reporting Standards (IFRSs). Consequently, the amendments change the wording used to describe many of the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements. The FASB does not intend for these amendments to result in a change of application for many of the requirements in ASC 820, Fair Value Measurements and Disclosures. There are new disclosures requirements in this update including a disclosure of quantitative information about the unobservable inputs used for all Level 3 value measurements, a qualitative discussion about the sensitivity of recurring Level 3 measurements to changes in the unobservable inputs disclosed, and a description of the company’s valuation processes. There are also additional disclosure requirements such as disclosure of any transfers between Levels 1 and 2 (not just significant transfers), information about when the current use of a non-financial asset measured at fair value differs from its highest and best use, and the hierarchy classification for items whose fair value is not recorded on the balance sheet but is disclosed in the notes to financial statements. ASU No. 2011-04 is effective for periods beginning after December 15, 2011. We do not expect the adoption of ASU No. 2011-04 to have a material impact on our financial condition or results of operations.

In July 2011, the FASB issued ASU No. 2011-06, Other Expenses (Topic 720), Fees Paid to the Federal Government by Health Insurers (a consensus of the FASB Emerging Task Force). This update affects reporting entities that are subject to the fee imposed on health insurers mandated by the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act (the Acts). The Acts impose an annual fee on health insurers for each calendar year beginning on or after January 1, 2014. This fee is not tax

13

deductible and allocated to the individual health insurers based on the ratio of the amount of net premiums to the amount of health insurance for any U.S. health risk. This ASU addresses the recognition and classification of the entity’s share of this imposed fee. The liability for the fee should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using a straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. The amendments in this update are effective for calendar years beginning after December 31, 2013, when the fee initially becomes effective. We will evaluate the impact of this update on our consolidated financial statements.

3.    SEGMENT INFORMATION

Our Western Region Operations reportable segment includes the operations of our commercial, Medicare and Medicaid health plans, our health and life insurance companies, and our behavioral health and pharmaceutical services subsidiaries. These operations are conducted primarily in California, Arizona, Oregon and Washington. Our Government Contracts reportable segment includes government-sponsored managed care and administrative services plans through the TRICARE program and other health care-related government contracts. For the three and six months ended June 30, 2011, our Northeast Operations reportable segment included the operations of our businesses that provided administrative services to United and its affiliates pursuant to the United Administrative Services Agreements prior to their termination on July 1, 2011 and the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Beginning July 1, 2011, our Northeast Operations reportable segment will include the operations of our businesses that are adjudicating run out claims and providing limited other administrative services to United and its affiliates pursuant to the Claims Servicing Agreements.

As a result of the Northeast Sale, we operate the Northeast business in a manner that is different than the rest of our health plans. For additional information on the Northeast Sale, the United Administrative Services Agreements and the Claims Servicing Agreements, see Note 2. The rest of our health plans are operated as continuing core health plans.

We evaluate performance and allocate resources based on segment pretax income. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 2 to the consolidated financial statements included in our Form 10-K, except that intersegment transactions are not eliminated.

We also have a Corporate/Other segment that is not a business operating segment. It is added to our reportable segments to provide a reconciliation to our consolidated results. The Corporate/Other segment includes costs that are excluded from the calculation of segment pretax income because they are not managed within the segments and are not directly identified with a particular operating segment (for example, see Note 8 for the charge included in Corporate/Other in the six months ended June 30, 2011 related to the decision rendered by the Louisiana Supreme Court in the AmCareco litigation). Accordingly, these costs are not included in the performance evaluation of the reportable segments by our chief operating decision maker. In addition, certain charges, including those related to our operations strategy and corporate overhead cost reduction efforts, as well as asset impairments, are reported as part of Corporate/Other.

14

Our segment information is as follows:

	Western Region Operations		Government Contracts		Northeast Operations			Corporate/ Other/ Eliminations			Total
	(Dollars in millions)
Three Months Ended June 30, 2011
Revenues from external sources	$	2,593.6	$	171.0	$	11.3		$	0		$	2,775.9
Intersegment revenues		3.0		0		0			(3.0	)		0
Segment pretax income (loss)	$	72.5	$	40.2	$	(21.0	)	$	(3.2	)	$	88.5
Three Months Ended June 30, 2010
Revenues from external sources	$	2,507.9	$	851.9	$	82.6		$	(5.4	)	$	3,437.0
Intersegment revenues		13.0		0		0			(13.0	)		0
Segment pretax income (loss)	$	58.1	$	41.5	$	(9.4	)	$	(12.3	)		77.9
Six Months Ended June 30, 2011
Revenues from external sources	$	5,230.4	$	1,046.1	$	25.9		$	0		$	6,302.4
Intersegment revenues		5.9		0		0			(5.9	)		0
Segment pretax income (loss)	$	109.0	$	98.0	$	(25.9	)	$	(191.5	)	$	(10.4	)
Six Months Ended June 30, 2010
Revenues from external sources	$	5,038.6	$	1,661.4	$	158.5		$	(5.4	)	$	6,853.1
Intersegment revenues		25.1		0		0			(25.1	)		0
Segment pretax income (loss)	$	98.8	$	79.5	$	(47.0	)	$	(26.8	)	$	104.5

Our health plan services premium revenue by line of business is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
	(Dollars in millions)
Commercial premium revenue	$	1,481.4	$	1,411.0	$	2,971.1	$	2,823.2
Medicare premium revenue		734.4		770.7		1,526.5		1,557.6
Medicaid premium revenue		350.6		302.6		679.2		605.8
Total Western Region Operations health plan services premiums		2,566.4		2,484.3		5,176.8		4,986.6
Total Northeast Operations health plan services premiums		0.3		23.0		2.3		48.2
Total health plans services premiums	$	2,566.7	$	2,507.3	$	5,179.1	$	5,034.8

4.    INVESTMENTS

Investments classified as available-for-sale, which consist primarily of debt securities, are stated at fair value. Unrealized gains and losses are excluded from earnings and reported as other comprehensive income, net of income tax effects. The cost of investments sold is determined in accordance with the specific identification method, and realized gains and losses are included in net investment income. We periodically assess our available-for-sale investments for other-than-temporary impairment. Any such other-than-temporary impairment loss is recognized as a realized loss, which is recorded through earnings, if related to credit losses.

There were no investments available-for-sale-noncurrent as of June 30, 2011. As of December 31, 2010, we classified $8.8 million as investments available-for-sale-noncurrent because we believed it would take longer than a year for such impaired securities to recover. All available-for-sale-noncurrent investments were sold in the three months ended June 30, 2011.

15

As of June 30, 2011 and December 31, 2010, the amortized cost, gross unrealized holding gains and losses, and fair value of our current investments available-for-sale and our investments available-for-sale-noncurrent, after giving effect to other-than-temporary impairments, were as follows:

	June 30, 2011
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	667.7	$	4.5	$	(1.3	)	$	670.9
U.S. government and agencies		88.3		0.2		0.0			88.5
Obligations of states and other political subdivisions		479.0		5.9		(1.1	)		483.8
Corporate debt securities		331.6		2.2		(1.0	)		332.8
Other securities		0.0		0.1		0.0			0.1
	$	1,566.6	$	12.9	$	(3.4	)	$	1,576.1

	December 31, 2010
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	642.3	$	8.1	$	(2.2	)	$	648.2
U.S. government and agencies		103.6		0.1		(0.4	)		103.3
Obligations of states and other political subdivisions		533.2		2.1		(8.1	)		527.2
Corporate debt securities		374.5		11.8		(1.8	)		384.5
Other securities		0.0		0.0		0.0			0.0
	$	1,653.6	$	22.1	$	(12.5	)	$	1,663.2
Noncurrent:
Obligations of states and other political subdivisions	$	10.5	$	0.0	$	(1.7	)	$	8.8

As of June 30, 2011, the contractual maturities of our current investments available-for-sale were as follows:

	Amortized Cost		Estimated Fair Value
	(Dollars in millions)
Due in one year or less	$	45.5	$	45.9
Due after one year through five years		502.3		506.2
Due after five years through ten years		256.7		258.2
Due after ten years		94.4		94.8
Asset-backed securities		667.7		670.9
Other securities		0.0		0.1
Total current investments available-for-sale	$	1,566.6	$	1,576.1

Proceeds from sales of investments available-for-sale during the three and six months ended June 30, 2011 were $799.3 million and $1,197.8 million, respectively. Gross realized gains and losses totaled $16.3 million and $1.7 million, respectively, for the three months ended June 30, 2011, and $29.3 million and $2.4 million, respectively, for the six months ended June 30, 2011. Proceeds from sales of investments available-for-sale during the three and six months ended June 30, 2010 were $215.9 million and $660.1 million, respectively. Gross

16

realized gains and losses totaled $4.1 million and $0.1 million, respectively, for the three months ended June 30, 2010, and $12.5 million and $1.6 million, respectively, for the six months ended June 30, 2010.

The following table shows our current investments’ fair values and gross unrealized losses for individual securities that have been in a continuous loss position at June 30, 2011:

	Less than 12 Months					12 Months or More				Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	246.6	$	(1.3	)	$	0.0	$	0.0	$	246.6	$	(1.3	)
U.S. government and agencies		4.0		0.0			0.0		0.0		4.0		0.0
Obligations of states and other political subdivisions		93.9		(1.1	)		0.3		0.0		94.2		(1.1	)
Corporate debt securities		129.0		(1.0	)		0.0		0.0		129.0		(1.0	)
Other securities		0.0		0.0			0.0		0.0		0.0		0.0
	$	473.5	$	(3.4	)	$	0.3	$	0.0	$	473.8	$	(3.4	)

The following table shows the number of individual securities included in our current investments that have been in a continuous loss position at June 30, 2011:

	Less than 12 Months		12 Months or More		Total
Asset-backed securities		54		0		54
U.S. government and agencies		1		0		1
Obligations of states and other political subdivisions		50		1		51
Corporate debt securities		75		0		75
Other securities		0		0		0
		180		1		181

The following table shows our current investments’ fair values and gross unrealized losses for individual securities that have been in a continuous loss position at December 31, 2010:

	Less than 12 Months					12 Months or More					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	188.2	$	(2.2	)	$	0.2	$	0.0		$	188.4	$	(2.2	)
U.S. government and agencies		65.1		(0.4	)		0.0		0.0			65.1		(0.4	)
Obligations of states and other political subdivisions		372.7		(8.0	)		1.8		(0.1	)		374.5		(8.1	)
Corporate debt securities		97.9		(1.8	)		0.0		0.0			97.9		(1.8	)
Other securities		0.0		0.0			0.0		0.0			0.0		0.0
	$	723.9	$	(12.4	)	$	2.0	$	(0.1	)	$	725.9	$	(12.5	)

The following table shows our noncurrent investments’ fair values and gross unrealized losses for individual securities that have been in a continuous loss position at December 31, 2010:

	Less than 12 Months				12 Months or More					Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Obligations of states and other political subdivisions	$	0.0	$	0.0	$	8.8	$	(1.7	)	$	8.8	$	(1.7	)

17

The above referenced investments are interest-yielding debt securities of varying maturities. We have determined that the unrealized loss position for these securities is primarily due to market volatility. Generally, in a rising interest rate environment, the estimated fair value of fixed income securities would be expected to decrease; conversely, in a decreasing interest rate environment, the estimated fair value of fixed income securities would be expected to increase. These securities may also be negatively impacted by illiquidity in the market.

5.    STOCK REPURCHASE PROGRAM

On March 18, 2010, our Board of Directors authorized our 2010 stock repurchase program pursuant to which a total of $300 million of our common stock could be repurchased. We completed our 2010 stock repurchase program in April 2011. During the three and six months ended June 30, 2011, we repurchased 1.4 million shares and 4.9 million shares, respectively, of our common stock for aggregate consideration of approximately $45.2 million and $149.8 million, respectively, under our 2010 stock repurchase program. As of June 30, 2011, we had repurchased an aggregate of 10.8 million shares of our common stock under our 2010 stock repurchase program since its inception at an average price of $27.80 per share for aggregate consideration of $300 million.

On May 4, 2011, our Board of Directors authorized our 2011 stock repurchase program pursuant to which a total of $300 million of our outstanding common stock could be repurchased. Subject to Board approval, we may repurchase our common stock under our 2011 stock repurchase program from time to time in privately negotiated transactions, through accelerated stock repurchase programs or open market transactions, including pursuant to a trading plan in accordance with Rules 10b5-1 and 10b-18 of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of stock repurchases will depend on a variety of factors, including the stock price, corporate and regulatory requirements, restrictions under the Company’s debt obligations, and other market and economic conditions. Our 2011 stock repurchase program may be suspended or discontinued at any time.

During the three months ended June 30, 2011, we repurchased 870,000 shares of our common stock for aggregate consideration of approximately $27.1 million under our 2011 stock repurchase program. The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. We used net free cash available, including cash at the parent company, Health Net, Inc., to fund the share repurchases.

6.    FINANCING ARRANGEMENTS

Termination of Amortizing Financing Facility

On May 26, 2010, we terminated our five-year non-interest bearing, $175 million amortizing financing facility with a non-U.S. lender that we entered into on December 19, 2007 by exercising our option to call the facility. In connection with the call, we recorded a $3.5 million pretax early debt extinguishment charge in the quarter ended June 30, 2010.

Senior Notes

In 2007 we issued $400 million in aggregate principal amount of 6.375% Senior Notes due 2017 (Senior Notes). The indenture governing the Senior Notes limits our ability to incur certain liens, or consolidate, merge or sell all or substantially all of our assets. In the event of the occurrence of both (1) a change of control of Health Net, Inc. and (2) a below investment grade rating by any two of Fitch, Inc., Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services within a specified period, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes plus accrued and unpaid interest to the date of repurchase. As of June 30, 2011, no default or event of default had occurred under the indenture governing the Senior Notes.

18

The Senior Notes may be redeemed in whole at any time or in part from time to time, prior to maturity at our option, at a redemption price equal to the greater of:

• 100% of the principal amount of the Senior Notes then outstanding to be redeemed; or

• the sum of the present values of the remaining scheduled payments of principal and interest on the Senior Notes to be redeemed (not including any portion of such payments of interest accrued to the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the applicable treasury rate plus 30 basis points

plus, in each case, accrued and unpaid interest on the principal amount being redeemed to the redemption date.

Each of the following will be an Event of Default under the indenture governing the Senior Notes:

• failure to pay interest for 30 days after the date payment is due and payable; provided that an extension of an interest payment period by us in accordance with the terms of the Senior Notes shall not constitute a failure to pay interest;

• failure to pay principal or premium, if any, on any note when due, either at maturity, upon any redemption, by declaration or otherwise;

• failure to perform any other covenant or agreement in the notes or indenture for a period of 60 days after notice that performance was required;

• (A) our failure or the failure of any of our subsidiaries to pay indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, at the later of final maturity and the expiration of any related applicable grace period and such defaulted payment shall not have been made, waived or extended within 30 days after notice or (B) acceleration of the maturity of indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, if that acceleration results from a default under the instrument giving rise to or securing such indebtedness for money borrowed and such indebtedness has not been discharged in full or such acceleration has not been rescinded or annulled within 30 days after notice; or

• events in bankruptcy, insolvency or reorganization of our Company.

Our Senior Notes payable balances were $398.8 million as of June 30, 2011 and $398.7 million as of and December 31, 2010, respectively.

Revolving Credit Facility

We have a $900 million five-year revolving credit facility with Bank of America, N.A. as Administrative Agent, Swingline Lender, and L/C Issuer, and the other lenders party thereto. As of June 30, 2011, $185.0 million was outstanding under our revolving credit facility and the maximum amount available for borrowing under the revolving credit facility was $654.8 million (see “—Letters of Credit” below). The revolving credit facility matures on June 25, 2012. Accordingly, the balance outstanding of $185.0 million as of June 30, 2011 is classified as a current liability.

Amounts outstanding under our revolving credit facility will bear interest, at our option, at (a) the base rate, which is a rate per annum equal to the greater of (i) the federal funds rate plus one-half of one percent and (ii) Bank of America’s prime rate (as such term is defined in the facility), (b) a competitive bid rate solicited from the syndicate of banks, or (c) the British Bankers Association LIBOR rate (as such term is defined in the facility), plus an applicable margin, which is initially 70 basis points per annum and is subject to adjustment according to our credit ratings, as specified in the facility.

19

Our revolving credit facility includes, among other customary terms and conditions, limitations (subject to specified exclusions) on our and our subsidiaries’ ability to incur debt; create liens; engage in certain mergers, consolidations and acquisitions; sell or transfer assets; enter into agreements which restrict the ability to pay dividends or make or repay loans or advances; make investments, loans, and advances; engage in transactions with affiliates; and make dividends. In addition, we are required to maintain a specified consolidated leverage ratio and consolidated fixed charge coverage ratio throughout the term of the revolving credit facility.

Our revolving credit facility contains customary events of default, including nonpayment of principal or other amounts when due; breach of covenants; inaccuracy of representations and warranties; cross-default and/or cross-acceleration to other indebtedness of the Company or our subsidiaries in excess of $50 million; certain ERISA-related events; noncompliance by us or any of our subsidiaries with any material term or provision of the HMO Regulations or Insurance Regulations (as each such term is defined in the facility); certain voluntary and involuntary bankruptcy events; inability to pay debts; undischarged, uninsured judgments greater than $50 million against us and/or our subsidiaries; actual or asserted invalidity of any loan document; and a change of control. If an event of default occurs and is continuing under the revolving credit facility, the lenders thereunder may, among other things, terminate their obligations under the facility and require us to repay all amounts owed thereunder.

Letters of Credit

We can obtain letters of credit in an aggregate amount of $400 million under our revolving credit facility. The maximum amount available for borrowing under our revolving credit facility is reduced by the dollar amount of any outstanding letters of credit. As of June 30, 2011 and December 31, 2010, we had outstanding letters of credit of $60.2 million and $249.1 million, respectively, resulting in a maximum amount available for borrowing under the revolving credit facility of $654.8 million and $650.9 million, respectively. During the three months ended June 30, 2011, approximately $88.1 million in outstanding letters of credit were released in connection with our satisfaction of the entirety of the AmCareco litigation judgment (see Note 8 for more information on the AmCareco litigation ruling). As of June 30, 2011 and December 31, 2010, no amounts had been drawn on any of these letters of credit.

7.    FAIR VALUE MEASUREMENTS

We record certain assets and liabilities at fair value in the consolidated balance sheets and categorize them based upon the level of judgment associated with the inputs used to measure their fair value and the level of market price observability. We also estimate fair value when the volume and level of activity for the asset or liability have significantly decreased or in those circumstances that indicate when a transaction is not orderly.

Investments measured and reported at fair value using Level inputs are classified and disclosed in one of the following categories:

Level 1—Quoted prices are available in active markets for identical investments as of the reporting date. The types of investments included in Level 1 include U.S. Treasury securities and listed equities. We do not adjust the quoted price for these investments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2—Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models and/or other valuation methodologies which are based on an income approach. Examples include, but are not limited to, multidimensional relational model, option adjusted spread model, and various matrices. Specific pricing inputs include quoted prices for similar securities in both active and non-active markets, other observable inputs such as interest rates, yield curve volatilities, default rates, and inputs that are derived principally from or corroborated by other observable market data. Investments that are generally included in this category include asset-backed securities, corporate bonds and loans, municipal bonds, auction rate securities and interest rate swap assets.

20

Level 3—Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation using assumptions that market participants would use, including assumptions for risk. The investments included in Level 3 are auction rate securities which have experienced failed auctions at one time or are experiencing failed auctions and thus have minimal liquidity. These bonds have frequent reset of coupon rates and have extended to the legal final maturity. The coupons are based on a margin plus a LIBOR rate and continue to pay above market rates. As with most variable or floating rate securities, we believe that based on a market approach, the fair values of these securities are equal to their par values due to the short time periods between coupon resets and based on each issuer’s credit worthiness. Also included in the Level 3 category is a derivative held by the Company estimated at fair value. Significant inputs used in the derivative valuation model include the estimated growth in health care expenditures and the discount rate to estimate the present value of the cash flows. The growth in these expenditures was modeled using a Monte Carlo simulation approach.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

The following tables present information about our assets and liabilities measured at fair value on a recurring basis at June 30, 2011 and December 31, 2010, and indicate the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (dollars in millions):

	Level 1		Level 2- current		Level 2- noncurrent		Level 3		Total
As of June 30, 2011
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	526.8	$	0	$	0	$	526.8
Commercial mortgage-backed securities		0		87.0		0		0		87.0
Other asset-backed securities		0		57.1		0		0		57.1
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		62.8		0		0		62.8
Obligations of states and other political subdivisions		0		473.9		0		9.9		483.8
Corporate debt securities		0		332.8		0		0		332.8
Other securities		0.1		0		0		0		0.1
Total investments at fair value	$	25.8	$	1,540.4	$	0	$	9.9	$	1,576.1
Embedded contractual derivative		0		0		0		0.8		0.8
Total assets at fair value	$	25.8	$	1,540.4	$	0	$	10.7	$	1,576.9
As of December 31, 2010
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	527.6	$	0	$	0	$	527.6
Commercial mortgage-backed securities		0		80.4		0		0		80.4
Other asset-backed securities		0		40.2		0		0		40.2
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		77.6		0		0		77.6
Obligations of states and other political subdivisions		0		517.3		8.8		9.9		536.0
Corporate debt securities		0		384.5		0		0		384.5
Other securities		0		0		0		0		0
Total assets at fair value	$	25.7	$	1,627.6	$	8.8	$	9.9	$	1,672.0

21

We had no transfers between Levels 1 and 2 of financial assets or liabilities that are fair valued on a recurring basis during the three and six months ended June 30, 2011 and 2010. In determining when transfers between levels are recognized, our accounting policy is to recognize the transfers based on the actual date of the event or change in circumstances that caused the transfer.

The changes in the balances of Level 3 financial assets for the three and six months ended June 30, 2011 and 2010 were as follows (dollars in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Beginning balance on April 1 and January 1	$	9.9	$	10.0	$	9.9	$	10.0
Transfers into Level 3		0		0		0		0
Transfers out of Level 3		0		0		0		0
Total gains and losses
Realized in net income		0		0		0		0
Unrealized in accumulated other comprehensive income		0		0		0		0
Purchases, sales, issuances and settlements
Purchases/additions		0.8		0		0.8		0
Sales		0		0		0		0
Issuances		0		0		0		0
Settlements		0		0		0		0
Ending balance		10.7	$	10.0		10.7	$	10.0
Change in unrealized gains (losses) included in net income related to assets still held	$	0	$	0	$	0	$	0

We had no financial assets or liabilities that were fair valued on a non-recurring basis during the three and six months ended June 30, 2011.

The following table presents information about financial assets measured at fair value on a non-recurring basis during the three and six months ended June 30, 2010 and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (dollars in millions):

	Level 1		Level 2		Level 3		Total Loss
As of June 30, 2010
Goodwill—Northeast Operations	$	0	$	0	$	0	$	(6.0	)

The changes in the balances of Level 3 financial assets that are fair valued on a non-recurring basis for the three and six months ended June 30, 2010 were as follows (dollars in millions):

	Three Months Ended June 30, 2010			Six Months Ended June 30, 2010
Beginning Northeast Operations’ goodwill balance on April 1 and January 1	$	6.0		$	6.0
Impairment related to Northeast Operations		(6.0	)		(6.0	)
Ending Northeast Operations’ goodwill balance	$	0		$	0

See Note 2 for a discussion on the goodwill valuation and the impairment of the Northeast Operations’ goodwill.

22

8.    LEGAL PROCEEDINGS

Litigation and Investigations Related to Unaccounted-for Server Drives

We are a defendant in three related litigation matters pending in California state and federal courts relating to information security issues. On January 21, 2011, International Business Machines Corp. (IBM), which handles our data center operations, notified us that it could not locate several hard disk drives that had been used in our data center located in Rancho Cordova, California. We have since determined that personal information of approximately two million former and current Health Net members, employees and health care providers is on the drives. Commencing on March 14, 2011, we provided written notification to the individuals whose information is on the drives. To help protect the personal information of affected individuals, we offered them two years of free credit monitoring services, in addition to identity theft insurance and fraud resolution and restoration of credit files services, if needed.

On March 18, 2011, a putative class action relating to this incident was filed against us in the U.S. District Court for the Central District of California, and similar actions were later filed against us in other federal and state courts in California. A number of those actions were transferred to and consolidated in the U.S. District Court for the Eastern District of California, and the two remaining actions are currently pending in San Francisco County Superior Court and the U.S. District Court for the Central District of California. The consolidated amended complaint in the federal action pending in the Eastern District of California is filed on behalf of a putative class of over 800,000 of our current or former members who received the written notification, and also names IBM as a defendant. It seeks to state claims for violation of the California Confidentiality of Medical Information Act and the California Customer Records Act, and seeks statutory damages of up to $1,000 for each class member, as well as injunctive and declaratory relief, attorneys’ fees and other relief. We have not yet filed a response to the consolidated complaint.

The other federal court proceeding was instituted on July 7, 2011 in Riverside County Superior Court and is brought on behalf of a putative nationwide class of all former and current members affected by this incident, and seeks to state similar claims against us , as well as a claim for invasion of privacy. We removed this case to the Central District of California on August 1, 2011. We have not yet filed a response to the complaint in this action.

The San Francisco Superior Court proceeding was instituted on March 28, 2011 and is brought on behalf of a putative class of California residents who received the written notification, and seeks to state similar claims against us, as well as claims for violation of the Unfair Competition Law, and seeks similar relief. We have moved to compel arbitration of the two named plaintiffs’ claims.

We have also been informed that a number of regulatory agencies are investigating the incident, including the California Department of Managed Health Care, the California Department of Insurance, the California Office of the Attorney General, the Connecticut Attorney General, the Connecticut Department of Insurance, and the Office of Civil Rights of the U.S. Department of Health and Human Services.

We intend to vigorously defend ourselves against these claims; however, these proceedings are subject to many uncertainties. At this time we cannot reasonably estimate the range of loss that may result from these legal and regulatory proceedings in light of the facts that (i) legal and regulatory proceedings are inherently unpredictable, (ii) there are multiple parties in each of the disputes (and uncertainty as to how liability, if any, may be shared among the defendants), (iii) the proceedings are in their early stages and discovery is not complete, (iv) there are significant facts in dispute, (v) the matters present legal uncertainties, (vi) there is a wide range of potential outcomes in each dispute and (vii) there are various levels of judicial review available to us in each matter in the event damages are awarded or fines or penalties are assessed. Nevertheless, an adverse resolution of or development in the proceedings could have a material adverse affect on our financial condition, results of operations, cash flow and liquidity and could affect our reputation.

23

Litigation Related to the Sale of Businesses

We were a defendant in two related litigation matters pending in Louisiana and Texas state courts, both of which related to claims asserted by three separate state receivers overseeing the liquidation of three health plans in Louisiana, Texas and Oklahoma that were previously owned by our former subsidiary, Foundation Health Corporation (FHC), which merged into Health Net, Inc. in January 2001. In 1999, FHC sold its interest in these plans to AmCareco, Inc. (AmCareco). We retained a minority interest in the three plans after the sale. Thereafter, the three plans became known as AmCare of Louisiana (AmCare-LA), AmCare of Oklahoma (AmCare-OK) and AmCare of Texas (AmCare-TX). In 2002, three years after the sale of the plans to AmCareco, each of the AmCare plans was placed under state oversight and ultimately into receivership. The receivers for each of the AmCare plans filed suit against us, contending that we bore responsibility for the plans failing and ultimately being placed into receivership.

On June 16, 2005, a consolidated trial of the claims asserted against us by the three receivers commenced in state court in Baton Rouge, Louisiana. The claims of the receiver for AmCare-TX were tried before a jury and the claims of the receivers for the AmCare-LA and AmCare-OK were tried before the judge in the same proceeding. On June 30, 2005, the jury considering the claims of the receiver for AmCare-TX returned a verdict against us in the amount of $117.4 million, consisting of $52.4 million in compensatory damages and $65 million in punitive damages. The court later reduced the compensatory and punitive damages awards to $36.7 million and $45.5 million, respectively, and entered judgments against us in those amounts.

The proceedings regarding the claims of the receivers for AmCare-LA and AmCare-OK concluded on July 8, 2005. On November 4, 2005, the court issued separate judgments on those claims and awarded $9.5 million in compensatory damages to AmCare-LA and $17 million in compensatory damages to AmCare-OK, respectively. We appealed these judgments, and on December 30, 2008, the court of appeal issued its judgment on each of the appeals. It reversed in their entirety the trial court’s judgments in favor of the AmCare-TX and AmCare-OK receivers, and entered judgment in our favor against those receivers, finding that the receivers’ claims failed as a matter of law. The court of appeal also reversed the trial court judgment in favor of the AmCare-LA receiver, with the exception of a single breach of contract claim, on which it entered judgment in favor of the AmCare-LA receiver in the amount of $2 million.

Each of the receivers ultimately filed applications for a writ with the Louisiana Supreme Court, which were granted in 2009. On April 1, 2011, the Louisiana Supreme Court reinstated the original jury verdict in favor of the AmCare-TX receiver and affirmed the trial court’s judgment notwithstanding the verdict reducing the jury’s compensatory damages award. The Louisiana Supreme Court reversed the trial court’s judgment notwithstanding the verdict reducing the jury’s award of punitive damages to the AmCare-TX receiver. The Louisiana Supreme Court also reinstated the trial court’s judgments in favor of the AmCare-OK and AmCare-LA receivers. We filed a request for rehearing with the Louisiana Supreme Court, which was denied on April 29, 2011. On May 6, 2011, we filed a motion to stay enforcement on the portion of the judgment relating to the punitive damage award with the Louisiana Supreme Court, which was denied. We subsequently sought a stay of enforcement of the punitive damages award from the United States Supreme Court, which was also denied. As a result of the Louisiana Supreme Court’s decision, we recorded in general and administrative expenses a pretax charge of $177.2 million, or $157.9 million after tax, in the first quarter of 2011. During the quarter ended June 30, 2011, we fully satisfied the entirety of the judgment rendered by the Louisiana Supreme Court, paying a total of $181.3 million to the three receivers, inclusive of all accrued interest and court costs. Our net income per diluted share for the six months ended June 30, 2011 decreased by $1.72 due to the charges related to this judgment.

Miscellaneous Proceedings

In the ordinary course of our business operations, we are subject to periodic reviews, investigations and audits by various federal and state regulatory agencies with respect to our compliance with a wide variety of rules and regulations applicable to our business, including, without limitation, the Health Insurance Portability and Accountability Act of 1996, or HIPAA, rules relating to pre-authorization penalties, payment of out-of-network

24

claims, timely review of grievances and appeals, and timely and accurate payment of claims, any one of which may result in remediation of certain claims, contract termination, the loss of licensure or the right to participate in certain programs, and the assessment of regulatory fines or penalties, which could be substantial. From time to time, we receive subpoenas and other requests for information from, and are subject to investigations by, such regulatory agencies, as well as from state attorneys general. There also continues to be heightened review by regulatory authorities of, and increased litigation regarding, the health care industry’s business practices, including, without limitation, information privacy, premium rate increases, utilization management, appeal and grievance processing, rescission of insurance coverage and claims payment practices.

In addition, in the ordinary course of our business operations, we are party to various other legal proceedings, including, without limitation, litigation arising out of our general business activities, such as contract disputes, employment litigation, wage and hour claims, real estate and intellectual property claims, claims brought by members seeking coverage or additional reimbursement for services allegedly rendered to our members, but which allegedly were denied, underpaid, not timely paid or not paid, and claims arising out of the acquisition or divestiture of various business units or other assets. We are also subject to claims relating to the performance of contractual obligations to providers, members, employer groups and others, including the alleged failure to properly pay claims and challenges to the manner in which we process claims, and claims alleging that we have engaged in unfair business practices. In addition, we are subject to claims relating to information security incidents and breaches, reinsurance agreements, rescission of coverage and other types of insurance coverage obligations and claims relating to the insurance industry in general. We are, and may be in the future, subject to class action lawsuits brought against various managed care organizations and other class action lawsuits.

We intend to vigorously defend ourselves against the miscellaneous legal and regulatory proceedings to which we are currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against us, substantial non-economic or punitive damages are being sought.

We record reserves and accrue costs for certain legal proceedings and regulatory matters to the extent that we determine an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect our best estimate of the probable loss for such matters, our recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to that they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages, present novel legal theories, involve disputed facts, represent a shift in regulatory policy, involve a large number of parties, claimants or regulatory bodies, are in the early stages of the proceedings, or could result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding in the event damages are awarded or a fine or penalty is assessed. It is possible that in a particular quarter or annual period our financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including those described above in this Note 8 under the heading Litigation and Investigations Related to Unaccounted-for Server Drives,” depending, in part, upon our financial condition, results of operations, cash flow or liquidity in such period, and our reputation may be adversely affected. Except for the regulatory and legal proceedings discussed in this Note 8 under the heading “Litigation and Investigations Related to Unaccounted-for Server Drives,” management believes that the ultimate outcome of any of the regulatory and legal proceedings which are currently pending against us should not have a material adverse effect on our financial condition, results of operations, cash flow and liquidity.

Potential Settlements

We regularly evaluate legal proceedings and regulatory matters pending against us, including those described above in this Note 8, to determine if settlement of such matters would be in the best interests of the Company and its stockholders. The costs associated with any settlement of the various legal proceedings and

25

regulatory matters to which we are or may be subject from time to time, including those described above in this Note 8, could be substantial and, in certain cases, could result in a significant earnings charge in any particular quarter in which we enter into a settlement agreement and could have a material adverse effect on our financial condition, results of operations, cash flow and/or liquidity and may affect our reputation.

9.    CREDIT QUALITY OF FINANCING RECEIVABLES

As of June 30, 2011 and December 31, 2010, our financing receivables consisted of the following (amounts in millions):

	June 30, 2011		December 31, 2010
Amounts due for contingent membership renewals	$	41.3	$	33.8
Loans to health care providers		7.9		13.6

Amounts due for contingent membership renewals arose from the Northeast Sale (see Note 2). United is required to pay us additional consideration for the value of the Transitioning HNL Members and the members of the Acquired Companies that transitioned to other United products based on a formula set forth in the Stock Purchase Agreement to the extent such amounts exceeded the initial minimum payment of $60 million that United made to us at closing. This membership transition was completed on July 1, 2011. The receivable amount accrued as of December 31, 2010 was received in March 2011. The receivable amount as of June 30, 2011 is due in September 2011. Loans to health care providers are made from time to time to provide funding to certain health care providers and are generally due within twelve months from the time of the loan.

These financing receivables are considered past due if the required principal payments have not been received as of the date such payments were due. We do not accrue interest on these financing receivables, and interest income is recognized only to the extent any such cash payments are received. We had no past due financing receivables as of June 30, 2011 and December 31, 2010. Financing receivables are considered impaired when, based on current information and events, it is probable we will be unable to collect all amounts due in accordance with the original contractual terms of the agreement, including scheduled principal payments. Impairment is evaluated in total for smaller-balance receivables of a similar nature and on an individual receivable basis for other larger receivables. If a receivable is impaired, a specific valuation allowance is established. Impaired receivables, or portions thereof, are charged off when deemed uncollectible. We had no impaired receivables as of June 30, 2011 and December 31, 2010.

As part of the on-going monitoring of the credit quality of our financing receivables, we track and monitor certain credit quality indicators such as the counterparties’ credit rating and financial condition, including their capital strength, amount of leverage, and stability of earnings and growth. The counterparty for the amounts due for contingent membership renewals is investment grade and in strong financial condition. We believe that the counterparties for the loans to health care providers are of strong financial condition.

The allowance for possible bad debt is a reserve established through a bad debt provision charged to general and administrative expense, which represents our best estimate of probable losses that have been incurred within the existing receivables. The allowance, in our judgment, is necessary to reserve for estimated bad debt and risks inherent in the receivables. Our allowance for bad debt methodology is based on historical loss experience by type of credit and internal risk assessment, with adjustments for current events and conditions. The allowance for bad debt was not material as of June 30, 2011 and December 31, 2010.

26

10.    INCOME TAXES

The effective income tax rate was 34.1% and 42.1% for the three months ended June 30, 2011 and 2010, respectively, and (380.7)% and 41.5% for the six months ended June 30, 2011 and 2010, respectively. The change in the effective income tax rate from 2010 is primarily the result of the decision rendered in 2011 by the Louisiana Supreme Court in the AmCareco litigation (see Note 8). The decision resulted in deferred tax assets of $51.1 million for which realization is uncertain and as such, a valuation allowance for the full amount was established as of March 31, 2011.

11.    SUBSEQUENT EVENT

In November 2010, CMS imposed sanctions against us suspending the marketing to and enrollment of new members into all of our Medicare Advantage and stand-alone Prescription Drug Plan (PDP) products. These sanctions related to our compliance with certain Medicare rules and regulations. On August 1, 2011, CMS lifted its marketing and enrollment sanctions against us. We have resumed marketing of our Medicare Advantage and stand-alone PDP products and are enrolling beneficiaries with effective dates beginning September 1, 2011. We will participate in the upcoming annual enrollment period, which begins October 15, 2011 for January 1, 2012 enrollment. CMS continues to prohibit our stand-alone PDP products from receiving auto-assignment of low income subsidy (LIS) eligible Medicare beneficiaries under CMS’ LIS auto-assignment process. However, LIS members can make their own choice to enroll in our products during the upcoming annual enrollment period, or in the month they become eligible for PDP coverage.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

CAUTIONARY STATEMENTS

The following discussion and other portions of this Quarterly Report on Form 10-Q contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and Section 27A of the Securities Act of 1933, as amended, regarding our business, financial condition and results of operations. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. These forward-looking statements involve risks and uncertainties. All statements other than statements of historical information provided or incorporated by reference herein may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate” and “intend” and other similar expressions are intended to identify forward-looking statements. Managed health care companies operate in a highly competitive, constantly changing environment that is significantly influenced by, among other things, aggressive marketing and pricing practices of competitors and regulatory oversight. Factors that could cause our actual results to differ materially from those reflected in forward-looking statements include, but are not limited to, the factors set forth under the heading “Risk Factors” in our Form 10-K, as updated by our quarterly report on Form 10-Q for the quarter ended March 31, 2011, and the risks discussed in our other filings from time to time with the SEC.

Any or all forward-looking statements in this Form 10-Q and in any other public filings or statements we make may turn out to be incorrect. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many of the factors discussed in our filings with the SEC may impact future results. These factors should be considered in conjunction with any discussion of operations or results by us or our representatives, including any forward-looking discussion, as well as comments contained in press releases, presentations to securities analysts or investors or other communications by us or our representatives. You should not place undue reliance on any forward-looking statements, which reflect management’s analysis, judgment, belief or expectation only as of the date thereof. Except as may be required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that arise after the date of this report.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations, together with the consolidated financial statements included elsewhere in this report, should be read in their entirety since they contain detailed information that is important to understanding Health Net, Inc. and its subsidiaries’ results of operations and financial condition.

OVERVIEW

General

We are a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Our mission is to help people be healthy, secure and comfortable. We provide and administer health benefits to approximately 6.0 million individuals across the country through group, individual, Medicare Advantage, stand-alone Prescription Drug Plan (“PDP”) products, Medicaid, U.S. Department of Defense (“Department of Defense” or “DoD”), including TRICARE, and Veterans Affairs programs. Our behavioral health services subsidiary, Managed Health Network, Inc., provides mental health benefits to approximately 5.0 million individuals in all 50 states, including our own health plan members. Our subsidiaries also offer managed health care products related to prescription drugs, and offer managed health care product coordination for multi-region employers and administrative services for medical groups and self-funded benefits programs.

How We Report Our Results

We operate within three reportable segments, Western Region Operations, Government Contracts and Northeast Operations, each of which is described below.

28

Our health plan services are provided under our Western Region Operations reportable segment, which includes the operations primarily conducted in California, Arizona, Oregon and Washington of our commercial, Medicare and Medicaid health plans, our health and life insurance companies, and our behavioral health and pharmaceutical services subsidiaries. We have approximately 2.9 million medical members (including PDP members) in our Western Region Operations reportable segment.

Our Government Contracts segment includes our government-sponsored managed care federal contract with the DoD under the TRICARE program in the North Region and other health care related government contracts. On April 1, 2011, we began delivery of administrative services under a new Managed Care Support Contract (“T-3”) for the TRICARE North Region. The T-3 contract was awarded to us on May 13, 2010. Under the T-3 contract for the TRICARE North Region, we provide administrative services to approximately 3.1 million Military Health System (“MHS”) eligible beneficiaries. See Note 2 to our consolidated financial statements under the heading “T-3 TRICARE Contract” for additional information on the T-3 contract. We also provide behavioral health services to military families under the Department of Defense Military Family Life Counseling contract, which is included in our Government Contracts segment.

Prior to its conclusion on March 31, 2011, our previous TRICARE contract for the North Region was included in our Government Contracts segment. Under our previous TRICARE contract for the North Region, we provided health care services to approximately 3.1 million MHS eligible beneficiaries (active duty personnel and TRICARE/Medicare dual eligible beneficiaries), including 1.8 million TRICARE eligible beneficiaries for whom we provided health care and administrative services and 1.3 million other MHS eligible beneficiaries for whom we provided ASO.

For the three and six months ended June 30, 2011, our Northeast Operations reportable segment included the operations of our businesses that provided administrative services to United and its affiliates pursuant to the United Administrative Services Agreements prior to their termination on July 1, 2011 and the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Beginning July 1, 2011, our Northeast Operations reportable segment will include the operations of our businesses that are adjudicating run out claims and providing limited other administrative services to United and its affiliates pursuant to the Claims Servicing Agreements. For additional information on the Transitioning HNL Members, the United Administrative Services Agreements and the Claims Servicing Agreements, see Note 2 to our consolidated financial statements under the heading “Subsequent Accounting for the Northeast Sale.”

How We Measure Our Profitability

Our profitability depends in large part on our ability to, among other things, effectively price our health care products; manage health care costs and pharmacy costs; contract with health care providers; attract and retain members; and manage our general and administrative (“G&A”) and selling expenses. In addition, factors such as state and federal health care reform legislation and regulation, competition and general economic conditions affect our operations and profitability. The effect of escalating health care costs, as well as any changes in our ability to negotiate competitive rates with our providers, may impose further risks to our ability to profitably underwrite our business, and may have a material impact on our business, financial condition or results of operations.

We measure our Western Region Operations reportable segment profitability based on medical care ratio (“MCR”) and pretax income. The MCR is calculated as health plan services expense divided by health plan services premiums. The pretax income is calculated as health plan services premiums and administrative services fees and other income less health plan services expense and G&A and other net expenses. See “—Results of Operations—Western Region Operations Reportable Segment—Western Region Operations Segment Results” for a calculation of the MCR and pretax income.

Health plan services premiums include health maintenance organization (“HMO”), point of service (“POS”) and preferred provider organization (“PPO”) premiums from employer groups and individuals and from

29

Medicare recipients who have purchased supplemental benefit coverage (which premiums are based on a predetermined prepaid fee), Medicaid revenues based on multi-year contracts to provide care to Medicaid recipients, and revenue under Medicare risk contracts, including Medicare Part D, to provide care to enrolled Medicare recipients. Medicare revenue can also include amounts for risk factor adjustments and additional premiums that we charge in some places to members who purchase our Medicare risk plans. The amount of premiums we earn in a given period is driven by the rates we charge and enrollment levels. Administrative services fees and other income primarily include revenue for administrative services such as claims processing, customer service, medical management, provider network access and other administrative services. Health plan services expense includes medical and related costs for health services provided to our members, including physician services, hospital and related professional services, outpatient care, and pharmacy benefit costs. These expenses are impacted by unit costs and utilization rates. Unit costs represent the health care cost per visit, and the utilization rates represent the volume of health care consumption by our members.

G&A expenses include those costs related to employees and benefits, consulting and professional fees, marketing, premium taxes and assessments, occupancy costs and litigation and regulatory-related costs. Such costs are driven by membership levels, introduction of new products, system consolidations, outsourcing activities and compliance requirements for changing regulations, among other things. These expenses also include expenses associated with corporate shared services and other costs to reflect the fact that such expenses are incurred primarily to support health plan services. Selling expenses primarily consist of external broker commission expenses and generally vary with premium volume.

We measure our Government Contracts segment profitability based on pretax income, which is calculated as government contracts revenue less government contracts cost. See “—Results of Operations—Government Contracts Reportable Segment—Government Contracts Segment Results” for a calculation of the government contracts pretax income.

Under the T-3 contract for the TRICARE North Region, we provide various types of administrative services including: provider network management, referral management, medical management, disease management, enrollment, customer service, clinical support service, and claims processing. We also provide assistance in the transition into and out of the T-3 contract. These services are structured similar to administrative services only arrangements with fees received in the form of cost plus fixed price, and fixed unit price, and contingent fees and payments based on various incentives and penalties. We recognize revenue related to administrative services on a straight line basis over the option period, when the fees become fixed and determinable. The TRICARE North Region members are served by our network and out-of-network providers in accordance with the T-3 contract. We pay health care costs related to these services to the providers and are later reimbursed by the DoD for such payments. Under the terms of the T-3 contract, we are not the primary obligor for health care services and accordingly, we do not include health care costs and related reimbursements in our consolidated statement of operations. The contract also includes various performance-based incentives and penalties. For each of the incentives or penalties, we adjust revenue accordingly based on the amount that we have earned or incurred at each interim date and are legally entitled to in the event of a contract termination. See Note 2 to our consolidated financial statements under the heading “T-3 TRICARE Contract” for additional information on our T-3 contract.

Under our previous TRICARE contract for the North Region, which concluded on March 31, 2011, Government Contracts revenue was made up of two major components: health care and administrative services. The health care component included revenue recorded for health care costs for the provision of services to our members, including paid claims and estimated incurred but not reported claims (“IBNR”) expenses for which we were at risk, and underwriting fees earned for providing the health care and assuming underwriting risk in the delivery of care. The administrative services component encompassed fees received for all other services provided to both the government customer and to beneficiaries, including services such as medical management, claims processing, enrollment, customer services and other services unique to the managed care support contract with the government. Government Contracts revenue and expenses included the impact from underruns and overruns relative to our target cost under the applicable contracts.

30

We measure our Northeast Operations segment profitability based on pretax income. The pretax income is calculated as Northeast Operations segment total revenues, including Northeast administrative services fees, less Northeast segment total expenses, including Northeast administrative services expenses. Under the United Administrative Services Agreements, which terminated on July 1, 2011, we provided claims processing, customer services, medical management, provider network access and other administrative services to United and certain of its affiliates. Administrative services fees were recognized as revenue in the period services are provided. Upon the termination of the United Administrative Services Agreements, we entered into Claims Servicing Agreements with United and certain of its affiliates pursuant to which we will continue to adjudicate run out claims and perform limited other administrative services. For additional information on the United Administrative Services Agreements and the Claims Servicing Agreements, see Note 2 to our consolidated financial statements under the heading “Subsequent Accounting for the Northeast Sale.” See “—Results of Operations—Northeast Operations Reportable Segment Results” for a calculation of our pretax income.

Health Care Reform Legislation

During the first quarter of 2010, the President signed into law both the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the “ACA”), which is causing and will continue to cause significant changes to the U.S. health care system and alter the dynamics of the health care insurance industry. The provisions of the new legislation include, among others, imposing significant new taxes and fees on health insurers, including an excise tax on high premium insurance policies, stipulating a minimum medical loss ratio (as defined by the National Association of Insurance Commissioners (“NAIC”) and adopted by the Secretary of the U.S. Department of Health and Human Services (“HHS”)), new annual fees on companies in our industry which may not be deductible for income tax purposes, limiting Medicare Advantage payment rates, mandated additional benefits, elimination of medical underwriting for medical insurance coverage decisions, or “guaranteed issue,” increased restrictions on rescinding coverage, prohibitions on some annual and all lifetime limits on amounts paid on behalf of or to our members, requirements that limit the ability of health plans to vary premiums based on assessments of underlying risk, limitations on the amount of compensation paid to health insurance executives that is tax deductible, additional regulations governing premium rate increase requests, requirements that individuals obtain coverage and the creation of government controlled “exchanges” where individuals and small business groups may purchase health coverage.

Some provisions of the health care reform legislation became effective in 2010, including those that increase the restrictions on rescinding coverage, those that bar health insurance companies from placing lifetime limits on “essential benefits,” which are only partially defined, those that prohibit annual limits below specified caps for essential benefits for some benefit plans and those that require health plans to cover certain out-of-network services with no additional co-pay to their enrollees. Some provisions that significantly increase federal regulation of the handling of appeals and grievances were to become effective in 2010, but enforcement of some of the provisions was postponed until July 1, 2011 and a subset of those again until January 1, 2012. Some of the potentially more significant changes, including the annual fees on health insurance companies, the excise tax on high premium insurance policies, the guaranteed issue requirements, the requirement that individuals obtain coverage, and the creation of exchanges, as described above, do not become effective until 2014 or later. Implementation of other provisions generally varies from as early as enactment or six months from the date of enactment to as late as 2018. In advance of the September 2010 federal implementation date, we voluntarily provided the option of continuing coverage for adult dependents up to age 26 who are currently enrolled on their parents’ health care policies. In addition, we reaffirmed our existing policy against rescinding members without approval from an external third-party reviewer, which has been in effect since 2007.

Various aspects of the health care reform legislation could have an adverse impact on our revenues enrollment and premium growth in certain products and market segments and the cost of operating our business. For example, the new legislation will lower the rates of Medicare payments we receive, may make it more difficult for us to attract and retain members, increase the amount of certain taxes and fees we pay, impose a sales tax on medical device manufacturers and increase the amount of fees pharmaceutical manufacturers pay (both of which in turn could increase

31

our medical costs), require rebates related to minimum medical loss ratios and require premium rate review. We could also face additional competition as competitors seize on opportunities to expand their business as a result of the new legislation, though there remains considerable uncertainty about the impact of these changes on the health insurance market as a whole and what actions our competitors could take. The response of other companies to the ACA and related adjustments to their offerings, if any, could cause meaningful disruption in the local health care markets. For example, companies could modify their product features or benefits, change their pricing, adjust their mix of business or even exit segments of the market. Companies could also seek to adjust their operating costs to support reduced premiums by making changes to their distribution arrangements or decreasing spending on non-medical product features and services. Because of the magnitude, scope and complexity of the new legislation, we also need to dedicate substantial resources and incur material expenses to implement the new legislation, including implementing the current and future regulations that will provide guidance and clarification on important parts of the legislation. Any delay or failure by us to execute our operational and strategic initiatives with respect to health care reform or otherwise appropriately react to the new legislation and implementing regulations could result in operational disruptions, disputes with our providers or members, regulatory issues, damage to our existing or potential member relationships or other adverse consequences. Moreover, there are numerous steps required to implement this new legislation, with clarifying regulations and other guidance expected over several years.

New guidance on certain other provisions of the federal reform legislation has been issued (for example, guidance relating to guaranteed issuance of coverage to children under age 19, coverage for preventive health services without cost-sharing, lifetime and annual limits, rescissions and patient protections and most recently on rate review of unreasonable rates), but we are still awaiting further final guidance on a number of key topics such as essential benefits, the application of the health insurer fee, and federal criteria for participation in state-based exchanges (Notices of Proposed Rulemaking were issued by HHS on July 15, 2011 regarding the establishment of exchanges and standards for states related to reinsurance, risk corridors and risk adjustment) among others. On April 7, 2011, HHS released proposed new rules under the ACA on Accountable Care Organizations (“ACOs”) and the Medicare Shared Savings Program. These new rules are intended to create incentives for health care providers to work together to treat an individual across different care settings. The impact of these new rules on the healthcare market and the role to be played by health plans in the creation and operation of ACOs remains to be determined. Though the federal government has issued interim final regulations, there remains considerable uncertainty around the ultimate requirements of the legislation, as the interim final regulations are sometimes unclear or incomplete, and are subject to further change. The federal government has also issued additional forms of “guidance” that may not be consistent with the interim final regulations. As a result, many of the impacts of health care reform will not be known for certain until the ultimate requirements of the legislation have been definitively determined.

In addition to new federal regulations, various health insurance reform proposals are also emerging at the state level. Many of the states in which we operate are already implementing parts of the federal health care reform and many states have added new requirements that exceed the federal health care reform requirements, such as prior approval of rates. Some states have passed legislation or are considering proposals to establish an insurance exchange within the state to comply with provisions of the health care reform legislation that become effective in 2014. For example, California recently passed legislation establishing a state-based insurance exchange and authorizing an oversight board to negotiate the price of plans sold on the insurance exchange. This could increase the pressure on us to contain our premium prices and thereby could negatively impact our revenues and profitability. This legislation also could increase the competition we face from companies that have lower health care or administrative costs than we do and therefore can price their premiums at lower levels than we can. California is the first state to adopt such a structure for a state-based insurance exchange in response to the ACA. If other states in which we operate adopt a similar format for their exchanges, that could further increase the competition that we face and the pressure on us to contain our premiums. At least some states and possibly the federal government may condition health carrier participation in an exchange on a number of factors, which could mean that some carriers would be excluded from participation. In addition, legislation under consideration in California (“SB 703”) would create a Basic Health Plan (“BHP”), which is authorized, but not required by the ACA, and would be administered by the Managed Risk Medical Insurance Board. If this legislation is enacted in its current form, individuals with incomes between 133% and 200% of the federal poverty limit would be required to enroll in the BHP and would

32

receive a premium subsidy from the federal government. Federal law prohibits states with a BHP from allowing these individuals to enroll in the state exchanges, so the number of individuals eligible for the exchange would be reduced by the number of individuals receiving coverage in the BHP. We are evaluating the potential impact of a BHP in California on us should SB 703 be signed into law. Even in cases where state action is limited to implementing federal reforms, new or amended state laws will be required in many cases. States also may disagree in their interpretations of the federal statute and regulations, and state “guidance” that is issued could be unclear or untimely. The interaction of new federal regulations and the implementation efforts of the various states in which we do business will create substantial uncertainty for us and other health insurance companies about the requirements under which we must operate.

Adding to the uncertainty, there also have been Congressional and legal challenges to federal health care reform that, if ultimately successful, could result in changes to the existing legislation or the repeal of ACA in its entirety. In early 2011, a majority of the U.S. House of Representatives voted in favor of repealing the federal health care reform legislation. A similar proposal was voted on by the U.S. Senate, but failed by a vote of 47 to 51. Most of the bills proposed to repeal or replace certain provisions of ACA do not have bipartisan and bicameral support, and are not expected to be signed into law by the current President. However, earlier this year the President signed legislation that repeals the ACA provision which would have required businesses to file 1099 tax forms for purchases over $600. The President also signed legislation to eliminate $2.2 billion of the $6 billion in start-up funding that the ACA provided to support the launch of health insurance cooperatives, and Congress may also withhold the funding necessary to implement the ACA. In addition, some recent U.S. District Court cases have found that all or part of ACA is unconstitutional. For example, in December 2010, the U.S. District Court for the Eastern District of Virginia ruled that ACA’s mandate that U.S. citizens purchase health insurance, or the individual mandate, is unconstitutional. In January 2011, the U.S. District Court for the Northern District of Florida found the individual mandate provision unconstitutional and declared the entire statute to be invalid. On the other hand, other U.S. District Courts have upheld the law. On June 29, 2011, the Sixth Circuit Court of Appeals upheld the constitutionality of the individual mandate provision. It is expected that the constitutionality of the individual mandate and ACA itself will be ultimately decided by the U.S. Supreme Court. Additionally, in California, the ongoing state budget deficits continue to threaten funding for the current Medicaid program and Children’s Health Insurance Program, and the future expansion of these programs authorized by federal health care reform is uncertain.

Due to the unsettled nature of these reforms and the numerous steps required to implement them, we cannot predict how future regulations and laws, including state laws, implementing the new legislation will impact our business. As a result, although we continue to evaluate the impacts of the new legislation, it could have a material adverse effect on our business, financial condition and results of operations.

In addition, federal and state governmental authorities also are considering additional legislation and regulations that could negatively impact us. Among other potential new laws and regulations, state regulators are considering new requirements that would restrict our ability to implement changes to our premium rates. On May 19, 2011, HHS issued a final rule providing that HHS will perform rate reviews for states that are determined by HHS not to have an “effective review process”, in place for proposed premium rate increases. Anzona is one of the states determined by HHS not to have “effective review processes” currently in place. These changes could, among other things, lower the amount of premium increases we receive or extend the amount of time that it takes for us to obtain regulatory approval to implement increases in our premium rates. In addition, state regulators could impose standards that are more stringent than those required under the ACA. For example, earlier this year, the California Department of Insurance passed emergency regulations requiring immediate compliance with the ACA minimum medical loss ratio requirements. Also, many states may continue to consider legislation to extend coverage to the uninsured through Medicaid expansions, mandate minimum medical loss ratios, implement rate reforms and enact benefit mandates that go beyond essential benefits. We cannot predict whether additional legislation or regulations will be enacted at the federal and state levels, and if they are, what provisions they will contain or what effect they will have on us. As a result, additional federal and state legislation and regulations could have a material adverse effect on our business, cash flows, financial condition and results of operations.

33

Recent Developments

In November 2010, CMS imposed sanctions against us suspending the marketing to and enrollment of new members into all of our Medicare Advantage and stand-alone Prescription Drug Plan (“PDP”) products. These sanctions related to our compliance with certain Medicare rules and regulations. On August 1, 2011, CMS lifted its marketing and enrollment sanctions against us. We have resumed marketing of our Medicare Advantage and stand-alone PDP products and are enrolling beneficiaries with effective dates beginning September 1, 2011. We will participate in the upcoming annual enrollment period, which begins October 15, 2011 for January 1, 2012 enrollment. CMS continues to prohibit our stand-alone PDP products from receiving auto-assignment of low income subsidy (LIS) eligible Medicare beneficiaries under CMS’ LIS auto-assignment process. However, LIS members can make their own choice to enroll in our products during the upcoming annual enrollment period, or in the month they become eligible for PDP coverage.

RESULTS OF OPERATIONS

Consolidated Results

The table below and the discussion that follows summarize our results of operations for the three and six months ended June 30, 2011 and 2010.

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in thousands, except per share data)
Revenues
Health plan services premiums	$	2,566,719		$	2,507,318		$	5,179,103		$	5,034,825
Government contracts		171,015			851,939			1,046,142			1,661,398
Net investment income		25,091			16,567			48,926			36,489
Administrative services fees and other income		2,084			1,837			4,805			10,693
Northeast administrative services fees and other		11,021			59,301			23,470			109,661
Total revenues		2,775,930			3,436,962			6,302,446			6,853,066
Expenses
Health plan services (excluding depreciation and amortization)		2,231,278			2,163,191			4,513,612			4,374,447
Government contracts		130,828			811,386			952,980			1,583,288
General and administrative		219,029			237,378			645,390			484,474
Selling		57,571			56,574			118,262			115,405
Depreciation and amortization		8,953			8,466			17,781			17,129
Interest		8,238			8,761			15,858			18,645
Northeast administrative services expenses		37,825			71,951			90,080			153,829
Adjustment to loss on sale of Northeast health plan subsidiaries		(6,283	)		(8,171	)		(41,137	)		(8,171	)
Asset impairment		0			6,000			0			6,000
Early debt extinguishment charge		0			3,532			0			3,532
Total expenses		2,687,439			3,359,068			6,312,826			6,748,578
Income (loss) from operations before income taxes		88,491			77,894			(10,380	)		104,488
Income tax provision		30,191			32,828			39,515			43,332
Net income (loss)	$	58,300		$	45,066		$	(49,895	)	$	61,156
Net income (loss) per share:
Basic	$	0.64		$	0.46		$	(0.54	)	$	0.61
Diluted	$	0.63		$	0.45		$	(0.54	)	$	0.61

34

For the three and six months ended June 30, 2011, we reported net income of $58.3 million or $0.63 per diluted share and a net loss of $(49.9) million or $(0.54) per share, respectively, as compared to net income of $45.1 million or $0.45 per diluted share and $61.2 million or $0.61 per diluted share, respectively, for the same periods in 2010. Pretax margins were 3.2 percent and (0.2) percent for the three and six months ended June 30, 2011, respectively, compared to 2.3 percent and 1.5 percent for the same periods in 2010, respectively.

Our total revenues decreased 19.2 percent in the three months ended June 30, 2011 to $2.8 billion from $3.4 billion in the same period in 2010 and decreased 8.0 percent in the six months ended June 30, 2011 to $6.3 billion from $6.9 billion in the same period in 2010. Health plan services premium revenues increased by approximately 2.4 percent to $2.6 billion and by approximately 2.9 percent to $5.2 billion in the three and six months ended June 30, 2011, respectively, compared with $2.5 billion and $5.0 billion in the three and six months ended June 30, 2010, respectively. Health plan services expenses were $2.2 billion in the three months ended June 30, 2011 and 2010. Health plan services expenses increased from $4.4 billion in the six months ended June 30, 2010 to $4.5 billion in the six months ended June 30, 2011. Investment income increased to $25.1 million and $48.9 million in the three and six months ended June 30, 2011, respectively, compared with $16.6 million and $36.5 million in the three and six months ended June 30, 2010, respectively.

Our Government Contracts revenues decreased by approximately 79.9 percent in the three months ended June 30, 2011 to $171.0 million from $851.9 million in the same period of 2010, and by approximately 37.0 percent in the six months ended June 30, 2011 to $1,046.1 million from $1,661.4 million in the same period of 2010. The decline in our Government contracts revenue is due to our new T-3 contract for the TRICARE North Region that commenced on April 1, 2011. For additional information on our T-3 contract, see “—Government Contracts Reportable Segment.”

Our operating results for the six months ended June 30, 2011 were impacted by a $181 million pretax, or $158 million after-tax, charge incurred as a result of the Louisiana Supreme Court’s decision rendered on April 1, 2011 in connection with the AmCareco litigation. See Note 8 to our consolidated financial statements for additional information regarding the AmCareco litigation and the Louisiana Supreme Court’s decision. These charges were recorded as part of our G&A expenses. In addition, our operating results for the three and six months ended June 30, 2011 were impacted by a $6.3 million and $41.1 million, respectively, favorable adjustment to loss on sale of Northeast health plan subsidiaries, partially offset by pretax costs of $2.4 million and $13.4 million, respectively, related to our cost management initiatives.

Our operating results for the three and six months ended June 30, 2010 were impacted by $33.9 million and $48.4 million, respectively, in pretax costs related to our operations strategy, other cost management initiatives and early debt extinguishment and termination of a related interest rate swap, reduced by a $21.6 million benefit from a litigation reserve true-up in the three and six months ended June 30, 2010. See “—Corporate/Other” for further discussion on these charges.

Days Claims Payable

Days claims payable (“DCP”) for the second quarter of 2011 was 36.7 days compared with 39.3 days in the second quarter of 2010. On an adjusted basis (adjusting to exclude capitation, provider and other claim settlements and Medicare Advantage-Prescription Drug (“MAPD”) and stand-alone PDP payables/costs), DCP in the second quarter of 2011 was 52.0 days compared with 53.6 days in the second quarter of 2010. Set forth below is a reconciliation of adjusted DCP, a non-GAAP financial measure, to the comparable GAAP financial measure, DCP.

DCP is calculated by dividing the amount of reserve for claims and other settlements (“Claims Reserve”) by health plan services cost (“Health Plan Costs”) during the quarter and multiplying that amount by the number of days in the quarter. The following table presents an adjusted DCP metric which subtracts capitation, provider and other claim settlements and MAPD and stand-alone PDP payables/costs from the Claims Reserve and Health Plan Costs. Management believes that adjusted DCP provides useful information to investors because the

35

adjusted DCP calculation excludes from both Claims Reserve and Health Plan Costs amounts related to health care costs for which no or minimal reserves are maintained. Therefore, management believes that adjusted DCP may present a more accurate reflection of DCP calculated from claims-based reserves than does GAAP DCP, which includes such costs. This non-GAAP financial information should be considered in addition to, not as a substitute for, financial information prepared in accordance with GAAP. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating the adjusted amounts, you should be aware that we have incurred expenses that are the same as or similar to some of the adjustments in the current presentation and we may incur them again in the future. Our presentation of the adjusted amounts should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

	Three Months Ended June 30,
	2011			2010
	(Dollars in millions)
Reconciliation of Days Claims Payable:
(1) Reserve for Claims and Other Settlements	$	900.7		$	934.9
Less: Capitation, Provider and Other Claim Settlements and MAPD and stand-alone PDP Payables		(121.0	)		(155.6	)
(2) Reserve for Claims and Other Settlements—Adjusted	$	779.7		$	779.3
(3) Health Plan Services Cost	$	2,231.3		$	2,163.2
Less: Capitation, Provider and Other Claim Settlements and MAPD and stand-alone PDP Costs		(867.8	)		(839.0	)
(4) Health Plan Services Cost—Adjusted	$	1,363.5		$	1,324.2
(5) Number of Days in Period		91			91
= (1) / (3) * (5) Days Claims Payable—(using end of period reserve amount)		36.7			39.3
= (2) / (4) * (5) Days Claims payable—Adjusted (using end of period reserve amount)		52.0			53.6

Income Tax Provision

Our income tax expense and the effective income tax rate for the three and six months ended June 30, 2011 and 2010 are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in millions)
Income tax expense	$	30.2		$	32.8		$	39.5		$	43.3
Effective income tax rate		34.1	%		42.1	%		(380.7	%)		41.5	%

The effective income tax rate differs from the statutory federal tax rate of 35% for the three and six months ended June 30, 2011 and June 30, 2010 due to state income taxes and tax-exempt investment income. In addition, during the six months ended June 30, 2011, the effective income tax rate was impacted by the effect of a valuation allowance against deferred tax assets established as a result of the decision rendered in 2011 by the Louisiana Supreme Court in the AmCareco litigation (see Note 8 to our consolidated financial statements). Also, during the three and six months ended June 30, 2010, the effective income tax rate included an adjustment for the impairment of non-deductible goodwill that did not recur in the same periods in 2011.

Western Region Operations Reportable Segment

Our Western Region Operations segment includes the operations of our commercial, Medicare and Medicaid health plans, the operations of our health and life insurance companies primarily in California, Arizona, Oregon and Washington and our behavioral health and pharmaceutical services subsidiaries in several states including Arizona, California and Oregon.

36

Western Region Operations Segment Membership (in thousands)

	June 30, 2011		June 30, 2010		Increase/ (Decrease)			% Change
California
Large Group		834		836		(2	)		(0.2	)%
Small Group and Individual		328		355		(27	)		(7.6	)%
Commercial Risk		1,162		1,191		(29	)		(2.4	)%
ASO		0		5		(5	)		(100.0	)%
Total Commercial		1,162		1,196		(34	)		(2.8	)%
Medicare Advantage		125		132		(7	)		(5.3	)%
Medi-Cal/Medicaid		963		877		86			9.8	%
Total California		2,250		2,205		45			2.0	%
Arizona
Large Group		75		53		22			41.5	%
Small Group and Individual		56		39		17			43.6	%
Commercial Risk		131		92		39			42.4	%
Medicare Advantage		41		49		(8	)		(16.3	)%
Total Arizona		172		141		31			22.0	%
Oregon (including Washington)
Large Group		49		52		(3	)		(5.8	)%
Small Group and Individual		42		47		(5	)		(10.6	)%
Commercial Risk		91		99		(8	)		(8.1	)%
Medicare Advantage		39		38		1			2.6	%
Total Oregon (including Washington)		130		137		(7	)		(5.1	)%
Total Health Plan Enrollment
Large Group		958		941		17			1.8	%
Small Group and Individual		426		441		(15	)		(3.4	)%
Commercial Risk		1,384		1,382		2			0.1	%
ASO		0		5		(5	)		(100.0	)%
Total Commercial		1,384		1,387		(3	)		(0.2	)%
Medicare Advantage		205		219		(14	)		(6.4	)%
Medi-Cal/Medicaid		963		877		86			9.8	%
Medicare PDP (stand-alone)		389		434		(45	)		(10.4	)%
		2,941		2,917		24			0.8	%

Total Western Region Operations enrollment at June 30, 2011 was approximately 2.9 million members, an increase of 0.8 percent compared with enrollment at June 30, 2010. Total enrollment in our California health plans increased by 2.0 percent to approximately 2.3 million members from June 30, 2010 to June 30, 2011.

Western Region Operations commercial enrollment was flat at approximately 1.4 million members as of June 30, 2010 and 2011. Enrollment in our large group segment increased by 1.8 percent or 17,000 members to 958,000 members at June 30, 2011. Enrollment in our small group and individual segment in the Western Region Operations decreased by 3.4 percent, from 441,000 members at June 30, 2010 to 426,000 members at June 30, 2011, consistent with the overall weak employment levels Membership in an tailored network products increased by 48.2 percent, or 137,000 members, from June 30, 2010 to June 30, 2011. As of June 30, 2011, tailored network products accounted for 31 percent of our Western Region Operations commercial enrollment compared with 21 percent at June 30, 2010. For additional information on our tailored network products, see Part I, Item 1. Business—Segment Information—Western Region Operations Segment—Managed Health Care Operations of the Form 10-K.

37

Enrollment in our Medicare Advantage plans in the Western Region Operations at June 30, 2011 was 205,000 members, a decrease of 6.4 percent compared with June 30, 2010. The decline in Medicare Advantage membership was due to a loss of 8,000 members in Arizona and 7,000 members in California, partially offset by a gain of 1,000 members in Oregon. Membership in our stand-alone Medicare PDP products was 389,000 at June 30, 2011, a 10.4 percent decrease compared with June 30, 2010. This decline in Medicare membership was primarily driven by sanctions imposed against us by CMS.

In November 2010, CMS imposed sanctions against us suspending the marketing to and enrollment of new members into all of our Medicare Advantage and stand-alone PDP products. These sanctions related to our compliance with certain Medicare rules and regulations. On August 1, 2011, CMS lifted the sanctions, and we resumed marketing our Medicare Advantage and stand-alone PDP products and enrolling beneficiaries with effective dates on or after September 1, 2011. While we could not enroll new members into these products until CMS lifted these sanctions, the enrollment status of our existing members, including Medicare Advantage and stand-alone PDP members, was not impacted by the sanctions. During the period of the sanctions, we continued to provide benefits to and serve our existing Medicare Advantage and stand-alone PDP members. Our stand-alone PDP products are offered in 49 states and the District of Columbia.

We participate in the state Medicaid program in California, where the program is known as Medi-Cal. Medi-Cal enrollment increased by 86,000 members or 9.8 percent to 963,000 members as of June 30, 2011 compared with June 30, 2010. We attribute the increase in Medicaid enrollment to an increase in the Medicaid-eligible population due to continuing high unemployment and depressed economic conditions.

Our subsidiary, Health Net of California, Inc. (“HN California”), participates in the Children’s Health Insurance Program (“CHIP”), which, in California, is known as the Healthy Families program. Commencing with the 2011-12 Healthy Families benefit year that starts October 1, 2011, HN California will no longer be offering the Healthy Families EPO product. As a result, approximately 1,500 Healthy Families EPO members will transition to other carriers in the counties we serve with this product. In addition, the HN California will no longer be offering the Healthy Families HMO in Marin County, California, resulting in approximately 580 members being transitioned to other carriers.

38

Western Region Operations Segment Results

The following table summarizes the operating results for our Western Region Operations segment for the three and six months ended June 30, 2011 and June 30, 2010:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in thousands, except PMPM data)
Health plan services premiums	$	2,566,393		$	2,484,282		$	5,176,773		$	4,986,640
Investment income		10,428			12,296			21,904			25,019
Gain on sale of investments		14,653			4,028			26,951			10,882
Administrative services fees and other income		2,084			7,275			4,805			16,107
Total revenues		2,593,558			2,507,881			5,230,433			5,038,648
Health plan services		2,231,738			2,164,164			4,513,174			4,354,057
General and administrative		214,779			212,699			456,735			436,576
Selling		57,503			55,750			118,090			113,475
Depreciation and amortization		8,947			8,448			17,769			17,069
Interest		8,053			8,761			15,673			18,645
Total expenses		2,521,020			2,449,822			5,121,441			4,939,822
Income from operations before income taxes		72,538			58,059			108,992			98,826
Income tax provision		26,870			21,967			40,346			37,346
Net income	$	45,668		$	36,092		$	68,646		$	61,480
Pretax margin		2.8	%		2.3	%		2.1	%		2.0	%
Commercial premium yield		4.7	%		9.3	%		5.2	%		8.8	%
Commercial premium PMPM (d)	$	356.51		$	340.38		$	356.06		$	338.40
Commercial health care cost trend		4.0	%		9.1	%		4.5	%		8.7	%
Commercial health care cost PMPM (d)	$	305.63		$	293.81		$	305.24		$	292.13
Commercial MCR (e)		85.7	%		86.3	%		85.7	%		86.3	%
Medicare Advantage MCR (e)		90.9	%		88.5	%		90.0	%		88.3	%
Medicare PDP (stand-alone) MCR (e)		87.4	%		85.9	%		95.2	%		91.8	%
Medicaid MCR (e)		85.2	%		88.5	%		85.1	%		87.7	%
Health plan services MCR (a)		87.0	%		87.1	%		87.2	%		87.3	%
G&A expense ratio (b)		8.4	%		8.5	%		8.8	%		8.7	%
Selling costs ratio (c)		2.2	%		2.2	%		2.3	%		2.3	%

(a) MCR is calculated as health plan services cost divided by health plan services premiums revenue.

(b) The G&A expense ratio is computed as G&A expenses divided by the sum of health plan services premiums and administrative services fees and other income.

(c) The selling costs ratio is computed as selling expenses divided by health plan services premiums revenue.

(d) PMPM is calculated based on commercial at-risk member months and excludes ASO member months.

(e) MCR is calculated as commercial, Medicare Advantage, Medicare PDP (stand-alone) or Medicaid health care cost divided by commercial, Medicare Advantage, Medicare PDP (stand-alone) or Medicaid premiums, as applicable.

Revenues

Total revenues in the Western Region Operations increased 3.4 percent to $2.6 billion for the three months ended June 30, 2011 and increased 3.8 percent to $5.2 billion for the six months ended June 30, 2011, compared to the same periods in 2010. Health plan services premiums in the Western Region Operations increased 3.3 percent to $2.6 billion for the three months ended June 30, 2011 and increased 3.8 percent to $5.2 billion for the six months ended June 30, 2011, compared to the same periods in 2010.

39

Investment income in the Western Region Operations increased to $25.1 million for the three months ended June 30, 2011 from $16.3 million for the same period in 2010 due to an increase in realized gains. Investment income in the Western Region Operations increased to $48.9 million for the six months ended June 30, 2011 from $35.9 million for the same period in 2010 due to an increase in realized gains.

Health Plan Services Expenses

Health plan services expenses in the Western Region Operations were $2.2 billion and $4.5 billion for the three and six months ended June 30, 2011, respectively, compared to $2.2 billion and $4.4 billion for the three and six months ended June 30, 2010, respectively.

Commercial Premium Yield and Health Care Cost Trends

In the Western Region Operations, commercial premium yields per member per month (“PMPM”) increased by 4.7 percent to approximately $357 during the three months ended June 30, 2011 compared to an increase of 9.3 percent to approximately $340 during the same period of 2010, and increased by 5.2 percent to approximately $356 during the six months ended June 30, 2011 compared to an increase of 8.8 percent to approximately $338 for the same period of 2010.

Commercial health care costs PMPM in the Western Region Operations increased by 4.0 percent to approximately $306 during the three months ended June 30, 2011 compared to an increase of 9.1 percent to approximately $294 during the same period of 2010, and increased by 4.5 percent to approximately $305 during the six months ended June 30, 2011 compared to an increase of 8.7 percent to approximately $292 during the same period of 2010.

Medical Care Ratios

The health plan services MCR in the Western Region Operations was 87.0 percent and 87.2 percent for the three and six months ended June 30, 2011, respectively, compared with 87.1 and 87.3 percent for the three and six months ended June 30, 2010, respectively.

The Western Region Operations commercial MCR was 85.7 percent for the three and six months ended June 30, 2011, compared with 86.3 percent for the three and six months ended June 30, 2010.

The Medicare Advantage MCR in the Western Region Operations was 90.9 percent and 90.0 percent for the three and six months ended June 30, 2011, respectively, compared with 88.5 percent and 88.3 percent for the three and six months ended June 30, 2010, respectively. The Medicare PDP (stand-alone) MCR was 87.4 percent and 95.2 percent for the three and six months ended June 30, 2011, respectively, compared with 85.9 percent and 91.8 percent for the same periods in 2010. These increases are due to the adverse effect of limited new member growth.

The Medicaid MCR was 85.2 percent and 85.1 percent for the three and six months ended June 30, 2011, respectively, compared with 88.5 percent and 87.7 percent for the three and six months ended June 30, 2010, respectively. These decreases are due to an increase in the premium yield outpacing the increase in the health care cost trend.

G&A, Selling and Interest Expenses

G&A expense in the Western Region Operations was $214.8 million and $456.7 million for the three and six months ended June 30, 2011, respectively, compared with $212.7 million and $436.6 million for the three and

40

six months ended June 30, 2010, respectively. The G&A expense ratio decreased 10 basis points from 8.5 percent for the three months ended June 30, 2010 to 8.4 percent for the three months ended June 30, 2011. The G&A expense ratio increased 10 basis points from 8.7 percent for the six months ended June 30, 2010 to 8.8 percent for the six months ended June 30, 2011.

Selling expense in our Western Region Operations was $57.5 million and $118.1 million for the three and six months ended June 30, 2011, respectively, compared with $55.8 million and $113.5 million for the three and six months ended June 30, 2010, respectively. The selling costs ratio was 2.2 percent and 2.3 percent for the three and six months ended June 30, 2011, respectively, compared with 2.2 percent and 2.3 percent for the three and six months ended June 30, 2010, respectively.

Interest expense was $8.1 million and $15.7 million for the three and six months ended June 30, 2011, respectively, compared with $8.8 million and $18.6 million for the three and six months ended June 30, 2010, respectively. The decline is due to the retirement of our amortizing financing facility in May 2010 (see “—Liquidity and Capital Resources—Capital Structure—Termination of Amortizing Financing Facility” for additional information), offset by higher borrowings under our revolving credit facility.

Government Contracts Reportable Segment

On April 1, 2011, we began delivery of administrative services under our T-3 contract for the TRICARE North Region. The T-3 contract was awarded to us on May 13, 2010. Under the T-3 contract for the TRICARE North Region, we provide administrative services to approximately 3.1 million MHS eligible beneficiaries (active duty personnel and TRICARE/Medicare dual eligible beneficiaries) as of June 30, 2011.

Under the T-3 contract for the TRICARE North Region, we provide various types of administrative services including: provider network management, referral management, medical management, disease management, enrollment, customer service, clinical support service, and claims processing. We also provide assistance in the transition into and out of the T-3 contract. These services are structured similar to administrative services only arrangements with fees received in the form of cost plus fixed price and fixed unit price, and contingent fees and payments based on various incentives and penalties. We recognize revenue related to administrative services on a straight line basis over the option period, when the fees become fixed and determinable. The T-3 members are served by our network and out-of-network providers in accordance with the T-3 contract. We pay health care costs related to these services to the providers and are later reimbursed by the DoD for such payments. Under the terms of the T-3 contract, we are not the primary obligor for health care services and accordingly, we do not include health care costs and related reimbursements in our consolidated statement of operations. The contract also includes various performance-based incentives and penalties. For each of the incentives or penalties, we adjust revenue accordingly based on the amount that we have earned or incurred at each interim date and are legally entitled to in the event of a contract termination.

In addition, responsibility for the delivery of services for the Fort Campbell area of Kentucky and Tennessee has been realigned from the TRICARE North Region to the TRICARE South Region, as expected, as a result of the recent T-3 contract award for the TRICARE South Region. Consequently, effective April 1, 2012 we will no longer be responsible for servicing the approximately 105,000 eligible beneficiaries in the Fort Campbell area under our T-3 contract. See Note 2 to our consolidated financial statements under the heading “T-3 TRICARE Contract” for additional information on the T-3 contract.

Under our previous TRICARE contract for the North Region, we provided health care services to approximately 3.1 million eligible beneficiaries in the MHS as of June 30, 2010. Included in the 3.1 million eligible beneficiaries as of June 30, 2010 were 1.8 million TRICARE eligible beneficiaries for whom we provided health care and administrative services and 1.3 million other MHS eligible beneficiaries for whom we provided administrative services only. As of June 30, 2010, there were approximately 1.5 million TRICARE eligible beneficiaries enrolled in TRICARE Prime under our North Region contract. Our TRICARE North Region contract ended on March 31, 2011.

41

In addition to the beneficiaries that we service under the T-3 contract, we administer contracts with the U.S. Department of Veterans Affairs to manage community based outpatient clinics in eight states covering approximately 20,000 enrollees.

Government Contracts Segment Results

The following table summarizes the operating results for the Government Contracts segment for the three and six months ended June 30, 2011 and 2010:

	Three Months Ended June  30,				Six Months Ended June 30,
	2011		2010		2011		2010
			(Dollars in thousands)
Government contracts revenues	$	171,015	$	851,939	$	1,046,142	$	1,661,398
Government contracts costs		130,802		810,466		948,101		1,581,902
Income from operations before income taxes		40,213		41,473		98,041		79,496
Income tax provision		16,341		17,042		39,730		32,545
Net income	$	23,872	$	24,431	$	58,311	$	46,951

Government contracts revenues decreased by $680.9 million, or 79.9 percent, for the three months ended June 30, 2011 and by $615.3 million, or 37.0 percent, for the six months ended June 30, 2011 as compared to the same periods in 2010. Government contracts costs decreased by $679.7 million, or 83.9 percent for the three months ended June 30, 2011 and by $633.8 million, or 40.1 percent for the six months ended June 30, 2011 as compared to the same periods in 2010. These declines were primarily due to the impact of the new T-3 contract for the TRICARE North Region, under which health care costs and related reimbursements are excluded from our consolidated statement of operations.

Northeast Operations Reportable Segment Results

The following table summarizes the operating results for the Northeast Operations segment for the three and six months ended June 30, 2011 and 2010:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
				(Dollars in thousands)
Health plan services premiums	$	326		$	23,036		$	2,330		$	48,185
Investment income		10			243			71			588
Administrative services fees and other income		0			22			0			46
Northeast administrative services fees and other		11,021			59,301			23,470			109,661
Total revenues		11,357			82,602			25,871			158,480
Health plan services		(160	)		20,660			738			42,023
General and administrative		689			687			1,717			9,844
Selling		68			824			172			1,930
Depreciation and amortization		6			18			12			60
Interest		185			0			185			0
Northeast administrative services expenses		37,825			71,951			90,080			153,829
Adjustment to loss on sale of Northeast health plan subsidiaries		(6,283	)		(8,171	)		(41,137	)		(8,171	)
Asset impairment		0			6,000			0			6,000
Total expenses		32,330			91,969			51,767			205,515
Loss from operations before income taxes		(20,973	)		(9,367	)		(25,896	)		(47,035	)
Income tax benefit		(11,239	)		(1,343	)		(15,237	)		(16,336	)
Net loss	$	(9,734	)	$	(8,024	)	$	(10,659	)	$	(30,699	)

42

The Northeast Operations segment had approximately $11.4 million and $82.6 million in total revenues in the three months ended June 30, 2011 and 2010, respectively, which represent less than 1 percent and approximately 2 percent of our total revenues for the three months ended June 30, 2011 and 2010, respectively. The Northeast Operations segment had approximately $25.9 million and $158.5 million in total revenues in the six months ended June 30, 2011 and 2010, respectively, which represent less than 1 percent and approximately 2 percent of our total revenues for the six months ended June 30, 2011 and 2010, respectively. The Northeast Operations segment had a pretax loss of $(21.0) million and $(25.9) million for the three and six months ended June 30, 2011, respectively, compared to a pretax loss of $(9.4) million and $(47.0) million for the three and six months ended June 30, 2010, respectively. Our operating results for the three and six months ended June 30, 2011 were impacted by a $6.3 million and $41.1 million, respectively, favorable adjustment to loss on sale of our Northeast health plan subsidiaries. Our operating results for the three and six months ended June 30, 2010 were impacted by a $6.0 million goodwill impairment reduced by an $8.2 million adjustment to loss on sale of our Northeast health plan subsidiaries. See Note 2 to our consolidated financial statements for additional information regarding the adjustment to loss on sale of our Northeast health plan subsidiaries.

The Northeast Operations segment had $0.3 million and $23.0 million of health plan services premiums for the three months ended June 30, 2011 and 2010, respectively, and $(0.2) million and $20.7 million of health plan services costs for the three months ended June 30, 2011 and 2010, respectively. The Northeast Operations segment had $2.3 million and $48.2 million of health plan services premiums for the six months ended June 30, 2011 and 2010, respectively, and $0.7 million and $42.0 million of health plan services costs for the six months ended June 30, 2011 and 2010, respectively. The revenues and expenses associated with providing services under the United Administrative Services Agreements were $11.0 million and $37.8 million for the three months ended June 30, 2011, respectively, and $59.3 million and $72.0 million for the same period in 2010, and $23.5 million and $90.1 million for the six months ended June 30, 2011, respectively, and $109.7 million and $153.8 million for the same period in 2010, and they are shown separately in the accompanying consolidated statements of operations. The United Administrative Services Agreements terminated effective July 1, 2011, and at that time we entered into Claims Servicing Agreements pursuant to which we will adjudicate run out claims and provide limited other administrative services to United and its affiliates.

The decreases in the revenues and expenses in the Northeast Operations segment in 2011 from 2010 reflect the ongoing run-out and wind-down of the Acquired Companies. For additional information on the United Administrative Services Agreements, the Claims Servicing Agreements and the ongoing run out and wind-down of the Acquired Companies, see Note 2 to the consolidated financial statements.

Corporate/Other

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
				(Dollars in thousands)
Charges included in health plan services costs	$	(300	)	$	(21,633	)	$	(300	)	$	(21,633	)
Charges included in government contract costs		26			920			4,879			1,386
Charges included in G&A		3,561			23,992			186,938			38,054
Early debt extinguishment charge and related interest rate swap termination		0			8,992			0			8,992
Loss from operations before income taxes		(3,287	)		(12,271	)		(191,517	)		(26,799	)
Income tax benefit		(1,781	)		(4,838	)		(25,324	)		(10,223	)
Net loss	$	(1,506	)	$	(7,433	)	$	(166,193	)	$	(16,576	)

43

Our Corporate/Other segment is not a business operating segment. It is added to our reportable segments to reconcile to our consolidated results. The Corporate/Other segment includes costs that are excluded from the calculation of segment pretax income because they are not managed within the reportable segments.

Our operating results for the three months ended June 30, 2011 were impacted by $2.7 million in pretax costs related to our cost management initiatives and $0.9 in additional interest related to the decision rendered in the AmCareco litigation, reduced by a $0.3 million benefit from a litigation reserve true-up. Our operating results for the six months ended June 30, 2011 were impacted by a $181 million pretax charge related to the decision rendered in the AmCareco litigation and $13.7 million in pretax costs related to our cost management initiatives. See Note 8 to our consolidated financial statements for more information regarding the decision rendered in the AmCareco litigation.

Our operating results for the three and six months ended June 30, 2010 were impacted by $33.9 million and $48.4 million, respectively, in pretax costs related to our operations strategy, other cost management initiatives and early debt extinguishment and related interest rate swap termination, reduced by a $21.6 million benefit from a litigation reserve true-up.

LIQUIDITY AND CAPITAL RESOURCES

Market and Economic Conditions

The current state of the global economy and market conditions continue to be challenging with relatively high levels of unemployment, diminished business and consumer confidence, and volatility in both U.S. and international capital and credit markets. Market conditions could limit our ability to timely replace maturing liabilities, including our revolving credit facility which matures on June 25, 2012, or otherwise access capital markets for liquidity needs, which could adversely affect our business, financial condition and results of operations. Furthermore, if our customer base experiences cash flow problems and other financial difficulties, it could, in turn, adversely impact membership in our plans. For example, our customers may modify, delay or cancel plans to purchase our products, may reduce the number of individuals to whom they provide coverage, or may make changes in the mix or products purchased from us. In addition, if our customers experience financial issues, they may not be able to pay, or may delay payment of, accounts receivable that are owed to us. Further, our customers or potential customers may force us to compete more vigorously on factors such as price and service to retain or obtain their business. A significant decline in membership in our plans and the inability of current and/or potential customers to pay their premiums as a result of unfavorable conditions may adversely affect our business, including our revenues, profitability and cash flow.

Cash and Investments

As of June 30, 2011, the fair value of the investment securities available-for-sale was $1.6 billion. We hold high-quality fixed income securities primarily comprised of corporate bonds, mortgage-backed bonds and municipal bonds. We evaluate and determine the classification of our investments based on management’s intent. We also closely monitor the fair values of our investment holdings and regularly evaluate them for other-than-temporary impairments.

Our cash flow from investing activities is primarily impacted by the sales, maturities and purchases of our available-for-sale investment securities and restricted investments. Our investment objective is to maintain safety and preservation of principal by investing in a diversified mix of high-quality, investment grade securities while maintaining liquidity in each portfolio sufficient to meet our cash flow requirements and attaining an expected total return on invested funds.

44

Our investment holdings are comprised of investment grade securities with an average rating of “AA-” and “Aa3” as rated by S&P and/or Moody’s, respectively. At this time, there is no indication of default on interest and/or principal payments under our holdings. We have the ability and current intent to hold to recovery all securities with an unrealized loss position. Our investment portfolio includes $670.9 million, or 42.6% of our portfolio holdings, of mortgage-backed and asset-backed securities. The majority of our mortgage-backed securities are Fannie Mae, Freddie Mac and Ginnie Mae issues, and the average rating of our entire asset-backed securities is AA+/Aa1. However, any failure by Fannie Mae or Freddie Mac to honor the obligations under the securities they have issued or guaranteed could cause a significant decline in the value or cash flow of our mortgage-backed securities. Our investment portfolio also includes $483.8 million, or 30.7% of our portfolio holdings of obligations of state and other political subdivisions. Our investment portfolio also includes $9.9 million, or less than 1% of our portfolio holdings, of auction rate securities (“ARS”). These ARS have long-term nominal maturities for which the interest rates are reset through a dutch auction process every 7, 28 or 35 days. At June 30, 2011, these ARS had at one point or are continuing to experience “failed” auctions. These securities are entirely municipal issues and rates are set at the maximum allowable rate as stipulated in the applicable bond indentures. We continue to receive income on all ARS. If all or any portion of the ARS continue to experience failed auctions, it could take an extended amount of time for us to realize our investments’ recorded value.

We had gross unrealized losses of $3.4 million as of June 30, 2011, and $14.1 million as of December 31, 2010. Included in the gross unrealized losses as of June 30, 2011 and December 31, 2010 are $0 and $1.7 million, respectively, related to noncurrent investments available-for-sale. We believe that these impairments are temporary and we do not intend to sell these investments. It is not likely that we will be required to sell any security in an unrealized loss position before recovery of its amortized cost basis. Given the current market conditions and the significant judgments involved, there is a continuing risk that further declines in fair value may occur and additional material other-than-temporary impairments may be recorded in future periods. No impairment was recognized during either the three and six months ended June 30, 2011 or 2010.

Liquidity

We believe that expected cash flow from operating activities, existing cash reserves and other working capital and lines of credit are adequate to allow us to fund existing obligations, repurchase shares under our stock repurchase program, introduce new products and services, and continue to operate and develop health care-related businesses at least for the next twelve months. We regularly evaluate cash requirements for current operations and commitments, and for acquisitions and other strategic transactions. We may elect to raise additional funds for these purposes, either through issuance of debt or equity, the sale of investment securities or otherwise, as appropriate. Based on the composition and quality of our investment portfolio, our expected ability to liquidate our investment portfolio as needed, and our expected operating and financing cash flows, we do not anticipate any liquidity constraints as a result of the current credit environment. However, continued turbulence in U.S. and international markets and certain costs associated with the implementation of health care reform legislation could adversely affect our liquidity.

Our cash flow from operating activities is impacted by, among other things, the timing of collections on our amounts receivable from state and federal governments and agencies. Our receivable from CMS related to our Medicare business was $181.5 million as of June 30, 2011 and $121.0 million as of December 31, 2010. The receivable from the Department of Health Services related to our California Medicaid business was $71.4 million as of June 30, 2011 and $112.3 million as of December 31, 2010. Our receivable from the DoD for the TRICARE contract for the North Region was $334.9 million as of June 30, 2011 and $266.5 million as of December 31, 2010. The timing of collection of such receivables is impacted by government audit and negotiation, as well as the budget process, and can extend for periods beyond a year.

During the six months ended June 30, 2011, we paid $181 million related to the AmCareco litigation ruling with borrowings from our revolving credit facility. For additional information regarding charges, see “–Results of Operations” above.

45

Operating Cash Flows

Our net cash flow (used in) provided by operating activities for the six months ended June 30, 2011 compared to the same period in 2010 is as follows:

	June 30, 2011			June 30, 2010		Change 2011 over 2010
	(Dollars in millions)
Net cash (used in) provided by operating activities	$	(295.8	)	$	111.1	$	(406.9	)

The decrease of $406.9 million in operating cash flow is primarily due to the following:

• $181 million in payments related to the decision rendered in the AmCareco litigation,

• $70 million in quarterly net payments to United in accordance with the terms of the Stock Purchase Agreement,

• A $68 million decrease in collections of Medicare premiums due to timing,

• $43 million paid in connection with our transition under the T-3 contract for the TRICARE North Region, and

• partially offset by $24 million in severance payments

• $26 million collected in T-3 contract transition fees.

Investing Activities

Our net cash flow provided by (used in) investing activities for the six months ended June 30, 2011 compared to the same period in 2010 is as follows:

	June 30, 2011		June 30, 2010			Change 2011 over 2010
	(Dollars in millions)
Net cash provided by (used in) investing activities	$	112.8	$	(79.5	)	$	192.3

Net cash provided by investing activities increased during the six months ended June 30, 2011 primarily due to a $154.9 million increase in net sales of investments in available-for-sale securities and a $49.5 million increase in cash received related to the Northeast Sale.

Financing Activities

Our net cash flow used in financing activities for the six months ended June 30, 2011 compared to the same period in 2010 is as follows:

	June 30, 2011			June 30, 2010			Change 2011 over 2010
	(Dollars in millions)
Net cash used in financing activities	$	(0.7	)	$	(288.7	)	$	288.0

Net cash used in financing activities decreased during the six months ended June 30, 2011 by $288.0 million due to a net increase in revolving credit facility borrowings of $185.0 million and the payment of $116.8 million in connection with the termination of our amortizing financing facility during the six months ended June 30, 2010, partially offset by a $16.4 million increase in stock repurchases.

See “—Capital Structure” below for additional information regarding our share repurchases, our revolving credit facility and the termination of our amortizing financing facility.

46

Capital Structure

Our debt-to-total capital ratio was 28.2 percent as of June 30, 2011 compared with 19.0 percent as of December 31, 2010. This increase was the result of increased borrowings under our revolving credit facility to fund the judgment in the Amcareco litigation.

Share Repurchases. On March 18, 2010, our Board of Directors authorized our 2010 stock repurchase program pursuant to which a total of $300 million of our common stock could be repurchased. We completed our 2010 stock repurchase program in April 2011. During the three and six months ended June 30, 2011, we repurchased 1.4 million shares and 4.9 million shares, respectively, of our common stock for aggregate consideration of approximately $45.2 million and $149.8 million, respectively, under our 2010 stock repurchase program. As of June 30, 2011, we had repurchased an aggregate of 10.8 million shares of our common stock under our 2010 stock repurchase program since its inception in March 2010 at an average price of $27.80 per share for aggregate consideration of $300.0 million.

On May 4, 2011, our Board of Directors authorized our 2011 stock repurchase program pursuant to which a total of $300 million of our outstanding common stock could be repurchased. During the three months ended June 30, 2011, we repurchased 870,000 shares of our common stock for aggregate consideration of approximately $27.1 million under our 2011 stock repurchase program. The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. We used net free cash available, including cash at the parent company, Health Net, Inc., to fund the share repurchases. For additional information on our 2010 stock repurchase program and 2011 stock repurchase program, see Note 5 of our consolidated financial statements.

Under the Company’s various stock option and long-term incentive plans, employees and non-employee directors may elect for the Company to withhold shares to satisfy minimum statutory federal, state and local tax withholding and/or exercise price obligations, as applicable, arising from the exercise of stock options. For certain other equity awards, the Company has the right to withhold shares to satisfy any tax obligations for employees that may be required to be withheld or paid in connection with such equity award, including any tax obligation arising on the vesting date. These repurchases were not part of either of our stock repurchase programs.

The following table presents monthly information related to repurchases of our common stock, including shares withheld by the Company to satisfy tax withholdings and exercise price obligations as of June 30, 2011:

Period	Total Number of Shares Purchased (a)			Average Price Paid per Share		Total Price Paid		Total Number of Shares Purchased as Part of Publicly Announced Programs (b), (c)		Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Programs (b), (c)
January 1—January 31		1,211,977	(d)	$	28.31	$	34,315,821		1,211,720	$	115,497,448
February 1—February 28		1,330,412	(d)		29.95		39,847,861		587,890	$	97,853,713
March 1—March 31		1,714,865	(d)		30.73		52,705,924		1,713,100	$	45,203,916
April 1—April 30		1,401,031			32.26		45,203,895		1,401,031	$	0
May 1—May 31		210,000			31.41		6,595,827		210,000	$	293,404,173
June 1—June 30		660,083	(d)		31.05		20,493,637		660,000	$	272,913,180
		6,528,368	(d)		30.51	$	199,162,965		5,783,741

(a) During the six months ended June 30, 2011, we did not repurchase any shares of our common stock outside our publicly announced stock repurchase program, except shares withheld in connection with our various stock option and long-term incentive plans.

(b) On March 18, 2010, our Board of Directors authorized our 2010 stock repurchase program, pursuant to which a total of $300 million of our common stock could be repurchased. The 2010 stock repurchase program was completed in April 2011.

47

(c) On May 4, 2011, our Board of Directors authorized our 2011 stock repurchase program, pursuant to which a total of $300 million of our common stock can be repurchased. Our 2011 stock repurchase program does not have an expiration date. Accordingly, during the six months ended June 30, 2011, we did not have any repurchase program that expired or was terminated, other than our 2010 stock repurchase program, and we did not terminate any repurchase program prior to its expiration date.

(d) Includes shares withheld by the Company to satisfy tax withholding and/or exercise price obligations arising from the vesting and/or exercise of RSUs, stock options and other equity awards.

Termination of Amortizing Financing Facility. On May 26, 2010, we terminated our five-year non-interest bearing, $175 million amortizing financing facility with a non-U.S. lender that we entered into on December 19, 2007 by exercising our option to call the facility. We paid a total of $116.8 million to retire the facility, which included the outstanding balance of $113.8 million and a $3.0 million call premium. We used a combination of a $100 million draw on our revolving credit facility and operating cash to repay our amortizing financing facility.

Senior Notes. We have issued $400 million in aggregate principal amount of 6.375% Senior Notes due 2017 (the “Senior Notes”). The indenture governing the Senior Notes limits our ability to incur certain liens, or consolidate, merge or sell all or substantially all of our assets. In the event of the occurrence of both (1) a change of control of Health Net, Inc. and (2) a below investment grade rating by any two of Fitch, Inc., Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services, within a specified period, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes plus accrued and unpaid interest to the date of repurchase. As of June 30, 2011, we were in compliance with all of the covenants under the indenture governing the Senior Notes.

The Senior Notes may be redeemed in whole at any time or in part from time to time, prior to maturity at our option, at a redemption price equal to the greater of:

• 100% of the principal amount of the Senior Notes then outstanding to be redeemed; or

• the sum of the present values of the remaining scheduled payments of principal and interest on the Senior Notes to be redeemed (not including any portion of such payments of interest accrued to the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the applicable treasury rate plus 30 basis points

plus, in each case, accrued and unpaid interest on the principal amount being redeemed to the redemption date.

Each of the following will be an Event of Default under the indenture governing the Senior Notes:

• failure to pay interest for 30 days after the date payment is due and payable; provided that an extension of an interest payment period by us in accordance with the terms of the Senior Notes shall not constitute a failure to pay interest;

• failure to pay principal or premium, if any, on any note when due, either at maturity, upon any redemption, by declaration or otherwise;

• failure to perform any other covenant or agreement in the notes or indenture for a period of 60 days after notice that performance was required;

• (A) our failure or the failure of any of our subsidiaries to pay indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, at the later of final maturity and the expiration of any related applicable grace period and such defaulted payment shall not have been made, waived or extended within 30 days after notice or (B) acceleration of the maturity of indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, if that acceleration results from a default under the instrument

48

giving rise to or securing such indebtedness for money borrowed and such indebtedness has not been discharged in full or such acceleration has not been rescinded or annulled within 30 days after notice; or

• events in bankruptcy, insolvency or reorganization of our Company.

Revolving Credit Facility. We have a $900 million five-year revolving credit facility with Bank of America, N.A. as Administrative Agent, Swingline Lender, and L/C Issuer, and the other lenders party thereto. Our revolving credit facility provides for aggregate borrowings in the amount of $900 million, which includes a $400 million sub-limit for the issuance of standby letters of credit and a $50 million sub-limit for swing line loans. In addition, we have the ability from time to time to increase the facility by up to an additional $250 million in the aggregate, subject to the receipt of additional commitments. The revolving credit facility matures on June 25, 2012. Accordingly, the balance outstanding of $185 million as of June 30, 2011 is classified as a current liability.

Amounts outstanding under the revolving credit facility will bear interest, at our option, at (a) the base rate, which is a rate per annum equal to the greater of (i) the federal funds rate plus one-half of one percent and (ii) Bank of America’s prime rate (as such term is defined in the facility), (b) a competitive bid rate solicited from the syndicate of banks, or (c) the British Bankers Association LIBOR rate (as such term is defined in the facility), plus an applicable margin, which is initially 70 basis points per annum and is subject to adjustment according to our credit ratings, as specified in the facility.

Our revolving credit facility includes, among other customary terms and conditions, limitations (subject to specified exclusions) on our and our subsidiaries’ ability to incur debt; create liens; engage in certain mergers, consolidations and acquisitions; sell or transfer assets; enter into agreements which restrict the ability to pay dividends or make or repay loans or advances; make investments, loans, and advances; engage in transactions with affiliates; and make dividends. In addition, we are required to maintain a specified consolidated leverage ratio and consolidated fixed charge coverage ratio throughout the term of the revolving credit facility.

Our revolving credit facility contains customary events of default, including nonpayment of principal or other amounts when due; breach of covenants; inaccuracy of representations and warranties; cross-default and/or cross-acceleration to other indebtedness of the Company or our subsidiaries in excess of $50 million; certain ERISA-related events; noncompliance by us or any of our subsidiaries with any material term or provision of the HMO Regulations or Insurance Regulations (as each such term is defined in the facility); certain voluntary and involuntary bankruptcy events; inability to pay debts; undischarged, uninsured judgments greater than $50 million against us and/or our subsidiaries; actual or asserted invalidity of any loan document; and a change of control. If an event of default occurs and is continuing under the facility, the lenders thereunder may, among other things, terminate their obligations under the facility and require us to repay all amounts owed thereunder.

As of June 30, 2011, we were in compliance with all covenants under our revolving credit facility.

We had $185.0 million in outstanding borrowings under the revolving credit facility as of June 30, 2011, and no amounts were outstanding under the revolving credit facility as of December 31, 2010. We can obtain letters of credit in an aggregate amount of $400 million under our revolving credit facility. The maximum amount available for borrowing under our revolving credit facility is reduced by the dollar amount of any outstanding letters of credit. As of June 30, 2011 and December 31, 2010, respectively, we had outstanding an aggregate of $60.2 million and $249.1 million in letters of credit. The reduction of approximately $88.1 million in outstanding letters of credit during the quarter ended June 30, 2011 is due to the release of certain letters of credit that had been issued in connection with the AmCareco litigation (see Note 8 to our consolidated financial statements for more information on the AmCareco litigation). As a result, the maximum amount available for borrowing under the revolving credit facility was $654.8 million as of June 30, 2011, and no amount had been drawn on the letters of credit. As of August 3, 2011, we had $245.0 million in borrowings outstanding under our revolving credit facility.

49

Statutory Capital Requirements

Certain of our subsidiaries must comply with minimum capital and surplus requirements under applicable state laws and regulations, and must have adequate reserves for claims. Management believes that as of June 30, 2011, all of our active health plans and insurance subsidiaries met their respective regulatory requirements in all material respects.

By law, regulation and governmental policy, our health plan and insurance subsidiaries, which we refer to as our regulated subsidiaries, are required to maintain minimum levels of statutory capital and surplus or net worth. The minimum statutory capital and surplus or net worth requirements differ by state and are generally based on balances established by statute, a percentage of annualized premium revenue, a percentage of annualized health care costs, or risk-based capital (“RBC”) or tangible net equity (“TNE”) requirements. The RBC requirements are based on guidelines established by the National Association of Insurance Commissioners. The RBC formula, which calculates asset risk, underwriting risk, credit risk, business risk and other factors, generates the authorized control level (“ACL”), which represents the minimum amount of net worth believed to be required to support the regulated entity’s business. For states in which the RBC requirements have been adopted, the regulated entity typically must maintain the greater of the Company Action Level RBC, calculated as 200% of the ACL, or the minimum statutory net worth requirement calculated pursuant to pre-RBC guidelines. Because our regulated subsidiaries are also subject to their state regulators’ overall oversight authority, some of our subsidiaries are required to maintain minimum capital and surplus in excess of the RBC requirement, even though RBC has been adopted in their states of domicile. Historically, we generally managed our aggregate regulated subsidiary capital above 300% of ACL, although RBC standards are not yet applicable to all of our regulated subsidiaries. At June 30, 2011, our aggregate regulated subsidiary capital was approximately 400% of ACL.

Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (“Knox-Keene”), certain of our California subsidiaries must comply with TNE requirements. Under these Knox-Keene TNE requirements, actual net worth less unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums or (iii) a minimum amount based on health care expenditures, excluding capitated amounts. In addition, certain of our California subsidiaries have made certain undertakings to the Department of Managed Health Care to restrict dividends and loans to affiliates, to the extent that the payment of such would reduce such entities’ TNE below 130% of the minimum requirement, or reduce the cash-to-claims ratio below 1:1. At June 30, 2011, all of the subsidiaries subject to the TNE requirements and the undertakings to the Department of Managed Health Care exceeded the minimum requirements.

As necessary, we make contributions to and issue standby letters of credit on behalf of our subsidiaries to meet RBC or other statutory capital requirements under state laws and regulations. During the six months ended June 30, 2011, we made no such capital contributions. In addition, we made no capital contributions to any of our subsidiaries to meet RBC or other statutory capital requirements under state laws and regulations thereafter through August 3, 2011.

Legislation has been or may be enacted in certain states in which our subsidiaries operate imposing substantially increased minimum capital and/or statutory deposit requirements for HMOs in such states. Such statutory deposits may only be drawn upon under limited circumstances relating to the protection of policyholders.

As a result of the above requirements and other regulatory requirements, certain subsidiaries are subject to restrictions on their ability to make dividend payments, loans or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income and unassigned surplus.

50

CONTRACTUAL OBLIGATIONS

Pursuant to Item 303(a)(5) of Regulation S-K, we identified our known contractual obligations as of December 31, 2010 in our Form 10-K and identified additional significant contractual obligations in our Form 10-Q for the quarter ended March 31, 2011. During the three months ended June 30, 2011, there were no significant changes to our contractual obligations as previously disclosed in our Form 10-K and Form 10-Q, except as follows:

	July 1, 2011 to  December 31, 2011		2012		2013		2014		2015		Thereafter		Total
	(Dollars in Millions)
Draw on revolving credit facility (1)	$	0	$	185.0	$	0	$	0	$	0	$	0	$	185.0
Interest on revolving credit facility (1)		1.1		1.6		0		0		0		0		2.7

(1) See “Liquidity and Capital Resources—Capital Structure—Revolving Credit Facility.”

OFF-BALANCE SHEET ARRANGEMENTS

As of June 30, 2011, we did not have any off-balance sheet arrangements as defined under Item 303(a)(4) of Regulation S-K.

CRITICAL ACCOUNTING ESTIMATES

In our Form 10-K, we identified the critical accounting policies, which affect the more significant estimates and assumptions used in preparing our consolidated financial statements. Those policies include revenue recognition, health care costs, reserves for contingent liabilities, amounts receivable or payable under government contracts, goodwill and recoverability of long-lived assets and investments, income taxes and the consolidation of variable interest entities. We have not changed existing policies from those previously disclosed in our Form 10-K. Our critical accounting policy on estimating reserves for claims and other settlements and the quantification of the sensitivity of financial results to reasonably possible changes in the underlying assumptions used in such estimation as of June 30, 2011 is discussed below. There were no other significant changes to the critical accounting estimates as disclosed in our Form 10-K.

Reserves for claims and other settlements include reserves for claims (IBNR and received but unprocessed claims), and other liabilities including capitation payable, shared risk settlements, provider disputes, provider incentives and other reserves for our Western Region Operations reporting segment.

We estimate the amount of our reserves for claims primarily by using standard actuarial developmental methodologies. This method is also known as the chain-ladder or completion factor method. The developmental method estimates reserves for claims based upon the historical lag between the month when services are rendered and the month claims are paid while taking into consideration, among other things, expected medical cost inflation, seasonal patterns, product mix, benefit plan changes and changes in membership. A key component of the developmental method is the completion factor, which is a measure of how complete the claims paid to date are relative to the estimate of the claims for services rendered for a given period. While the completion factors are reliable and robust for older service periods, they are more volatile and less reliable for more recent periods since a large portion of health care claims are not submitted to us until several months after services have been rendered. Accordingly, for the most recent months, the incurred claims are estimated from a trend analysis based on per member per month claims trends developed from the experience in preceding months. This method is applied consistently year over year while assumptions may be adjusted to reflect changes in medical cost inflation, seasonal patterns, product mix, benefit plan changes and changes in membership.

51

An extensive degree of actuarial judgment is used in this estimation process, considerable variability is inherent in such estimates, and the estimates are highly sensitive to changes in medical claims submission and payment patterns and medical cost trends. As such, the completion factors and the claims per member per month trend factor are the most significant factors used in estimating our reserves for claims. Since a large portion of the reserves for claims is attributed to the most recent months, the estimated reserves for claims are highly sensitive to these factors. The following table illustrates the sensitivity of these factors and the estimated potential impact on our operating results caused by these factors:

Completion Factor (a) Percentage-point Increase (Decrease) in Factor	Western Region Operations Health Plan Services (Decrease) Increase in Reserves for Claims
2%	$(47.6) million
1%	$(24.3) million
(1)%	$25.2 million
(2)%	$51.4 million
Medical Cost Trend (b) Percentage-point Increase (Decrease) in Factor	Western Region Operations Health Plan Services Increase (Decrease) in Reserves for Claims
2%	$24.3 million
1%	$12.1 million
(1)%	$(12.1) million
(2)%	$(24.3) million

(a) Impact due to change in completion factor for the most recent three months. Completion factors indicate how complete claims paid to date are in relation to the estimate of total claims for a given period. Therefore, an increase in the completion factor percent results in a decrease in the remaining estimated reserves for claims.

(b) Impact due to change in annualized medical cost trend used to estimate the per member per month cost for the most recent three months.

Other relevant factors include exceptional situations that might require judgmental adjustments in setting the reserves for claims, such as system conversions, processing interruptions or changes, environmental changes or other factors. All of these factors are used in estimating reserves for claims and are important to our reserve methodology in trending the claims per member per month for purposes of estimating the reserves for the most recent months. In developing our best estimate of reserves for claims, we consistently apply the principles and methodology described above from year to year, while also giving due consideration to the potential variability of these factors. Because reserves for claims include various actuarially developed estimates, our actual health care services expense may be more or less than our previously developed estimates. Claims processing expenses are also accrued based on an estimate of expenses necessary to process such claims. Such reserves are continually monitored and reviewed, with any adjustments reflected in current operations.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to interest rate and market risk primarily due to our investing and borrowing activities. Market risk generally represents the risk of loss that may result from the potential change in the value of a financial instrument as a result of fluctuations in interest rates and/or market conditions and in equity prices. Interest rate risk is a consequence of maintaining variable interest rate earning investments and fixed rate liabilities or fixed income investments and variable rate liabilities. We are exposed to interest rate risks arising from changes in the level or volatility of interest rates, prepayment speeds and/or the shape and slope of the yield curve. In addition, we are exposed to the risk of loss related to changes in credit spreads. Credit spread risk arises from the potential that changes in an issuer’s credit rating or credit perception may affect the value of financial instruments. We believe that no material changes to any of these risks have occurred since December 31, 2010.

52

For a more detailed discussion of our market risks relating to these activities, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, included in our Form 10-K.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon the evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of such period.

Changes in Internal Control Over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the six months ended June 30, 2011 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

53

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

A description of the legal proceedings to which the Company and its subsidiaries are a party is contained under the heading “Legal Proceedings” in Note 8 to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A. Risk Factors of the Form 10-K, as updated by our quarterly report on Form 10-Q for the quarter ended March 31, 2011, which could materially affect our business, financial condition, results of operations or future results. The risks described in the Form 10-K, as updated by our quarterly report on Form 10-Q for the quarter ended March 31, 2011, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially adversely affect our business, cash flows, financial condition and/or results of operations. During the quarter ended June 30, 2011, there were no material changes to the risk factors disclosed in our Form 10-K, as updated by our quarterly report on Form 10-Q for the quarter ended March 31, 2011.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(c) Purchases of Equity Securities by the Issuer

On March 18, 2010, our Board of Directors authorized our 2010 stock repurchase program, pursuant to which a total of $300 million of our common stock could be repurchased. Our 2010 stock repurchase program was completed in April 2011. On May 4, 2011, our Board of Directors authorized our 2011 stock repurchase program for the repurchase of up to $300 million of our outstanding common stock. The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million.

Under the Company’s various stock option and long-term incentive plans, employees and non-employee directors may elect for the Company to withhold shares to satisfy minimum statutory federal, state and local tax withholding and/or exercise price obligations, as applicable, arising from the exercise of stock options. For certain other equity awards, the Company has the right to withhold shares to satisfy any tax obligations for employees that may be required to be withheld or paid in connection with such equity awards, including any tax obligation arising on the vesting date.

A description of our 2010 and 2011 stock repurchase programs and tabular disclosure of the information required under this Item 2 is contained in Note 5 to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q and in Part I— “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Capital Structure—Share Repurchases.”

Item 3. Defaults Upon Senior Securities.

None.

Item 4. [Removed and Reserved.]

Item 5. Other Information.

None.

54

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q:

Exhibit Number	Description
3.1	Seventh Amended and Restated Certificate of Incorporation of Health Net, Inc., a copy of which is filed herewith.
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
**101	The following materials from Health Net, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, formatted in XBRL (eXtensible Business Reporting Language): (1) Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2011 and 2010, (2) Consolidated Balance Sheets as of June 30, 2011 and December 31, 2010, (3) Consolidated Statements of Stockholders’ Equity for the Six Months Ended June 30, 2011 and 2010, (4) Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2011 and 2010 and (5) Condensed Notes to Consolidated Financial Statements.

** Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files referenced in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

55

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HEALTH NET, INC. (REGISTRANT)
Date: August 8, 2011	By:	/s/    JOSEPH C. CAPEZZA
		Joseph C. Capezza
		Chief Financial Officer and Principal Accounting Officer

56

EXHIBIT INDEX

Exhibit Number	Description
3.1	Seventh Amended and Restated Certificate of Incorporation of Health Net, Inc., a copy of which is filed herewith.
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, a copy of which is filed herewith.
**101	The following materials from Health Net, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, formatted in XBRL (eXtensible Business Reporting Language): (1) Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2011 and 2010, (2) Consolidated Balance Sheets as of June 30, 2011 and December 31, 2010, (3) Consolidated Statements of Stockholders’ Equity for the Six Months Ended June 30, 2011 and 2010, (4) Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2011 and 2010 and (5) Condensed Notes to Consolidated Financial Statements.

** Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files referenced in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

EX-3.1

Exhibit 3.1

SEVENTH AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

HEALTH NET, INC.

Health Net, Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:

1. The name of the corporation is Health Net, Inc. Health Net, Inc. was originally incorporated under the name HN Management Holdings, Inc., and its original certificate of incorporation was filed with the Secretary of State of the State of Delaware on June 7, 1990.

2. This Seventh Amended and Restated Certificate of Incorporation was duly adopted in accordance with Sections 245 and 242 of the General Corporation Law of the State of Delaware.

3. The text of the certificate of incorporation of Health Net, Inc. is hereby amended and restated to read in its entirety as follows:

ARTICLE I

NAME

The name of the corporation (hereinafter called the “Corporation”) is Health Net, Inc.

ARTICLE II

REGISTERED OFFICE

The registered office of the Corporation in the State of Delaware shall be located at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, County of New Castle. The name of the Corporation’s registered agent is The Corporation Trust Company.

ARTICLE III

PURPOSE

The purpose for which the Corporation is organized is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.

ARTICLE IV

AUTHORIZED CAPITAL STOCK

SECTION 1. The total number of shares of all classes of stock which the Corporation shall have authority to issue is Three Hundred Sixty Million (360,000,000) shares as follows: (a) Three Hundred Fifty Million (350,000,000) shares of Common Stock, $.001 par value per share (“Common

1

Stock”), and (b) Ten Million (10,000,000) shares of Preferred Stock, $.001 par value per share (“Preferred Stock”).

SECTION 2. The designations, preferences, qualifications, privileges, limitations and restrictions of the classes of stock of the Corporation and the express grant of authority to the Board of Directors of the Corporation (the “Board of Directors”) to fix by resolution the designations, preferences, qualifications, privileges, limitations, and restrictions relating to the classes of stock of the Corporation which are not fixed by this Certificate of Incorporation are as follows:

A. COMMON STOCK

(1) Dividends. Subject to any other provisions of this Certificate of Incorporation, as amended from time to time, holders of Common Stock shall be entitled to receive such dividends and other distributions in cash, stock or property of the Corporation as may be declared thereon from time to time by the Board of Directors out of assets or funds of the Corporation legally available therefor.

(2) Voting.

(a) At every meeting of the stockholders, every holder of Common Stock shall be entitled to one (1) vote in person or by proxy for each share of Common Stock standing in his or her name on the transfer books of the Corporation.

(b) The provisions of this Article IV of this Certificate of Incorporation shall not be modified, revised, altered or amended, repealed or rescinded, in whole or in part, without the affirmative vote of the holders of a majority of the shares of Common Stock.

B. SERIES A PARTICIPATING PREFERRED STOCK

(1) Designation and Amount. The shares of a series of Preferred Stock shall be designated as “Series A Junior Participating Preferred Stock” and the number of shares constituting such series shall be 350,000. The par value of the Series A Junior Participating Preferred Stock shall be $.001 per share.

(2) Dividends and Distributions.

(a) Subject to the prior and superior rights of the holders of any shares of any series of Preferred Stock, if any, issued from time to time ranking prior and superior to the shares of Series A Junior Participating Preferred Stock with respect to dividends, the holders of shares of Series A Junior Participating Preferred Stock shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available for the purpose, quarterly dividends payable in cash on the fifteenth day of January, April, July and October in each year (each such date being referred to herein as a “Quarterly Dividend Payment Date”), commencing on the first Quarterly Dividend Payment Date after the first issuance of a share or fraction of a share of Series A Junior Participating Preferred Stock, in an amount per share (rounded to the nearest cent) equal to the greater of (x) $1.00 or (y) subject to the provision for adjustment hereinafter set forth, 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions other than a dividend payable in shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date, or, with respect to the first Quarterly Dividend Payment Date,

2

since the first issuance of any share or fraction of a share of Series A Junior Participating Preferred Stock. In the event the Corporation shall at any time after July 27, 2006 (the “Rights Declaration Date”) (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the amount to which holders of shares of Series A Junior Participating Preferred Stock were entitled immediately prior to such event under clause (y) of the preceding sentence shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

(b) The Corporation shall declare a dividend or distribution on the Series A Junior Participating Preferred Stock as provided in paragraph (a) above immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares of Common Stock); provided that, in the event no dividend or distribution shall have been declared on the Common Stock during the period between any Quarterly Divided Payment Date and the next subsequent Quarterly Dividend Payment Date, a dividend of $1.00 per share as such amount may be adjusted pursuant to the last sentence of the preceding paragraph on the Series A Junior Participating Preferred Stock shall nevertheless be payable on such subsequent Quarterly Dividend Payment Date. (c) Dividends shall begin to accrue and be cumulative on outstanding shares of Series A Junior Participating Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares of Series A Junior Participating Preferred Stock, unless the date of issue of such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a date after the record date for the determination of holders of shares of Series A Junior Participating Preferred Stock entitled to receive a quarterly dividend and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series A Junior Participating Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record date for the determination of holders of shares of Series A Junior Participating Preferred Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be no more than 60 days prior to the date fixed for the payment thereof.

(3) Voting Rights. The holders of shares of Series A Junior Participating Preferred Stock shall have the following voting rights:

(a) Subject to the provision for adjustment hereinafter set forth, each share of Series A Junior Participating Preferred Stock shall entitle the holder thereof to 1,000 votes on all matters submitted to a vote of the stockholders of the Corporation. In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the number of votes per share to which holders of shares of Series A Junior Participating Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

3

(b) Except as otherwise provided herein or by law, the holders of shares of Series A Junior Participating Preferred Stock and the holders of shares of the Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.

(c) (i) If at any time dividends on any Series A Junior Participating Preferred Stock shall be in arrears in an amount equal to six (6) quarterly dividends thereon, the occurrence of such contingency shall mark the beginning of a period (herein called a “default period”) which shall extend until such time when all accrued and unpaid dividends for all previous quarterly dividend periods and for the current quarterly dividend period on all shares of Series A Junior Participating Preferred Stock then outstanding shall have been declared and paid or set apart for payment. During each default period, all holders of Preferred Stock (including holders of the Series A Junior Participating Preferred Stock) with dividends in arrears in an amount equal to six (6) quarterly dividends thereon, voting as a class, irrespective of series, shall have the right to elect two (2) Directors.

(ii) During any default period, such voting right of the holders of Series A Junior Participating Preferred Stock may be exercised initially at a special meeting called pursuant to subparagraph (iii) of this Section 2(B)(3)(c) or at any annual meeting of stockholders, and thereafter at annual meetings of stockholders, provided that neither such voting right nor the right of the holders of any other series of Preferred Stock, if any, to increase, in certain cases, the authorized number of Directors shall be exercised unless the holders of ten percent (10%) in number of shares of Preferred Stock outstanding shall be present in person or by proxy. The absence of a quorum of the holders of Common Stock shall not affect the exercise by the holders of Preferred Stock of such voting right. At any meeting at which the holders of Preferred Stock shall exercise such voting right initially during an existing default period, they shall have the right, voting as a class, to elect Directors to fill such vacancies, if any, in the Board of Directors as may then exist up to two (2) Directors or, if such right is exercised at an annual meeting, to elect two (2) Directors. If the number which may be so elected at any special meeting does not amount to the required number, the holders of the Preferred Stock shall have the right to make such increase in the number of Directors as shall be necessary to permit the election by them of the required number. After the holders of the Preferred Stock shall have exercised their right to elect Directors in any default period and during the continuance of such period, the number of Directors shall not be increased or decreased except by vote of the holders of Preferred Stock as herein provided or pursuant to the rights of any equity securities ranking senior to or pari passu with the Series A Junior Participating Preferred Stock.

(iii) Unless the holders of Preferred Stock shall, during an existing default period, have previously exercised their right to elect Directors, the Board of Directors may order, or any stockholder or stockholders owning in the aggregate not less than ten percent (10%) of the total number of shares of Preferred Stock outstanding, irrespective of series, may request, the calling of a special meeting of the holders of Preferred Stock, which meeting shall thereupon be called by the President, a Vice-President or the Secretary of the Corporation. Notice of such meeting and of any annual meeting at which holders of Preferred Stock are entitled to vote pursuant to this paragraph (c)(iii) shall be given to each holder of record of Preferred Stock by mailing a copy of such notice to him at his last address as the same appears on the books of the Corporation. Such meeting shall be called for a time not earlier than 20 days and not later than 60 days after such order or request or in default of the calling of such meeting within 60 days after such order or request, such meeting may be called on similar notice by any stockholder or stockholders owning in the aggregate not less than ten percent (10%) of the total number of shares of Preferred Stock outstanding.

4

Notwithstanding the provisions of this paragraph (c)(iii), no such special meeting shall be called during the period within 60 days immediately preceding the date fixed for the next annual meeting of the stockholders.

(iv) In any default period, the holders of Common Stock, and other classes of stock of the Corporation if applicable, shall continue to be entitled to elect the whole number of Directors until the holders of Preferred Stock shall have exercised their right to elect two (2) Directors voting as a class, after the exercise of which right (x) the Directors so elected by the holders of Preferred Stock shall continue in office until their successors shall have been elected by such holders or until the expiration of the default period, and (y) any vacancy in the Board of Directors may (except as provided in paragraph (c)(ii) of this Section 3) be filled by vote of a majority of the remaining Directors theretofore elected by the holders of the class of stock which elected the Director whose office shall have become vacant. References in this paragraph (c) to Directors elected by the holders of a particular class of stock shall include Directors elected by such Directors to fill vacancies as provided in clause (y) of the foregoing sentence.

(v) Immediately upon the expiration of a default period, (x) the right of the holders of Preferred Stock as a class to elect Directors shall cease, (y) the term of any Directors elected by the holders of Preferred Stock as a class shall terminate, and (z) the number of Directors shall be such number as may be provided for in the Certificate of Incorporation or by-laws irrespective of any increase made pursuant to the provisions of paragraph (x)(ii) of this Section 2(B)(3) (such number being subject, however, to change thereafter in any manner provided by law or in the Certificate of Incorporation or by-laws). Any vacancies in the Board of Directors effected by the provisions of clauses (y) and (z) in the preceding sentence may be filled by a majority of the remaining Directors.

(d) Except as set forth herein, holders of Series A Junior Participating Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of the Corporation’s Common Stock as set forth herein) for taking any corporate action.

(4) Certain Restrictions.

(a) Whenever quarterly dividends or other dividends or distributions payable on the Series A Junior Participating Preferred Stock as provided in Section 2(B)(2) are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series A Junior Participating Preferred Stock outstanding shall have been paid in full, the Corporation shall not

(i) declare or pay dividends on, make any other distributions on, or redeem or purchase or otherwise acquire for consideration any shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock;

(ii) declare or pay dividends on or make any other distributions on any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A Junior Participating Preferred Stock, except dividends paid ratably on the Series A Junior Participating Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders of all such shares are then entitled;

5

(iii) redeem or purchase or otherwise acquire for consideration shares of any stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A Junior Participating Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise acquire shares of any such parity stock in exchange for shares of any stock of the Corporation ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series A Junior Participating Preferred Stock; or

(iv) purchase or otherwise acquire for consideration any shares of Series A Junior Participating Preferred Stock, or any shares of stock ranking on a parity with the Series A Junior Participating Preferred Stock, except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and other relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable treatment among the respective series or classes.

(b) The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any shares of stock of the Corporation unless the Corporation could, under paragraph (a) of this Section 2(B)(4), purchase or otherwise acquire such shares at such time and in such manner.

(5) Reacquired Shares. Any shares of Series A Junior Participating Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of Preferred Stock to be created by resolution or resolutions of the Board of Directors, subject to the conditions and restrictions on issuance set forth herein.

(6) Liquidation, Dissolution or Winding Up.

(a) Upon any liquidation (voluntary or otherwise), dissolution or winding up of the Corporation, no distribution shall be made to the holders of shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Series A Junior Participating Preferred Stock shall have received $1,000 per share, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment (the “Series A Liquidation Preference”). Following the payment of the full amount of the Series A Liquidation Preference, no additional distributions shall be made to the holders of shares of Series A Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Common Stock shall have received an amount per share (the “Common Adjustment”) equal to the quotient obtained by dividing (i) the Series A Liquidation Preference by (ii) 1,000 (as appropriately adjusted as set forth in subparagraph (c) below to reflect such events as stock splits, stock dividends and recapitalization with respect to the Common Stock) (such number in clause (ii), the “Adjustment Number”). Following the payment of the full amount of the Series A Liquidation Preference and the Common Adjustment in respect of all outstanding shares of Series A Junior Participating Preferred Stock and Common Stock, respectively, holders of Series A Junior Participating Preferred Stock and holders of shares of Common Stock shall receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the Adjustment Number to 1 with respect to such Preferred Stock and Common Stock, on a per share basis, respectively.

6

(b) In the event, however, that there are not sufficient assets available to permit payment in full of the Series A Liquidation Preference and the liquidation preferences of all other series of preferred stock, if any, which rank on a parity with the Series A Junior Participating Preferred Stock, then such remaining assets shall be distributed ratably to the holders of such parity shares in proportion to their respective liquidation preferences. In the event, however, that there are not sufficient assets available to permit payment in full of the Common Adjustment, then such remaining assets shall be distributed ratably to the holders of Common Stock.

(c) In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the Adjustment Number in effect immediately prior to such event shall be adjusted by multiplying such Adjustment Number by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

(7) Consolidation, Merger, etc. In case the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case the shares of Series A Junior Participating Preferred Stock shall at the same time be similarly exchanged or changed in an amount per share (subject to the provision for adjustment hereinafter set forth) equal to 1000 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the amount set forth in the preceding sentence with respect to the exchange or change of shares of Series A Junior Participating Preferred Stock shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

(8) No Redemption. The shares of Series A Junior Participating Preferred Stock shall not be redeemable.

(9) Ranking. The Series A Junior Participating Preferred Stock shall rank junior to all other series of the Corporation’s Preferred Stock which may be issued from time to time as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise.

(10) Amendment. At any time when any shares of Series A Junior Participating Preferred Stock are outstanding, the certificate of incorporation of the Corporation shall not be amended in any manner which would materially alter or change the powers, preferences or special rights of the Series A Junior Participating Preferred Stock so as to affect them adversely without the affirmative vote of the holders of a majority or more of the outstanding shares of Series A Junior Participating Preferred Stock, voting separately as a class.

(11) Fractional Shares. Series A Junior Participating Preferred Stock may be issued in fractions of a share which shall entitle the holder, in proportion to such holder’s fractional shares, to

7

exercise voting rights, receive dividends, participate in distributions and to have the benefit of all other rights of holders of Series A Junior Participating Preferred Stock.

C. AUTHORITY TO PROVIDE FOR SERIES OF PREFERRED STOCK

The Board of Directors is authorized to provide, by resolution, for the issuance of one or more series of Preferred Stock out of the unissued shares of Preferred Stock. Except as may be required by law, the shares in any series of Preferred Stock or any shares of stock of any other class need not be identical to any other series of Preferred Stock or any other class. Before any shares of Preferred Stock of any series are issued, the Board of Directors shall fix, and is hereby expressly empowered to fix, by resolution, the following provisions regarding such shares:

(i) The designations of such series, the number of shares to constitute such series and the stated value thereof if different from the par value thereof;

(ii) Whether the shares of such series shall have voting rights, and, if so, the terms of the voting right, which may be general or limited;

(iii) The dividends, if any, payable on the Series, whether any dividends shall be cumulative, and, if so, from what dates; the conditions and dates upon which the dividends shall be payable; the preference or relation which the dividends shall bear to the dividends payable on any shares of stock of any other series of Preferred Stock;

(iv) Whether the shares of the series shall be subject to redemption by the Corporation and, if so, the times, prices and other conditions of the redemption;

(v) The amount or amounts payable upon shares of the series, and the rights of the holders of such series in the event of voluntary or involuntary liquidation, dissolution or winding up, or upon any distribution of the assets, of the Corporation;

(vi) Whether the shares of the series shall be subject to the operation of a retirement or sinking fund and, if so, the extent to and manner in which such retirement or sinking fund shall be applied to the purchase or redemption of the shares of the series for retirement or other corporate purposes and the terms and provisions relative to the operation thereof;

(vii) Whether the shares of the series shall be convertible into, or exchangeable for, shares of Common Stock or any other series of Preferred Stock or any other securities (whether or not issued by the Corporation), and, if so, the price or prices or the rate or rates of conversion or exchange and the method, if any, of adjusting the same, and any other terms and conditions of conversion or exchange;

(viii) The limitations and restrictions, if any, to be effective upon the payment of dividends or the making of other distributions on, and upon the purchase, redemption or other acquisition by the Corporation of Common Stock or shares of stock of any other class or any other series of Preferred Stock;

(ix) The conditions or restrictions, if any, upon the creation of indebtedness of the Corporation or upon the issuance of any additional stock, including additional shares of the series or any other series of Preferred Stock or any other class of stock;

8

(x) The ranking (be it pari passu, junior or senior) of each class or series vis-a-vis any other class or series of any class of Preferred Stock as to the payment of dividends, the distribution of assets and all other matters; and

(xi) Any other powers, preferences and relative, participating, optional and other special rights, and any qualifications, limitations and restrictions thereof, insofar as they are not inconsistent with the provisions of this Certificate of Incorporation, to the full extent permitted in accordance with the laws of the State of Delaware.

The powers, preferences and relative, participating, optional and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

ARTICLE V

COMPOSITION OF BOARD OF DIRECTORS AND STOCKHOLDER MEETINGS

The following provisions are inserted for the management of the business and for the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders:

SECTION 1. The business and affairs of the Corporation shall be managed by or under the direction of a Board of Directors consisting of not less than three nor more than twenty directors, the exact number of directors to be determined in accordance with the Bylaws of the Corporation. Directors shall be elected for a one-year term at each annual meeting of stockholders, but in no case shall a decrease in the number of directors shorten the term of any incumbent director. A director shall hold office until the next annual meeting and until his successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office.

SECTION 2. Subject to the rights of holders of any series of Preferred Stock then outstanding or any other securities of the Corporation, any vacancy on the Board of Directors that results from an increase in the number of directors may be filled by a majority of the Board of Directors then in office, provided that a quorum is present, and any other vacancy occurring in the Board of Directors may be filled by a majority of the directors then in office, even if less than a quorum, or by a sole remaining director. Any director elected to fill a vacancy not resulting from an increase in the number of directors shall have the same remaining term as that of his predecessor.

SECTION 3. Notwithstanding the foregoing, whenever the holders of any one or more series of Preferred Stock issued by the Corporation or of any other securities of the Corporation shall have the right, voting separately by series, to elect directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other features of such directorships shall be governed by the terms of this Certificate of Incorporation.

SECTION 4. Election of directors need not be by ballot unless the By-laws so provide.

SECTION 5. In addition to the powers and authorities hereinabove or by statute expressly conferred upon them, the Board of Directors is hereby empowered to exercise all powers and do all acts and things as may be exercised or done by the Corporation; subject, nevertheless, to the provisions of the statutes of Delaware, of this Certificate of Incorporation, and to any by-laws from

9

time to time made by the stockholders; provided, however, that no by-law so made shall invalidate any prior act of the Board of Directors which would have been valid if that by-law had not been made.

SECTION 6. The Board of Directors shall have the concurrent power with the stockholders to alter, amend, change, add to or repeal (collectively referred to as a “Change”) the By-laws of the Corporation; provided that any Change of the By-laws must be approved either by (i) a majority of the currently authorized number of directors and, if one or more Interested Stockholder exists, by a majority of the directors who are Continuing Directors (as defined in Article VIII), or (ii) the affirmative vote of the holders of at least a majority in voting power of the then outstanding shares of Voting Stock; provided that if the Change is proposed by or on behalf of an Interested Stockholder or a director affiliated with an Interested Stockholder, such change must be approved by the affirmative vote of the holders of a majority in voting power of the outstanding shares of Voting Stock, excluding Voting Stock beneficially owned by the Interested Stockholder.

SECTION 7. No action required or permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken by written consent without a meeting of such stockholders.

SECTION 8. Special meetings of the stockholders of the Corporation for any purpose or purposes may be called at any time by the Chairman of the Board, or by a majority of the members of the Board of Directors; provided, however, that where a proposal requiring stockholder approval is made by or on behalf of an Interested Stockholder or director affiliated with an Interested Stockholder, or where an Interested Stockholder otherwise seeks action requiring stockholder approval, then the affirmative vote of a majority of the Continuing Directors shall also be required to call a special meeting of stockholders for the purpose of considering such proposal or obtaining such approval. Such special meeting may not be called by any other person or persons or in any other manner.

ARTICLE VI

INDEMNIFICATION

SECTION 1. The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was a director or an officer of the Corporation, against expenses (including but not limited to, attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding to the fullest extent and in the manner set forth in and permitted by the General Corporation Law of the State of Delaware, and any other applicable law, as from time to time in effect. To the maximum extent permitted by law, the Corporation shall advance expenses (including attorneys’ fees) incurred by such person indemnified hereunder in defending any civil, criminal, administrative or investigative action, suit or proceeding upon an undertaking by or on behalf of such person to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the Corporation. Such rights of indemnification and advancement of expenses shall not be deemed to be exclusive of any other rights to which such director or officer may be entitled apart from the foregoing provisions. The foregoing provisions of this Section 1 shall be deemed to be a contract between the Corporation and each director and officer who serves in such capacity at any time while this Section 1 and the relevant provisions of the General Corporation Law of the State of Delaware and other applicable law, if any, are in effect, and

10

any repeal or modification thereof shall not affect any rights or obligations then existing, with respect to any state of facts then or theretofore existing, or any action, suit or proceeding theretofore or thereafter brought or threatened based in whole or in part upon any such state of facts.

SECTION 2. The Corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was an employee or agent of the Corporation, or is or was serving at the request of the Corporation, as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including, but not limited to, attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding to the extent and in the manner set forth in and permitted by the General Corporation Law of the State of Delaware and any other applicable law as from time to time in effect. Such right of indemnification shall not be deemed to be exclusive of any other rights to which any such person may be entitled apart from the foregoing provisions.

ARTICLE VII

LIABILITY FOR BREACH OF FIDUCIARY DUTY

No director shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty by the director as a director. Notwithstanding the foregoing sentence, a director shall be liable to the extent provided by applicable law (i) for breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the General Corporation Law of the State of Delaware, or (iv) for any transaction from which the director derived an improper personal benefit. No amendment to or repeal of this Article VII shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any act or omission of a director occurring prior to such amendment.

ARTICLE VIII

BUSINESS COMBINATIONS

SECTION 1. In addition to any affirmative vote required by law or this Certificate of Incorporation or the By-laws of the Corporation, and except as otherwise expressly provided in Section 2 of this Article VIII, a Business Combination (as defined below) shall require the affirmative vote of at least a majority of the votes entitled to be cast by the holders of all the then outstanding shares of Voting Stock, voting together as a single class, excluding Voting Stock beneficially owned by the Interested Stockholder. Such affirmative vote shall be required notwithstanding the fact that no vote may be required, or that a lesser percentage or separate class vote may be specified, by law or in any agreement with any national securities exchange or otherwise.

SECTION 2. The provisions of Section 1 of this Article VIII shall not be applicable to any particular Business Combination, and such Business Combination shall require only such affirmative vote, if any, as is required by law or by any other provision of this Certificate of Incorporation or the By-laws of the Corporation, or any agreement with any national securities exchange, if all of the conditions specified in either of the following paragraphs (a) or (b) are met, or in the case of a Business Combination not involving the payment of consideration to the holders of the Corporation’s

11

outstanding Capital Stock (as defined below), if the conditions specified in the following paragraph (a) are met:

(a) The Business Combination shall have been approved, either specifically or as a transaction which is within an approved category of transactions, by a majority (whether such approval is made prior to or subsequent to the acquisition of, or announcement or public disclosure of the intention to acquire, beneficial ownership of the Voting Stock that caused the Interested Stockholder to become an Interested Stockholder) of the Continuing Directors.

(b) All of the following conditions shall have been met:

(i) The aggregate amount of cash and the Fair Market Value (as defined below), as of the date of the consummation of the Business Combination, of consideration other than cash to be received per share by holders of Common Stock (as defined below) in such Business Combination shall be at least equal to the highest amount determined under clauses (A) and (B) below.

(A) (if applicable) the highest per share price (including any brokerage commissions, transfer taxes and soliciting dealers’ fees) paid by or on behalf of the Interested Stockholder for any share of Common Stock in connection with the acquisition by the Interested Stockholder of beneficial ownership of shares of Common Stock (x) within the two-year period immediately prior to the first public announcement of the proposed Business Combination (the “Announcement Date”) or (y) in the transaction in which it became an Interested Stockholder, whichever is higher, in either case as adjusted for any subsequent stock split, subdivision or reclassification with respect to the Common Stock; and

(B) the Fair Market Value per share of the Common Stock on the Announcement Date or on the date on which the Interested Stockholder became an Interested Stockholder (the “Determination Date”), whichever is higher, as adjusted for any subsequent stock split, stock dividend, subdivision or reclassification with respect to the Common Stock.

(ii) The aggregate amount of cash and the Fair Market Value, as of the date of the consummation of the Business Combination, of consideration other than cash to be received per share by holders of shares of any class or series of outstanding Capital Stock, other than Common Stock, shall be at least equal to the highest amount determined under clauses (A), (B) and (C) below:

(A) (if applicable) the highest per share price (including any brokerage commission, transfer taxes and soliciting dealers’ fees) paid by or on behalf of the Interested Stockholder for any share of such class or series of Capital Stock in connection with the acquisition by the Interested Stockholder of beneficial ownership of shares of such class or series of Capital Stock (x) within the two year period immediately prior to the Announcement Date or (y) in the transaction in which it became an Interested Stockholder, whichever is higher, in either case as adjusted for any subsequent stock split, stock dividend, subdivision or reclassification with respect to such class or series of Capital Stock;

12

(B) the Fair Market Value per share of such class or series of Capital Stock on the Announcement Date or on the Determination Date, whichever is higher, as adjusted for any subsequent stock split, stock dividend, subdivision or reclassification with respect to such class or series of Capital Stock; and

(C) (if applicable) the highest preferential amount per share to which the holders of shares of such class or series of Capital Stock would be entitled in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation regardless of whether the Business Combination to be consummated constitutes such an event.

The provisions of this paragraph (b) shall be required to be met with respect to every class or series of outstanding Capital Stock, whether or not the Interested Stockholder has previously acquired beneficial ownership of any shares of a particular class or series of Capital Stock.

(iii) The consideration to be received by holders of a particular class or series of outstanding Capital Stock shall be in cash or in the same form as previously has been paid by or on behalf of the Interested Stockholder in connection with its direct or indirect acquisition of beneficial ownership of shares of such class or series of Capital Stock. If the consideration so paid for shares of any class or series of Capital Stock varied as to form, the form of consideration for such class or series of Capital Stock shall be either cash or the form used to acquire beneficial ownership of the largest number of shares of such class or series of Capital Stock previously issued by the Interested Stockholder.

(iv) After the Determination Date or prior to the consummation of such Business Combination, (A) except as approved by a majority of the Continuing Directors, there shall have been no failure to declare and pay at the regular date therefor any full quarterly dividends (whether or not cumulative) payable in accordance with the terms of any outstanding Capital Stock; (B) there shall have been no reduction in the annual rate of dividends paid on the Common Stock (except as necessary to reflect any stock split, stock dividend or subdivision of the Common Stock) except as approved by a majority of the Continuing Directors; (C) there shall have been an increase in the annual rate of dividends paid on the Common Stock as necessary to reflect any reclassification (including any reverse stock split), recapitalization, reorganization or any similar transaction that has the effect of reducing the number of outstanding shares of Common Stock, unless the failure so to increase such annual rate is approved by a majority of the Continuing Directors; and (D) such Interested Stockholder shall not have become the beneficial owner of any additional shares of Capital Stock except as part of the transaction that results in such Interested Stockholder becoming an Interested Stockholder and except in a transaction that, after giving the effect thereto, would not result in any increase in the Interested Stockholder’s percentage beneficial ownership of any class or series of Capital Stock.

(v) After the Determination Date, such Interested Stockholder shall not have received the benefit, directly or indirectly (except proportionately as a stockholder of the Corporation), of any loans, advances, guarantees, pledges or other financial assistance or any tax credits or other tax advantages provided by the Corporation,

13

whether in anticipation of or in connection with such Business Combination or otherwise.

(vi) A proxy or information statement describing the proposed Business Combination and complying with the requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) (or any subsequent provisions replacing such Exchange Act, rules or regulations) shall be mailed to all stockholders of the Corporation at least 30 days prior to the consummation of such Business Combination (whether or not such proxy or information statement is required to be mailed pursuant to the Exchange Act or subsequent provisions). The proxy or information statement shall contain on the first page thereof, in a prominent place, any statement as to the advisability (or inadvisability) of the Business Combination that the Continuing Directors, or any of them, may choose to make and, if deemed advisable by a majority of the Continuing Directors, the opinion of an investment banking firm selected by a majority of the Continuing Directors as to the fairness (or unfairness) of the terms of the Business Combination from a financial point of view to the holders of the outstanding shares of Capital Stock other than the Interested Stockholder and its Affiliates or Associates, such investment banking firm to be paid a reasonable fee for its services by the Corporation.

(vii) Such Interested Stockholder shall not have made any major change in the Corporation’s business or equity capital structure without the approval of a majority of the Continuing Directors.

SECTION 3. The following definitions shall apply with respect to this Article VIII:

(a) The term “Business Combination” shall mean:

(i) any merger or consolidation of the Corporation or any Subsidiary (as defined below) with, or proposed by or on behalf of, (x) any Interested Stockholder or (y) any other corporation (whether or not itself an Interested Stockholder) which is or after such merger or consolidation would be an Affiliate or Associate of an Interested Stockholder; or

(ii) any sale, lease, exchange, mortgage, pledge, transfer or other disposition or security arrangement, investment, loan, advance, guarantee, agreement to purchase, agreement to pay, extension of credit, joint venture participation or other arrangement (in one transaction or a series of transactions) with or for the benefit of, or proposed by or on behalf of, any Interested Stockholder or any Affiliate or Associate of any Interested Stockholder involving any assets, securities or commitments of the Corporation, any Subsidiary or any Interested Stockholder or any Affiliate or Associate of any Interested Stockholder which, together with all other such arrangements (including all contemplated future events), has an aggregate Fair Market Value and/or involves aggregate commitments of $10,000,000 or more or constitutes more than five percent (5%) of the book value of the total assets (in the case of transactions involving assets or commitments other than Capital Stock) or five percent (5%) of the stockholders’ equity (in the case of transactions in Capital Stock) of the entity in question (the “Substantial Part”), as reflected in the most recent fiscal year-end consolidated balance sheet of such entity existing at the time the

14

stockholders of the Corporation would be required to approve or authorize the Business Combination involving the assets, securities and/or commitments constituting any Substantial Part; or

(iii) the adoption of any plan or proposal for the liquidation or dissolution of the Corporation or for any amendment to the Corporation’s By-laws or to this Certificate of Incorporation proposed by or on behalf of an Interested Stockholder or any Affiliate or Associate of any Interested Stockholder; or

(iv) any reclassification of securities (including any reverse stock split), or recapitalization of the Corporation, or any merger or consolidation of the Corporation with any of its subsidiaries or any other transaction (whether or not with or otherwise involving an Interested Stockholder) that has the effect, directly or indirectly, of increasing the proportionate share of any class or series of Capital Stock, or any securities convertible into Capital Stock or into equity securities of any Subsidiary, that is beneficially owned by any Interested Stockholder or any Affiliate or Associate of any Interested Stockholder; or

(v) any agreement, contract or other arrangement providing for any one or more of the actions specified in the foregoing clauses (i) to (iv).

(b) The term “Capital Stock” shall mean all capital stock of the Corporation authorized to be issued from time to time under Article IV of this Certificate of Incorporation. The term “Voting Stock” shall mean all Capital Stock which by its terms may be voted on all matters submitted to stockholders of the Corporation generally.

(c) The term “person” shall mean any individual, firm, corporation or other entity and shall include any group comprised of any person and any other person with whom such person or any Affiliate or Associate of such person has any agreement, arrangement or understanding, directly or indirectly, for the purpose of acquiring, holding, voting or disposing of Capital Stock.

(d) The term “Interested Stockholder” shall mean any person (other than the Corporation or any Subsidiary and other than any profit-sharing, employee stock ownership or other employee benefit plan of the Corporation or any Subsidiary or any trustee of or fiduciary with respect to any such plan when acting in such capacity or the Co-Presidents of the Corporation on January 28, 1994) who (i) is or has announced or publicly disclosed a plan or intention to become the beneficial owner of Voting Stock representing ten percent (10%) or more of the votes entitled to be cast by the holders of all then outstanding shares of Voting Stock; or (ii) is an Affiliate or Associate (other than the Co-Presidents of the Corporation on January 28, 1994) of the Corporation and at any time within the two year period immediately prior to the date in question was the beneficial owner of Voting Stock representing ten percent (10%) or more of the votes entitled to be cast by the holders of all then outstanding shares of Voting Stock.

(e) A person shall be a “beneficial owner” of any Capital Stock (i) which such person or any of its Affiliates or Associates beneficially owns, directly or indirectly; (ii) which such person or any of its Affiliates or Associates has, directly or indirectly, (A) the right to acquire (whether such right is exercisable immediately or subject only to the passage of time), pursuant to an agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise, or (B) the right to vote pursuant to any agreement, arrangement or understanding; or (iii) which is beneficially owned, directly or indirectly, by any other person with

15

which such person or any of its Affiliates or Associates has any agreement, arrangement or understanding for the purpose of acquiring, holding, voting or disposing of any shares of Capital Stock. For the purpose of determining whether a person is an Interested Stockholder pursuant to paragraph (d) of this Section 3, the number of shares of Capital Stock deemed to be outstanding shall include shares deemed beneficially owned by such person through application of this paragraph (e) of Section 3 but shall not include any other shares of Capital Stock that may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise.

(f) The terms “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 under the Exchange Act as in effect on January 28, 1994 (the term “registrant” in said Rule 12b-2 meaning in this case the Corporation).

(g) The term “Subsidiary” means any company of which a majority of any class of equity security is beneficially owned by the Corporation; provided, however, that for the purposes of the definition of Interested Stockholder set forth in paragraph (d) of this Section 3, the term “Subsidiary” shall mean only a company of which a majority of each class of equity security is beneficially owned by the Corporation.

(h) The term “Continuing Director” means any member of the Board of Directors, while such person is a member of the Board of Directors, who is not an Affiliate or Associate or representative of the Interested Stockholder and was a member of the Board of Directors prior to the time that an Interested Stockholder became an Interested Stockholder, and any successor of a Continuing Director while such successor is a member of the Board of Directors, who is not an Affiliate or Associate or representative of the Interested Stockholder and is recommended or elected to succeed the Continuing Director by a majority of the Continuing Directors.

(i) “Fair Market Value” means (i) in the case of cash, the amount of such cash; (ii) in the case of stock, the highest closing sale price during the 30-day period immediately preceding the date in question of a share of such stock on the Composite Tape for New York Stock Exchange-Listed Stocks, or, if such stock is not quoted on the Composite Tape, on the New York Stock Exchange, or, if such stock is not listed on such exchange, on the principal United States securities exchange registered under the Exchange Act on which such stock is listed, or, if such stock is not listed on any such exchange, the highest closing bid quotation with respect to a share of such stock during the 30-day period preceding the date in question on the National Association of Securities Dealers, Inc. Automated Quotations System or any similar system then in use, or if no such quotations are available, the fair market value on the date in question of a share of such stock as determined by a majority of the Continuing Directors in good faith; and (iii) in the case of property other than cash or stock, the Fair Market Value of such property on the date in question as determined in good faith by a majority of the Continuing Directors.

(j) In the event of any Business Combination in which the Corporation survives, the phrase “consideration other than cash to be received” as used in paragraphs (b)(i) and (b)(ii) of Section 2 of this Article VIII shall include the shares of Common Stock and/or the shares of any other class or series of Capital Stock retained by the holders of such shares.

SECTION 4. A majority of the Continuing Directors shall have the power and duty to determine for the purpose of this Article VIII, on the basis of information known to them after reasonable inquiry, all questions arising under this Article VIII, including, without limitation, (i) whether a person is an Interested Stockholder, (ii) the number of shares of Capital Stock or other

16

securities beneficially owned by any person, (iii) whether a person is an Affiliate or Associate of another, (iv) whether a Proposed Action (as defined below) is with, or proposed by, or on behalf of an Interested Stockholder or an Affiliate or Associate of an Interested Stockholder, (v) whether the assets that are the subject of any Business Combination have or the consideration to be received for the issuance or transfer of securities by the Corporation or any Subsidiary in any Business Combination has, an aggregated Fair Market Value of Ten Million Dollars 10,000,000) or more and (vi) whether the assets or securities that are the subject of any Business Combination constitute a Substantial Part. Any such determination made in good faith shall be binding and conclusive on all parties.

SECTION 5. Nothing contained in this Article VIII shall be construed to relieve any Interested Stockholder from any fiduciary obligation imposed by law.

SECTION 6. The fact that any Business Combination complies with the provisions of Section 2 of this Article VIII shall not be construed to impose any fiduciary duty, obligation or responsibility on the Board of Directors, or any member thereof, to approve such Business Combination or recommend its adoption or approval to the stockholders of the Corporation, nor shall such compliance limit, prohibit or otherwise restrict in any manner the Board of Directors, or any member thereof, with respect to evaluations of, or actions and responses taken with respect to, such Business Combination.

SECTION 7. For purposes of this Article VIII, a Business Combination or any proposal to amend, repeal or adopt any provision of this Certificate of Incorporation inconsistent with this Article VIII (collectively, “Proposed Action”) is presumed to have been proposed by, or on behalf of, an Interested Stockholder or an Affiliate or Associate of an Interested Stockholder or a person who thereafter would become such if (i) after the Interested Stockholder became such, the Proposed Action is proposed following the election of any director of the Corporation who, with respect to such Interested Stockholder, would not qualify to serve as a Continuing Director or (ii) such Interested Stockholder, Affiliate, Associate or person votes for or consents to the adoption of any such Proposed Action, unless as to such Interested Stockholder, Affiliate, Associate or person, a majority of the Continuing Directors makes a good-faith determination that such Proposed Action is not proposed by or on behalf of such Interested Stockholder, Affiliate, Associate or person, based on information known to them after reasonable inquiry.

SECTION 8. Notwithstanding any other provisions of this Certificate of Incorporation or the By-laws of the Corporation (and notwithstanding the fact that a lesser percentage or separate class vote may be specified by law, this Certificate of Incorporation or the By-laws of the Corporation), the affirmative vote of the holders of a majority of the votes entitled to be cast by the holders of all the then outstanding shares of Voting Stock, voting together as a single class, excluding Voting Stock beneficially owned by such Interested Stockholders, shall be required to amend or repeal, or adopt any provisions inconsistent with, this Article VIII; provided, however, that the foregoing provisions of this Section 8 shall not apply to (and such additional vote of stockholders provided thereby shall not be required for) any amendment, repeal or adoption of any such provision that is unanimously recommended by the Board of Directors if all of such directors are persons who would be eligible to serve as Continuing Directors within the meaning of Section 3, paragraph (h), of this Article VIII.

ARTICLE IX

BOOKS AND RECORDS

17

The books and records of the Corporation may be kept (subject to any provision contained in the statutes) outside the State of Delaware at such place or places as may be designated from time to time by the Board of Directors or in the By-laws of the Corporation.

ARTICLE X

RIGHT TO AMEND CERTIFICATE OF INCORPORATION

The Corporation reserves the right to Change (as defined in Article V) any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute and by the terms hereof, and all rights conferred upon stockholders herein are granted subject to this reservation.

18

IN WITNESS WHEREOF, Health Net, Inc. has caused this Seventh Amended and Restated Certificate of Incorporation to be signed by Angelee F. Bouchard, its Secretary, this 20th day of May, 2011.

HEALTH NET, INC.,
a Delaware corporation
By:	/s/ Angelee F. Bouchard
	Angelee F. Bouchard
	Senior Vice President, General Counsel and Secretary

19

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Jay M. Gellert, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Health Net, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2011	/s/    JAY M. GELLERT
	Jay M. Gellert
	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Joseph C. Capezza, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Health Net, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2011	/s/    JOSEPH C. CAPEZZA
	Joseph C. Capezza
	Chief Financial Officer

EX-32

Exhibit 32

Certification of CEO and CFO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Health Net, Inc. (the “Company”) for the quarterly period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Jay M. Gellert, as Chief Executive Officer of the Company, and Joseph C. Capezza, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    JAY M. GELLERT        

Jay M. Gellert

Chief Executive Officer

August 8, 2011

/s/    JOSEPH C. CAPEZZA        

Joseph C. Capezza

Chief Financial Officer

August 8, 2011

XML



Consolidated Balance Sheets (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
ASSETS
Cash and cash equivalents	$ 166,503	$ 350,138
Investments-available-for-sale (amortized cost: 2011-$1,566,673, 2010-$1,653,502)	1,576,132	1,663,218
Premiums receivable, net of allowance for doubtful accounts (2011-$3,408, 2010-$6,613)	348,567	298,892
Amounts receivable under government contracts	334,868	266,456
Incurred but not reported (IBNR) health care costs receivable under TRICARE North contract	52,373	284,247
Other receivables	93,868	136,323
Deferred taxes	16,990	45,769
Other assets	232,636	182,252
Total current assets	2,821,937	3,227,295
Property and equipment, net	122,713	123,137
Goodwill	605,886	605,886
Other intangible assets, net	22,413	24,217
Deferred taxes	41,886	50,648
Investments-available-for-sale-noncurrent (amortized cost: 2011-$0, 2010-$10,447)	0	8,756
Other noncurrent assets	120,535	91,754
Total Assets	3,735,370	4,131,693
LIABILITIES AND STOCKHOLDERS' EQUITY
Reserves for claims and other settlements	900,724	942,024
Health care and other costs payable under government contracts	94,219	113,865
IBNR health care costs payable under TRICARE North contract	52,373	284,247
Unearned premiums	160,613	158,493
Borrowings under revolving credit facility	185,000	0
Accounts payable and other liabilities	229,735	402,024
Total current liabilities	1,622,664	1,900,653
Senior notes payable	398,788	398,685
Other noncurrent liabilities	223,962	137,939
Total Liabilities	2,245,414	2,437,277
Commitments and contingencies
Stockholders' Equity:
Preferred stock ($0.001 par value, 10,000 shares authorized, none issued and outstanding)	0	0
Common stock ($0.001 par value, 350,000 shares authorized; issued 2011-146,707 shares; 2010-145,121 shares )	147	145
Additional paid-in capital	1,265,061	1,221,301
Treasury common stock, at cost (2011-57,002 shares of common stock; 2010-50,474 shares of common stock)	(1,826,076)	(1,626,856)
Retained earnings	2,049,444	2,099,339
Accumulated other comprehensive income	1,380	487
Total Stockholders' Equity	1,489,956	1,694,416
Total Liabilities and Stockholders' Equity	$ 3,735,370	$ 4,131,693

XML



Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data	Jun. 30, 2011	Dec. 31, 2010
Investments available for sale, amortized cost	$ 1,566,600
Premiums receivable, allowance for doubtful accounts	3,408	6,613
Total available-for-sale, amortized cost	1,566,600
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares issued	146,707,000	145,121,000
Treasury stock, shares	57,002,000	50,474,000
Current [Member]
Investments available for sale, amortized cost	1,566,673	1,653,502
Total available-for-sale, amortized cost	1,566,673	1,653,502
Noncurrent [Member]
Investments available for sale, amortized cost	0	10,447
Total available-for-sale, amortized cost	$ 0	$ 10,447

XML



Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2011

Jun. 30, 2010

Changes in the Balances of Level 3 Financial Assets on Recurring Basis

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Beginning balance on April 1 and January 1	$	9.9	$	10.0	$	9.9	$	10.0
Transfers into Level 3		0		0		0		0
Transfers out of Level 3		0		0		0		0
Total gains and losses
Realized in net income		0		0		0		0
Unrealized in accumulated other comprehensive income		0		0		0		0
Purchases, sales, issuances and settlements
Purchases/additions		0.8		0		0.8		0
Sales		0		0		0		0
Issuances		0		0		0		0
Settlements		0		0		0		0
Ending balance		10.7	$	10.0		10.7	$	10.0
Change in unrealized gains (losses) included in net income related to assets still held	$	0	$	0	$	0	$	0

Changes in the Balances of Level 3 Financial Assets on Non-Recurring Basis

	Three Months Ended June 30, 2010			Six Months Ended June 30, 2010
Beginning Northeast Operations' goodwill balance on April 1 and January 1	$	6.0		$	6.0
Impairment related to Northeast Operations		(6.0	)		(6.0	)
Ending Northeast Operations' goodwill balance	$	0		$	0

Fair Value, Measurements, Recurring [Member]

Assets and Liabilities measured at Fair Value on Recurring Basis

	Level 1		Level 2- current		Level 2- noncurrent		Level 3		Total
As of June 30, 2011
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	526.8	$	0	$	0	$	526.8
Commercial mortgage-backed securities		0		87.0		0		0		87.0
Other asset-backed securities		0		57.1		0		0		57.1
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		62.8		0		0		62.8
Obligations of states and other political subdivisions		0		473.9		0		9.9		483.8
Corporate debt securities		0		332.8		0		0		332.8
Other securities		0.1		0		0		0		0.1
Total investments at fair value	$	25.8	$	1,540.4	$	0	$	9.9	$	1,576.1
Embedded contractual derivative		0		0		0		0.8		0.8
Total assets at fair value	$	25.8	$	1,540.4	$	0	$	10.7	$	1,576.9
As of December 31, 2010
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	527.6	$	0	$	0	$	527.6
Commercial mortgage-backed securities		0		80.4		0		0		80.4
Other asset-backed securities		0		40.2		0		0		40.2
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		77.6		0		0		77.6
Obligations of states and other political subdivisions		0		517.3		8.8		9.9		536.0
Corporate debt securities		0		384.5		0		0		384.5
Other securities		0		0		0		0		0
Total assets at fair value	$	25.7	$	1,627.6	$	8.8	$	9.9	$	1,672.0

Fair Value, Measurements, Nonrecurring [Member]

Assets and Liabilities Measured at Fair Value

	Level 1		Level 2		Level 3		Total Loss
As of June 30, 2010
Goodwill—Northeast Operations	$	0	$	0	$	0	$	(6.0	)

XML



Document and Entity Information	6 Months Ended
	Jun. 30, 2011	Aug. 03, 2011	Dec. 31, 2010
Document and Entity Information
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2011
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q2
Entity Registrant Name	HEALTH NET INC
Entity Central Index Key	0000916085
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		89,083,967
Treasury Stock, Shares	57,002,000	57,634,331	50,474,000

XML



Subsequent Event (Details)	6 Months Ended
	Jun. 30, 2011
Subsequent Event
Date of subsequent event	Aug. 01, 2011
Enrollment of beneficiaries, effective date	September 1, 2011
CMS sanctions, effective date	November 2010
Annual enrollment, start date	October 15, 2011
Annual enrollment, effective date	January 1, 2012

XML



Significant Accounting Policies (Earnings per Share, Goodwill and Restricted Assets) (Narrative) (Details) (USD $)	1 Months Ended		3 Months Ended		6 Months Ended
	May 31, 2011	Mar. 31, 2010	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Common stock equivalents			1,507,000	791,000		929,000
Option to purchase of common stock			1,328,000	2,712,000		2,700,000
Stock repurchase program authorized amount	$ 300,000,000	$ 300,000,000
Stock repurchase program remaining authorized repurchase amount					272,900,000
Impairment related to Northeast Operations			0	(6,000,000)	0	(6,000,000)
Restricted cash and cash equivalents included in other noncurrent assets			300,000		300,000		400,000
Investment securities held by trustees or agencies			25,700,000		25,700,000		25,800,000
Northeast Operations Health Plan Services Premiums [Member]
Impairment related to Northeast Operations				$ (6,000,000)
Performance Share Units [Member] | Restricted Stock Units [Member]
Common stock equivalents					1,530,000

XML



Income Taxes (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Income Taxes
Effective income tax rate	34.10%	42.10%	(380.70%)	41.50%
Deferred tax benefit, long-term			$ 51.1

XML



Stock Repurchase Program

6 Months Ended

Jun. 30, 2011

Stock Repurchase Program

Stock Repurchase Program

5.    STOCK REPURCHASE PROGRAM

On March 18, 2010, our Board of Directors authorized the 2010 stock repurchase program pursuant to which a total of $300 million of our common stock could be repurchased.  We completed our 2010 stock repurchase program in April 2011.  During the three and six months ended June 30, 2011, we repurchased 1.4 million shares and 4.9 million shares, respectively, of our common stock for aggregate consideration of approximately $45.2 million and $149.8 million, respectively, under our 2010 stock repurchase program.  As of June 30, 2011, we had repurchased an aggregate of 10.8 million shares of our common stock under our 2010 stock repurchase program since its inception at an average price of $27.80 per share for aggregate consideration of $300 million.

On May 4, 2011, our Board of Directors authorized our 2011 stock repurchase program pursuant to which a total of $300 million of our outstanding common stock could be repurchased. Subject to Board approval, we may repurchase our common stock under our 2011 stock repurchase program from time to time in privately negotiated transactions, through accelerated stock repurchase programs or open market transactions, including pursuant to a trading plan in accordance with Rules 10b5-1 and 10b-18 of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of stock repurchases will depend on a variety of factors, including the stock price, corporate and regulatory requirements, restrictions under the Company's debt obligations, and other market and economic conditions. Our 2011 stock repurchase program may be suspended or discontinued at any time.

During the three months ended June 30, 2011, we repurchased 870,000 shares of our common stock for aggregate consideration of approximately $27.1 million under our 2011 stock repurchase program. The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. We used net free cash available, including cash at the parent company, Health Net, Inc., to fund the share repurchases.

XML



Significant Accounting Policies (Interest Rate Swap Contracts, Subsequent Accounting for the Northeast Sale and Award of New TRICARE Contract) (Narrative) (Details) (USD $)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2011	Mar. 31, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Final estimated quarterly net payment	$ 19,700,000
Asset impairment	(6,283,000)		(8,171,000)	(41,137,000)	(8,171,000)
Other receivables	93,868,000			93,868,000		136,323,000
Costs paid and reimbursable	421,600,000			421,600,000
Northeast Operations Health Plan Services Premiums [Member]
Amortization of deferred revenue	500,000		24,600,000	2,700,000	27,100,000
Percentage of profits or losses associated with sold business						50.00%
Profits from transferred business		7,000,000				10,000,000
Asset impairment	6,300,000		8,200,000	41,100,000	8,200,000
Other receivables	41,300,000			41,300,000
Deferred revenue	48,000,000			48,000,000
Government Contracts [Member]
Effective date of T-3 TRICARE Contract				April 1, 2011
Deferred costs, transition-in activities	43,800,000			43,800,000
Deferred revenue	52,500,000			52,500,000
Northeast Operations Segment [Member]
Termination date of United ASA				July 1, 2011
Membership transition date				July 1, 2011
Contingent Membership Renewal [Member]
Initial payment for membership transferred				$ 60,000,000

XML



Fair Value Measurements (Assets and Liabilities Measured at Fair Value) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Investments-available-for-sale	$ 1,576,100,000		$ 1,576,100,000
Total assets at fair value	1,576,900,000		1,576,900,000		1,672,000,000
Goodwill	(605,886,000)		(605,886,000)		(605,886,000)
Impairment related to Northeast Operations	0	(6,000,000)	0	(6,000,000)
Western Region Operations Health Plan Services Premiums [Member]
Goodwill	(605,900,000)		(605,900,000)
Fair Value, Measurements, Nonrecurring [Member] | Northeast Operations Health Plan Services Premiums [Member]
Goodwill		(6,000,000)		(6,000,000)
Northeast Operations Goodwill beginning balance		6,000,000		6,000,000
Impairment related to Northeast Operations		(6,000,000)		(6,000,000)
Northeast Operations Goodwill ending balance		0		0
Fair Value, Measurements, Nonrecurring [Member] | Northeast Operations Health Plan Services Premiums [Member] | Fair Value, Inputs, Level 1 [Member]
Goodwill		0		0
Fair Value, Measurements, Nonrecurring [Member] | Northeast Operations Health Plan Services Premiums [Member] | Fair Value, Inputs, Level 2 [Member]
Goodwill		0		0
Fair Value, Measurements, Nonrecurring [Member] | Northeast Operations Health Plan Services Premiums [Member] | Fair Value, Inputs, Level 3 [Member]
Goodwill		0		0
Northeast Operations Health Plan Services Premiums [Member]
Impairment related to Northeast Operations		(6,000,000)
Embedded Derivative [Member]
Total assets at fair value	800,000		800,000
Embedded Derivative [Member] | Fair Value, Inputs, Level 1 [Member]
Total assets at fair value	0		0
Embedded Derivative [Member] | Fair Value Inputs Level 2 Current [Member]
Total assets at fair value	0		0
Embedded Derivative [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Total assets at fair value	0		0
Embedded Derivative [Member] | Fair Value, Inputs, Level 3 [Member]
Total assets at fair value	800,000		800,000
Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Fair Value Inputs Level 2 Current [Member] | Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale	87,000,000		87,000,000
Asset-backed Securities [Member] | Fair Value Inputs Level 2 Current [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale	57,100,000		57,100,000
Asset-backed Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member] | Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member] | Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale	0		0
Asset-backed Securities [Member] | Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale	87,000,000		87,000,000
Asset-backed Securities [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale	57,100,000		57,100,000
Corporate Debt Securities [Member]
Investments-available-for-sale	332,800,000		332,800,000		384,500,000
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	0		0		0
Corporate Debt Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	332,800,000		332,800,000		384,500,000
Corporate Debt Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0		0
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	0		0		0
Residential Mortgage Backed Securities [Member]
Investments-available-for-sale	526,800,000		526,800,000
Residential Mortgage Backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	0		0
Residential Mortgage Backed Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	526,800,000		526,800,000
Residential Mortgage Backed Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0
Residential Mortgage Backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	0		0
Fair Value, Inputs, Level 1 [Member] | Residential Mortgage Backed Securities [Member]
Investments-available-for-sale					0
Fair Value Inputs Level 2 Current [Member] | Residential Mortgage Backed Securities [Member]
Investments-available-for-sale					527,600,000
Fair Value Inputs Level 2 Noncurrent [Member] | Residential Mortgage Backed Securities [Member]
Investments-available-for-sale					0
Fair Value, Inputs, Level 3 [Member] | Residential Mortgage Backed Securities [Member]
Investments-available-for-sale					0
Residential Mortgage Backed Securities [Member]
Investments-available-for-sale					527,600,000
Other Securities [Member]
Investments-available-for-sale	100,000		100,000		0
Other Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	100,000		100,000		0
Other Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	0		0		0
Other Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0		0
Other Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	0		0		0
Commercial Mortgage Backed Securities [Member]
Investments-available-for-sale					80,400,000
Commercial Mortgage Backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale					0
Commercial Mortgage Backed Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale					80,400,000
Commercial Mortgage Backed Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale					0
Commercial Mortgage Backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale					0
Other Asset Backed Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale					0
Other Asset Backed Securities [Member] | Fair Value Inputs Level 2 Current [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale					40,200,000
Other Asset Backed Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale					0
Other Asset Backed Securities [Member] | Fair Value, Inputs, Level 3 [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale					0
Other Asset Backed Securities [Member] | Other Asset Backed Securities [Member]
Investments-available-for-sale					40,200,000
U.S. Treasury Securities [Member]
Investments-available-for-sale	25,700,000		25,700,000		25,700,000
U.S. Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	25,700,000		25,700,000		25,700,000
U.S. Treasury Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	0		0		0
U.S. Treasury Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0		0
U.S. Treasury Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	0		0		0
U.S. Agency Securities [Member]
Investments-available-for-sale	62,800,000		62,800,000		77,600,000
U.S. Agency Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	0		0		0
U.S. Agency Securities [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	62,800,000		62,800,000		77,600,000
U.S. Agency Securities [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0		0
U.S. Agency Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	0		0		0
Obligations of States and Other Political Subdivisions [Member]
Investments-available-for-sale	483,800,000		483,800,000		536,000,000
Obligations of States and Other Political Subdivisions [Member] | Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	0		0		0
Obligations of States and Other Political Subdivisions [Member] | Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	473,900,000		473,900,000		517,300,000
Obligations of States and Other Political Subdivisions [Member] | Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0		8,800,000
Obligations of States and Other Political Subdivisions [Member] | Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	9,900,000		9,900,000		9,900,000
Fair Value, Inputs, Level 1 [Member]
Investments-available-for-sale	25,800,000		25,800,000
Total assets at fair value	25,800,000		25,800,000		25,700,000
Fair Value Inputs Level 2 Current [Member]
Investments-available-for-sale	1,540,400,000		1,540,400,000
Total assets at fair value	1,540,400,000		1,540,400,000		1,627,600,000
Fair Value Inputs Level 2 Noncurrent [Member]
Investments-available-for-sale	0		0
Total assets at fair value	0		0		8,800,000
Fair Value, Inputs, Level 3 [Member]
Investments-available-for-sale	9,900,000		9,900,000
Total assets at fair value	$ 10,700,000		$ 10,700,000		$ 9,900,000

XML



Investments (Number of Securities Included In Loss Position of Current and Noncurrent Investments) (Details) (Current [Member])	Jun. 30, 2011 securities
Less than 12 months number of securities	180
12 months or more number of securities	1
Total number of securities	181
Asset-backed Securities [Member]
Less than 12 months number of securities	54
12 months or more number of securities	0
Total number of securities	54
Obligations of States and Other Political Subdivisions [Member]
Less than 12 months number of securities	50
12 months or more number of securities	1
Total number of securities	51
U.S. Government and Agencies [Member]
Less than 12 months number of securities	1
12 months or more number of securities	0
Total number of securities	1
Corporate Debt Securities [Member]
Less than 12 months number of securities	75
12 months or more number of securities	0
Total number of securities	75
Other Securities [Member]
Less than 12 months number of securities	0
12 months or more number of securities	0
Total number of securities	0

XML



Significant Accounting Policies (Cash and Equivalents, Investments, Fair Value of Financial Instruments and Concentrations of Credit Risk) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Checks outstanding, net of deposits	$ 37.1		$ 45.9
Other-than-temporary impairments	0	0
Concentration Risk, Percentage	100.00%
Fixed Income Interest Rate [Member]
Fair value of borrowings	414.0		401.2
Variable Income Interest Rate [Member]
Fair value of borrowings	$ 185.0

XML



Income Taxes

6 Months Ended

Jun. 30, 2011

Income Taxes

Income Taxes

10.    INCOME TAXES

The effective income tax rate was 34.1% and 42.1% for the three months ended June 30, 2011 and 2010, respectively, and (380.7)% and 41.5% for the six months ended June 30, 2011 and 2010, respectively. The change in the effective income tax rate from 2010 is primarily the result of the decision rendered in 2011 by the Louisiana Supreme Court in the AmCareco litigation (see Note 8). The decision resulted in deferred tax assets of $51.1 million for which realization is uncertain and as such, a valuation allowance for the full amount was established as of March 31, 2011.

XML



Basis of Presentation

6 Months Ended

Jun. 30, 2011

Basis of Presentation

Basis of Presentation

1.    BASIS OF PRESENTATION

Health Net, Inc. prepared the accompanying unaudited consolidated financial statements following the rules and regulations of the Securities and Exchange Commission (SEC) for interim reporting. In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms "Company," "Health Net," "we," "us," and "our" refer to Health Net, Inc. and its subsidiaries. As permitted under those rules and regulations, certain notes or other financial information that are normally required by accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted if they substantially duplicate the disclosures contained in the annual audited financial statements. The accompanying unaudited consolidated financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2010 (Form 10-K).

We are responsible for the accompanying unaudited consolidated financial statements. These consolidated financial statements include all normal and recurring adjustments that are considered necessary for the fair presentation of our financial position and operating results in accordance with GAAP. In accordance with GAAP, we make certain estimates and assumptions that affect the reported amounts. Actual results could differ from those estimates and assumptions. In addition, revenues, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these interim financial statements may not be indicative of those for the full year.

Certain items presented in the operating cash flow section of the consolidated statements of cash flows for the six months ended June 30, 2010 have been reclassified within the operating cash flow section. This reclassification had no impact on our operating cash flows, net earnings or balance sheets as previously reported.

XML



Investments (Fair Value of Investments Available-for-Sale) (Details) (USD $)	Jun. 30, 2011	Dec. 31, 2010
Amortized Cost	$ 1,566,600,000
Carrying Value	1,576,100,000
Asset-backed Securities [Member] | Current [Member]
Amortized Cost	667,700,000	642,300,000
Gross Unrealized Holding Gains	4,500,000	8,100,000
Gross Unrealized Holding Losses	(1,300,000)	(2,200,000)
Carrying Value	670,900,000	648,200,000
U.S. Government and Agencies [Member] | Current [Member]
Amortized Cost	88,300,000	103,600,000
Gross Unrealized Holding Gains	200,000	100,000
Gross Unrealized Holding Losses	0	(400,000)
Carrying Value	88,500,000	103,300,000
Corporate Debt Securities [Member] | Current [Member]
Amortized Cost	331,600,000	374,500,000
Gross Unrealized Holding Gains	2,200,000	11,800,000
Gross Unrealized Holding Losses	(1,000,000)	(1,800,000)
Carrying Value	332,800,000	384,500,000
Obligations of States and Other Political Subdivisions [Member] | Current [Member]
Amortized Cost	479,000,000	533,200,000
Gross Unrealized Holding Gains	5,900,000	2,100,000
Gross Unrealized Holding Losses	(1,100,000)	(8,100,000)
Carrying Value	483,800,000	527,200,000
Other Securities [Member] | Current [Member]
Amortized Cost	0	0
Gross Unrealized Holding Gains	100,000	0
Gross Unrealized Holding Losses	0	0
Carrying Value	100,000	0
Current [Member]
Amortized Cost	1,566,600,000	1,653,600,000
Gross Unrealized Holding Gains	12,900,000	22,100,000
Gross Unrealized Holding Losses	(3,400,000)	(12,500,000)
Carrying Value	1,576,100,000	1,663,200,000
Noncurrent [Member]
Amortized Cost		10,500,000
Gross Unrealized Holding Gains		0
Gross Unrealized Holding Losses		(1,700,000)
Carrying Value		$ 8,800,000

XML



Fair Value Measurements

6 Months Ended

Jun. 30, 2011

Fair Value Measurements

Fair Value Measurements

7.    FAIR VALUE MEASUREMENTS

We record certain assets and liabilities at fair value in the consolidated balance sheets and categorize them based upon the level of judgment associated with the inputs used to measure their fair value and the level of market price observability. We also estimate fair value when the volume and level of activity for the asset or liability have significantly decreased or in those circumstances that indicate when a transaction is not orderly.

Investments measured and reported at fair value using Level inputs are classified and disclosed in one of the following categories:

Level 1—Quoted prices are available in active markets for identical investments as of the reporting date. The types of investments included in Level 1 include U.S. Treasury securities and listed equities. We do not adjust the quoted price for these investments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.

Level 2—Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models and/or other valuation methodologies which are based on an income approach. Examples include but are not limited to multidimensional relational model, option adjusted spread model, and various matrices. Specific pricing inputs include quoted prices for similar securities in both active and non-active markets, other observable inputs such as interest rates, yield curve volatilities, default rates, and inputs that are derived principally from or corroborated by other observable market data. Investments that are generally included in this category include asset-backed securities, corporate bonds and loans, municipal bonds, auction rate securities and interest rate swap assets.

Level 3—Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation using assumptions that market participants would use, including assumptions for risk. The investments included in Level 3 are auction rate securities which have experienced failed auctions at one time or are experiencing failed auctions and thus have minimal liquidity. These bonds have frequent reset of coupon rates and have extended to the legal final maturity. The coupons are based on a margin plus a LIBOR rate and continue to pay above market rates. As with most variable or floating rate securities, we believe that based on a market approach, the fair values of these securities are equal to their par values due to the short time periods between coupon resets and based on each issuer's credit worthiness. Also included in the Level 3 category is a derivative held by the Company estimated at fair value. Significant inputs used in the derivative valuation model include the estimated growth in health care expenditures and the discount rate to estimate the present value of the cash flows. The growth in these expenditures was modeled using a Monte Carlo simulation approach. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

The following tables present information about our assets and liabilities measured at fair value on a recurring basis at June 30, 2011 and December 31, 2010, and indicate the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (dollars in millions):

	Level 1		Level 2- current		Level 2- noncurrent		Level 3		Total
As of June 30, 2011
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	526.8	$	0	$	0	$	526.8
Commercial mortgage-backed securities		0		87.0		0		0		87.0
Other asset-backed securities		0		57.1		0		0		57.1
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		62.8		0		0		62.8
Obligations of states and other political subdivisions		0		473.9		0		9.9		483.8
Corporate debt securities		0		332.8		0		0		332.8
Other securities		0.1		0		0		0		0.1
Total investments at fair value	$	25.8	$	1,540.4	$	0	$	9.9	$	1,576.1
Embedded contractual derivative		0		0		0		0.8		0.8
Total assets at fair value	$	25.8	$	1,540.4	$	0	$	10.7	$	1,576.9
As of December 31, 2010
Assets:
Investments—available-for-sale
Asset-backed debt securities:
Residential mortgage-backed securities	$	0	$	527.6	$	0	$	0	$	527.6
Commercial mortgage-backed securities		0		80.4		0		0		80.4
Other asset-backed securities		0		40.2		0		0		40.2
U.S. government and agencies:
U.S. Treasury securities		25.7		0		0		0		25.7
U.S. Agency securities		0		77.6		0		0		77.6
Obligations of states and other political subdivisions		0		517.3		8.8		9.9		536.0
Corporate debt securities		0		384.5		0		0		384.5
Other securities		0		0		0		0		0
Total assets at fair value	$	25.7	$	1,627.6	$	8.8	$	9.9	$	1,672.0

We had no transfers between Levels 1 and 2 of financial assets or liabilities that are fair valued on a recurring basis during the three and six months ended June 30, 2011 and 2010. In determining when transfers between levels are recognized, our accounting policy is to recognize the transfers based on the actual date of the event or change in circumstances that caused the transfer.

The changes in the balances of Level 3 financial assets for the three and six months ended June 30, 2011 and 2010 were as follows (dollars in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Beginning balance on April 1 and January 1	$	9.9	$	10.0	$	9.9	$	10.0
Transfers into Level 3		0		0		0		0
Transfers out of Level 3		0		0		0		0
Total gains and losses
Realized in net income		0		0		0		0
Unrealized in accumulated other comprehensive income		0		0		0		0
Purchases, sales, issuances and settlements
Purchases/additions		0.8		0		0.8		0
Sales		0		0		0		0
Issuances		0		0		0		0
Settlements		0		0		0		0
Ending balance		10.7	$	10.0		10.7	$	10.0
Change in unrealized gains (losses) included in net income related to assets still held	$	0	$	0	$	0	$	0

We had no financial assets or liabilities that were fair valued on a non-recurring basis during the three and six months ended June 30, 2011.

The following table presents information about financial assets measured at fair value on a non-recurring basis during the three and six months ended June 30, 2010 and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (dollars in millions):

	Level 1		Level 2		Level 3		Total Loss
As of June 30, 2010
Goodwill—Northeast Operations	$	0	$	0	$	0	$	(6.0	)

The changes in the balances of Level 3 financial assets that are fair valued on a non-recurring basis for the three and six months ended June 30, 2010 were as follows (dollars in millions):

	Three Months Ended June 30, 2010			Six Months Ended June 30, 2010
Beginning Northeast Operations' goodwill balance on April 1 and January 1	$	6.0		$	6.0
Impairment related to Northeast Operations		(6.0	)		(6.0	)
Ending Northeast Operations' goodwill balance	$	0		$	0

See Note 2 for a discussion on the goodwill valuation and the impairment of the Northeast Operations' goodwill.

XML



Significant Accounting Policies (Policy)

6 Months Ended

Jun. 30, 2011

Significant Accounting Policies

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with maturity of three months or less when purchased. We had checks outstanding, net of deposits, of $37.1 million as of June 30, 2011 and $45.9 million as of December 31, 2010. These amounts were classified as accounts payable and other liabilities in the consolidated balance sheets, and the changes in these amounts have been reflected in the line item net decrease in checks outstanding, net of deposits within the cash flows from financing activities in the consolidated statements of cash flows.

Investments

Investments

Investments classified as available-for-sale, which consist primarily of debt securities, are stated at fair value. Unrealized gains and losses are excluded from earnings and reported as other comprehensive income, net of income tax effects. The cost of investments sold is determined in accordance with the specific identification method, and realized gains and losses are included in net investment income. The Company analyzes all debt investments that have unrealized losses for impairment consideration and assesses the intent to sell such securities. If such intent exists, impaired securities are considered other-than-temporarily impaired. Management also assesses if the Company may be required to sell the debt investments prior to the recovery of amortized cost, which may also trigger an impairment charge. If securities are considered other-than-temporarily impaired based on intent or ability, management assesses whether the amortized costs of the securities can be recovered. If management anticipates recovering an amount less than its amortized cost, an impairment charge is calculated based on the expected discounted cash flows of the securities. Any deficit between the amortized cost and the expected cash flows is recorded through earnings as a charge. All other temporary impairment changes are recorded through other comprehensive income. During the three and six months ended June 30, 2011 and 2010, we did not recognize any losses from other-than-temporary impairments. See Note 4 to our consolidated financial statements for additional information regarding our investments.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The estimated fair value amounts of cash equivalents, investments available-for-sale, premiums and other receivables, notes receivable and notes payable have been determined by using available market information and appropriate valuation methodologies. The carrying amounts of cash equivalents approximate fair value due to the short maturity of those instruments. Fair values for debt and equity securities are generally based upon quoted market prices. Where quoted market prices were not readily available, fair values were estimated using valuation methodologies based on available and observable market information. Such valuation methodologies include reviewing the value ascribed to the most recent financing, comparing the security with securities of publicly traded companies in a similar line of business, and reviewing the underlying financial performance including estimating discounted cash flows. The carrying value of premiums and other receivables, long-term notes receivable and nonmarketable securities approximates the fair value of such financial instruments. The fair value of notes payable is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt with the same remaining maturities. The fair value of our fixed rate borrowings was $414.0 million and $401.2 million as of June 30, 2011 and December 31, 2010, respectively. The fair value of our variable rate borrowings under our revolving credit facility was $185.0 million as of June 30, 2011, which was equal to the carrying value because the interest rates paid on these borrowings were based on prevailing market rates. There were no borrowings outstanding under our revolving credit facility as of December 31, 2010. See Note 6 for additional information regarding our financing arrangements.

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments and premiums receivable. All cash equivalents and investments are managed within established guidelines, which provide us diversity among issuers. Concentrations of credit risk with respect to premiums receivable are limited due to the large number of payers comprising our customer base. The federal government is the primary customer of our Government Contracts segment (Government Contracts) with premiums and fees associated with this customer and, to a much lesser extent, state and local government contracts, accounting for 100% of our Government Contracts revenue. In addition, the federal government is a significant customer of our Western Region Operations segment (Western Region Operations) as a result of our contracts with the Centers for Medicare & Medicaid Services (CMS) for coverage of Medicare-eligible individuals.

Comprehensive Income

Comprehensive Income

Comprehensive income includes all changes in stockholders' equity (except those arising from transactions with stockholders) and includes net income, net unrealized appreciation (depreciation) after tax on investments available-for-sale, and prior service cost and net loss related to our defined benefit pension plan.

Accumulated other comprehensive income are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in millions)
Investments:
Unrealized (losses) gains on investments available-for-sale as of April 1 and January 1	$	(1.5	)	$	3.5		$	5.3		$	1.0
Net change in unrealized gains on investments available-for-sale		17.0			16.3			18.2			23.3
Reclassification of unrealized gains to earnings		(9.5	)		(2.6	)		(17.5	)		(7.1	)
Unrealized gains on investments available for sale as of June 30		6.0			17.2			6.0			17.2
Defined benefit pension plans:
Prior service cost and net loss amortization as of April 1 and January 1		(4.7	)		(0.9	)		(4.8	)		(0.9	)
Net change in prior service cost and net loss amortization		0.1			0.1			0.2			0.1
Prior service cost and net loss amortization as of June 30		(4.6	)		(0.8	)		(4.6	)		(0.8	)
Accumulated other comprehensive income	$	1.4		$	16.4		$	1.4		$	16.4

Earnings Per Share

Basic earnings per share excludes dilution and reflects net income divided by the weighted average shares of common stock outstanding during the periods presented. Diluted earnings per share is based upon the weighted average shares of common stock and dilutive common stock equivalents (this reflects the potential dilution that could occur if stock options were exercised and restricted stock units (RSUs) and performance share units (PSUs) were vested) outstanding during the periods presented.

Common stock equivalents arising from dilutive stock options, RSUs and PSUs are computed using the treasury stock method. For the three months ended June 30, 2011, 1,507,000 shares of dilutive common stock equivalents were outstanding. For the six months ended June 30, 2011, 1,530,000 shares were excluded from the computation of loss per share due to their anti-dilutive effect. There were 791,000 and 929,000 shares of dilutive common stock equivalents outstanding for the three and six months ended June 30, 2010, respectively.

Options, RSUs and PSUs to purchase an aggregate of 1,328,000 shares of common stock, during the three months ended June 30, 2011, and 2,712,000 and 2,700,000, during the three and six months ended June 30, 2010, respectively, were considered anti-dilutive and were not included in the computation of diluted earnings per share. Outstanding options expire at various times through April 2019.

In March 2010, our Board of Directors authorized a $300 million stock repurchase program (2010 stock repurchase program). We completed our 2010 stock repurchase program in April 2011. In May 2011, our Board of Directors authorized a new stock repurchase program for the repurchase of up to $300 million of our outstanding common stock (2011 stock repurchase program). The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. See Note 5 for more information regarding our 2010 and 2011 stock repurchase programs.

Earnings Per Share

Earnings Per Share

Basic earnings per share excludes dilution and reflects net income divided by the weighted average shares of common stock outstanding during the periods presented. Diluted earnings per share is based upon the weighted average shares of common stock and dilutive common stock equivalents (this reflects the potential dilution that could occur if stock options were exercised and restricted stock units (RSUs) and performance share units (PSUs) were vested) outstanding during the periods presented.

Common stock equivalents arising from dilutive stock options, RSUs and PSUs are computed using the treasury stock method. For the three months ended June 30, 2011, 1,507,000 shares of dilutive common stock equivalents outstanding. For the six months ended June 30, 2011, 1,530,000 shares were excluded from the computation of loss per share due to their anti-dilutive effect. There were 791,000 and 929,000 shares of dilutive common stock equivalents outstanding for the three and six months ended June 30, 2010, respectively.

Options, RSUs and PSUs to purchase an aggregate of 1,328,000 shares of common stock, during the three months ended June 30, 2011, and 2,712,000 and 2,700,000, during the three and six months ended June 30, 2010, respectively, were considered anti-dilutive and were not included in the computation of diluted earnings per share. Outstanding options expire at various times through April 2019.

In March 2010, our Board of Directors authorized a $300 million stock repurchase program (2010 stock repurchase program). We completed our 2010 stock repurchase program in April, 2011. In May 2011, our Board of Directors authorized a new stock repurchase program for the repurchase of up to $300 million of our outstanding common stock (2011 stock repurchase program). The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. See Note 5 for more information regarding our 2010 and 2011 stock repurchase programs.

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

The carrying amount of goodwill by reporting unit is as follows:

	Western Region Operations		Total
	(Dollars in millions)
Balance as of June 30, 2011 and December 31, 2010	$	605.9	$	605.9

The intangible assets that continue to be subject to amortization using the straight-line method over their estimated lives are as follows:

	Gross Carrying Amount		Accumulated Amortization			Net Balance		Weighted Average Life (in years)
	(Dollars in millions)
As of June 30, 2011:
Provider networks	$	40.5	$	(33.1	)	$	7.4		19.4
Customer relationships and other		29.5		(14.5	)		15.0		11.1
	$	70.0	$	(47.6	)	$	22.4
As of December 31, 2010:
Provider networks	$	40.5	$	(32.6	)	$	7.9		19.4
Customer relationships and other		29.5		(13.2	)		16.3		11.1
	$	70.0	$	(45.8	)	$	24.2

We performed our annual impairment test on our goodwill and other intangible assets as of June 30, 2011 for our Western Region Operations reporting unit, and no impairment was identified. We also re-evaluated the useful lives of our other intangible assets and determined that the current estimated useful lives were properly reflected.

During the three months ended June 30, 2010, we performed our annual impairment test and determined that the implied value of the Northeast Operations reporting unit's goodwill was zero. As a result, we recorded an impairment charge of $6 million for the total carrying value of the Northeast Operations' goodwill during the three months ended June 30, 2010.

Estimated annual pretax amortization expense for other intangible assets for the current year and each of the next four years ending December 31 is as follows (dollars in millions):

Year	Amount
2011	$	3.5
2012		3.4
2013		3.4
2014		2.8
2015		2.6

Restricted Assets

Restricted Assets

We and our consolidated subsidiaries are required to set aside certain funds which may only be used for certain purposes pursuant to state regulatory requirements. We have discretion as to whether we invest such funds in cash and cash equivalents or other investments. As of June 30, 2011 and December 31, 2010, the restricted cash and cash equivalents balances totaled $0.3 million and $0.4 million, respectively, and are included in other noncurrent assets. Investment securities held by trustees or agencies were $25.7 million and $25.8 million as of June 30, 2011 and December 31, 2010, respectively, and are included in investments available-for-sale.

Subsequent Accounting for the Northeast Sale

Subsequent Accounting for the Northeast Sale

On December 11, 2009, we completed the sale (the Northeast Sale) of all of the outstanding shares of capital stock of our health plan subsidiaries that were domiciled in Connecticut, New Jersey, New York and Bermuda (Acquired Companies) that had conducted businesses in our Northeast Operations segment (see Note 3) to UnitedHealth Group Incorporated (United). The sale was made pursuant to a Stock Purchase Agreement (Stock Purchase Agreement), dated as of July 20, 2009, by and among the Company, Health Net of the Northeast, Inc., Oxford Health Plans, LLC (Buyer) and, solely for the purposes of guaranteeing Buyer's obligations thereunder, United. At the closing of the Northeast Sale, affiliates of United also acquired membership renewal rights for certain commercial health care business conducted by our subsidiary, Health Net Life Insurance Company (Health Net Life) in the states of Connecticut and New Jersey (the Transitioning HNL Members). We were required to continue to serve the members of the Acquired Companies under United Administrative Services Agreements we entered into with United and certain of its affiliates (the United Administrative Services Agreements) until all members are either transitioned to a legacy United entity or non-renewed, which occurred on July 1, 2011. As part of the Northeast Sale, we retained certain financial responsibilities for the profits and losses of the Acquired Companies, subject to specified adjustments, for the period beginning on the closing date and ending on the earlier of the second anniversary of the closing date and the date that the last United Administrative Services Agreement was terminated. Accordingly, subsequent to the Northeast Sale, our Northeast Operations reportable segment (Northeast Operations) includes the operations of the businesses that provided administrative services pursuant to the United Administrative Services Agreements prior to the termination of the United Administrative Services Agreements on July 1, 2011, as well as the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Subsequent accounting for the Northeast Sale is reported as part of our Northeast Operations reportable segment (see Note 3).

Under the United Administrative Services Agreements, we provided claims processing, customer services, medical management, provider network access and other administrative services to United and certain of its affiliates. We recognized the revenue that we earned from providing these administrative services in the period these services were provided, and we reported such revenue in the line item, Northeast administrative services fees and other income, in our consolidated statements of operations. Also included in Northeast administrative services fees and other income was the amortization of the value of services provided under the United Administrative Services Agreements. In connection with the Northeast Sale, the United Administrative Services Agreements were fair valued at $48 million and recorded as deferred revenue. The deferred revenue was amortized and recorded as Northeast administrative services fees and other income using a level of effort approach. During the three months ended June 30, 2011 and 2010, $0.5 million and $24.6 million, respectively, and during the six months ended June 30, 2011 and 2010, $2.7 million and $27.1 million, respectively, were amortized from deferred revenue and recorded as Northeast administrative services fees and other income.

In addition, we were entitled to 50% of the profits or losses associated with the Acquired Companies' Medicare business for the year ended December 31, 2010 (subject to a cap of $10 million of profit or loss), and in the first quarter of 2011, we received $7 million related to our share of the profit associated with the Acquired Companies' Medicare business. The Medicare business was transferred to a United affiliate on January 1, 2011. As part of the Northeast Sale, we also retained certain financial responsibilities for the Acquired Companies, subject to specified adjustments for the period beginning on the closing date of the transaction and ending on the date that the last United Administrative Services Agreement was terminated. Accordingly, the Northeast administrative services fees and other income included a quarterly net payment (QNP) paid to United in accordance with the terms of the Stock Purchase Agreement. The QNP is a defined term in the Stock Purchase Agreement and represented the net profit or loss from the wind-down of the Acquired Companies, as adjusted in accordance with the Stock Purchase Agreement. We reported expenses we incurred in providing these administrative services as a separate line item, Northeast administrative services expenses, in our consolidated statements of operations.

Under the Stock Purchase Agreement, United is required to pay us additional consideration for the value of the Transitioning HNL Members and the members of the Acquired Companies that transitioned to other United products based upon a formula set forth in the Stock Purchase Agreement to the extent such amounts exceed the initial minimum payment of $60 million that United made to us at closing (referred to as contingent membership renewals). This membership transition was completed on July 1, 2011. In connection with contingent membership renewals, we recorded as an adjustment to the loss on sale of the Northeast health plan subsidiaries $6.3 million and $41.1 million in the three and six months ended June 30, 2011, respectively, and $8.2 million in the three and six months ended June 30, 2010. As of June 30, 2011, $41.3 million was due from United in connection with contingent membership renewals.

With the termination of the United Administrative Services Agreements on July 1, 2011, we have estimated and recorded the final QNP of $19.7 million in the second quarter of 2011. This estimated amount is subject to review by United, and the final QNP after such a review may be materially different than the amount recorded. At this time, we expect to complete the QNP review process with United by December 31, 2011. Upon the termination of the United Administrative Services Agreements, we entered into Claims Servicing Agreements with United and certain of its affiliates pursuant to which we will continue to adjudicate run out claims and perform limited other administrative services. The Claims Servicing Agreements will be in effect until the last run out claim under the applicable Claims Servicing Agreement has been adjudicated.

T-3 TRICARE Contract

T-3 TRICARE Contract

On April 1, 2011, we began delivering administrative services under the new Managed Care Support Contract (T-3) for the TRICARE North Region. The T-3 contract was awarded to us on May 13, 2010. We were the managed care contractor for the United States Department of Defense's (DoD) previous TRICARE contract in the North Region, which ended on March 31, 2011.

The T-3 contract has five one-year option periods; however, on March 15, 2011, the DoD exercised option period 2 (without exercising option period 1), due to a delay of approximately one year in the government's initial award of the T-3 contract. Accordingly, option period 2 commenced on April 1, 2011, and if all remaining option periods are exercised, the T-3 contract would conclude on March 31, 2015.

We provide various types of administrative services under the contract, including: provider network management, referral management, medical management, disease management, enrollment, customer service, clinical support service, and claims processing. We also provide assistance in the transition into and out of the T-3 contract. These services are structured similar to administrative services only (ASO) arrangements with fees received in the form of cost plus fixed price, and fixed unit price, and contingent fees and payments based on various incentives and penalties.

In accordance with GAAP, we evaluate, at the inception of the contract and as services are delivered, all deliverables in the service arrangement to determine whether they represent separate units of accounting. The delivered items are considered separate units of accounting if the delivered items have value to the customer on a standalone basis (i.e., they are sold separately by any vendor) and no general right of return exists relative to the delivered item. While we identified two separate units of accounting within the T-3 contract, no determination of estimated selling price was performed because both units of accounting are performed ratably over the option periods and, accordingly, the same methodology of revenue recognition applies to both units of accounting.

We recognize revenue related to administrative services on a straight line basis over the option period, when the fees become fixed and determinable.

The contract includes various performance-based incentives and penalties. For each of the incentives or penalties, we adjust revenue accordingly based on the amount that we have earned or incurred at each interim date and are legally entitled to in the event of a contract termination.

The transition-in process for the T-3 contract began in the second quarter of 2010. As of June 30, 2011, revenue in the amount of $52.5 million related to the transition-in activities has been recognized as an upfront fee, and amortized over the four-year customer relationship period on a straight-line basis. We have also deferred $43.8 million of costs related to the transition-in activities as of June 30, 2011. These deferred transition-in costs began amortizing on April 1, 2011 on a straight-line basis with the related deferred revenue over the customer relationship period. Fulfillment costs associated with the T-3 contract are expensed as incurred.

Revenues and expenses associated with the T-3 contract are reported as part of Government Contracts revenues and Government Contracts expenses in the consolidated statements of operations and included in the Government Contracts reportable segment.

The TRICARE members are served by our network and out-of-network providers in accordance with the T-3 contract. We pay health care costs related to these services to the providers and are later reimbursed by the DoD for such payments. Under the terms of the T-3 contract, we are not the primary obligor for health care services and accordingly, we do not include health care costs and related reimbursements in our consolidated statement of operations. Health care costs for the T-3 contract that are paid and reimbursable amounted to $421.6 million for the three and six months ended June 30, 2011.

XML



Legal Proceedings

6 Months Ended

Jun. 30, 2011

Legal Proceedings

Legal Proceedings

8.    LEGAL PROCEEDINGS

Litigation and Investigations Related to Unaccounted-for Server Drives

We are a defendant in three related litigation matters pending in California state and federal courts relating to information security issues. On January 21, 2011, International Business Machines Corp. (IBM), which handles our data center operations, notified us that it could not locate several hard disk drives that had been used in our data center located in Rancho Cordova, California. We have since determined that personal information of approximately two million former and current Health Net members, employees and health care providers is on the drives. Commencing on March 14, 2011, we provided written notification to the individuals whose information is on the drives. To help protect the personal information of affected individuals, we offered them two years of free credit monitoring services, in addition to identity theft insurance and fraud resolution and restoration of credit files services, if needed.

On March 18, 2011, a putative class action relating to this incident was filed against us in the U.S. District Court for the Central District of California, and similar actions were later filed against us in other federal and state courts in California. A number of those actions were transferred to and consolidated in the U.S. District Court for the Eastern District of California, and the two remaining actions are currently pending in San Francisco County Superior Court and the U.S. District Court for the Central District of California. The consolidated amended complaint in the federal action pending in the Eastern District of California is filed on behalf of a putative class of over 800,000 of our current or former members who received the written notification, and also names IBM as a defendant. It seeks to state claims for violation of the California Confidentiality of Medical Information Act and the California Customer Records Act, and seeks statutory damages of up to $1,000 for each class member, as well as injunctive and declaratory relief, attorneys' fees and other relief. We have not yet filed a response to the consolidated complaint.

The other federal court proceeding was instituted on July 7, 2011 in Riverside County Superior Court and is brought on behalf of a putative nationwide class of all former and current members affected by this incident, and seeks to state similar claims against us , as well as a claim for invasion of privacy. We removed this case to the Central District of California on August 1, 2011. We have not yet filed a response to the complaint in this action.

          The San Francisco Superior Court proceeding was instituted on March 28, 2011 and is brought on behalf of a putative class of California residents who received the written notification, and seeks to state similar claims against us, as well as claims for violation of the Unfair Competition Law, and seeks similar relief. We have moved to compel arbitration of the two named plaintiffs' claims.

We have also been informed that a number of regulatory agencies are investigating the incident, including the California Department of Managed Health Care, the California Department of Insurance, the California Office of the Attorney General, the Connecticut Attorney General, the Connecticut Department of Insurance, and the Office of Civil Rights of the U.S. Department of Health and Human Services.

We intend to vigorously defend ourselves against these claims; however, these proceedings are subject to many uncertainties. At this time we cannot reasonably estimate the range of loss that may result from these legal and regulatory proceedings in light of the facts that (i) legal and regulatory proceedings are inherently unpredictable, (ii) there are multiple parties in each of the disputes (and uncertainty as to how liability, if any, may be shared among the defendants), (iii) the proceedings are in their early stages and discovery is not complete, (iv) there are significant facts in dispute, (v) the matters present legal uncertainties, (vi) there is a wide range of potential outcomes in each dispute and (vii) there are various levels of judicial review available to us in each matter in the event damages are awarded or fines or penalties are assessed. Nevertheless, an adverse resolution of or development in the proceedings could have a material adverse affect on our financial condition, results of operations, cash flow and liquidity and could affect our reputation.

Litigation Related to the Sale of Businesses

We were a defendant in two related litigation matters pending in Louisiana and Texas state courts, both of which related to claims asserted by three separate state receivers overseeing the liquidation of three health plans in Louisiana, Texas and Oklahoma that were previously owned by our former subsidiary, Foundation Health Corporation (FHC), which merged into Health Net, Inc. in January 2001. In 1999, FHC sold its interest in these plans to AmCareco, Inc. (AmCareco). We retained a minority interest in the three plans after the sale. Thereafter, the three plans became known as AmCare of Louisiana (AmCare-LA), AmCare of Oklahoma (AmCare-OK) and AmCare of Texas (AmCare-TX). In 2002, three years after the sale of the plans to AmCareco, each of the AmCare plans was placed under state oversight and ultimately into receivership. The receivers for each of the AmCare plans filed suit against us, contending that we bore responsibility for the plans failing and ultimately being placed into receivership.

On June 16, 2005, a consolidated trial of the claims asserted against us by the three receivers commenced in state court in Baton Rouge, Louisiana. The claims of the receiver for AmCare-TX were tried before a jury and the claims of the receivers for the AmCare-LA and AmCare-OK were tried before the judge in the same proceeding. On June 30, 2005, the jury considering the claims of the receiver for AmCare-TX returned a verdict against us in the amount of $117.4 million, consisting of $52.4 million in compensatory damages and $65 million in punitive damages. The court later reduced the compensatory and punitive damages awards to $36.7 million and $45.5 million, respectively, and entered judgments against us in those amounts.

The proceedings regarding the claims of the receivers for AmCare-LA and AmCare-OK concluded on July 8, 2005. On November 4, 2005, the court issued separate judgments on those claims and awarded $9.5 million in compensatory damages to AmCare-LA and $17 million in compensatory damages to AmCare-OK, respectively. We appealed these judgments, and on December 30, 2008, the court of appeal issued its judgment on each of the appeals. It reversed in their entirety the trial court's judgments in favor of the AmCare-TX and AmCare-OK receivers, and entered judgment in our favor against those receivers, finding that the receivers' claims failed as a matter of law. The court of appeal also reversed the trial court judgment in favor of the AmCare-LA receiver, with the exception of a single breach of contract claim, on which it entered judgment in favor of the AmCare-LA receiver in the amount of $2 million.

Each of the receivers ultimately filed applications for a writ with the Louisiana Supreme Court, which were granted in 2009. On April 1, 2011, the Louisiana Supreme Court reinstated the original jury verdict in favor of the AmCare-TX receiver and affirmed the trial court's judgment notwithstanding the verdict reducing the jury's compensatory damages award. The Louisiana Supreme Court reversed the trial court's judgment notwithstanding the verdict reducing the jury's award of punitive damages to the AmCare-TX receiver. The Louisiana Supreme Court also reinstated the trial court's judgments in favor of the AmCare-OK and AmCare-LA receivers. We filed a request for rehearing with the Louisiana Supreme Court, which was denied on April 29, 2011. On May 6, 2011, we filed a motion to stay enforcement on the portion of the judgment relating to the punitive damage award with the Louisiana Supreme Court, which was denied. We subsequently sought a stay of enforcement of the punitive damages award from the United States Supreme Court, which was also denied. As a result of the Louisiana Supreme Court's decision, we recorded in general and administrative expenses a pretax charge of $177.2 million, or $157.9 million after tax, in the first quarter of 2011. During the quarter ended June 30, 2011, we fully satisfied the entirety of the judgment rendered by the Louisiana Supreme Court, paying a total of $181.3 million to the three receivers, inclusive of all accrued interest and court costs. Our net income per diluted share for the six months ended June 30, 2011 decreased by $1.72 due to the charges related to this judgment.

Miscellaneous Proceedings

In the ordinary course of our business operations, we are subject to periodic reviews, investigations and audits by various federal and state regulatory agencies with respect to our compliance with a wide variety of rules and regulations applicable to our business, including, without limitation, the Health Insurance Portability and Accountability Act of 1996, or HIPAA, rules relating to pre-authorization penalties, payment of out-of-network claims, timely review of grievances and appeals, and timely and accurate payment of claims, any one of which may result in remediation of certain claims, contract termination, the loss of licensure or the right to participate in certain programs, and the assessment of regulatory fines or penalties, which could be substantial. From time to time, we receive subpoenas and other requests for information from, and are subject to investigations by, such regulatory agencies, as well as from state attorneys general. There also continues to be heightened review by regulatory authorities of, and increased litigation regarding, the health care industry's business practices, including, without limitation, information privacy, premium rate increases, utilization management, appeal and grievance processing, rescission of insurance coverage and claims payment practices.

In addition, in the ordinary course of our business operations, we are party to various other legal proceedings, including, without limitation, litigation arising out of our general business activities, such as contract disputes, employment litigation, wage and hour claims, real estate and intellectual property claims, claims brought by members seeking coverage or additional reimbursement for services allegedly rendered to our members, but which allegedly were denied, underpaid, not timely paid or not paid, and claims arising out of the acquisition or divestiture of various business units or other assets. We are also subject to claims relating to the performance of contractual obligations to providers, members, employer groups and others, including the alleged failure to properly pay claims and challenges to the manner in which we process claims, and claims alleging that we have engaged in unfair business practices. In addition, we are subject to claims relating to information security incidents and breaches, reinsurance agreements, rescission of coverage and other types of insurance coverage obligations and claims relating to the insurance industry in general. We are, and may be in the future, subject to class action lawsuits brought against various managed care organizations and other class action lawsuits.

We intend to vigorously defend ourselves against the miscellaneous legal and regulatory proceedings to which we are currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against us, substantial non-economic or punitive damages are being sought.

We record reserves and accrue costs for certain legal proceedings and regulatory matters to the extent that we determine an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect our best estimate of the probable loss for such matters, our recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to that they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages, present novel legal theories, involve disputed facts, represent a shift in regulatory policy, involve a large number of parties, claimants or regulatory bodies, are in the early stages of the proceedings, or could result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding in the event damages are awarded or a fine or penalty is assessed. It is possible that in a particular quarter or annual period our financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including those described above in this Note 8 under the heading Litigation and Investigations Related to Unaccounted-for Server Drives," depending, in part, upon our financial condition, results of operations, cash flow or liquidity in such period, and our reputation may be adversely affected. Except for the regulatory and legal proceedings discussed in this Note 8 under the heading "Litigation and Investigations Related to Unaccounted-for Server Drives," management believes that the ultimate outcome of any of the regulatory and legal proceedings which are currently pending against us should not have a material adverse effect on our financial condition, results of operations, cash flow and liquidity.

Potential Settlements

We regularly evaluate legal proceedings and regulatory matters pending against us, including those described above in this Note 8, to determine if settlement of such matters would be in the best interests of the Company and its stockholders. The costs associated with any settlement of the various legal proceedings and regulatory matters to which we are or may be subject from time to time, including those described above in this Note 8, could be substantial and, in certain cases, could result in a significant earnings charge in any particular quarter in which we enter into a settlement agreement and could have a material adverse effect on our financial condition, results of operations, cash flow and/or liquidity and may affect our reputation.

XML



Segment Information (Segment Information) (Details) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues from external sources	$ 2,775.9	$ 3,437.0	$ 6,302.4	$ 6,853.1
Intersegment revenues	0	0	0	0
Segment pretax income (loss)	88.5	77.9	(10.4)	104.5
Western Region Operations Health Plan Services Premiums [Member]
Revenues from external sources	2,593.6	2,507.9	5,230.4	5,038.6
Intersegment revenues	3.0	13.0	5.9	25.1
Segment pretax income (loss)	72.5	58.1	109.0	98.8
Government Contracts [Member]
Revenues from external sources	171.0	851.9	1,046.1	1,661.4
Intersegment revenues	0	0	0	0
Segment pretax income (loss)	40.2	41.5	98.0	79.5
Northeast Operations Health Plan Services Premiums [Member]
Revenues from external sources	11.3	82.6	25.9	158.5
Intersegment revenues	0	0	0	0
Segment pretax income (loss)	(21.0)	(9.4)	(25.9)	(47.0)
Northeast Operations Segment [Member]
Termination date of United ASA			July 1, 2011
Start date of Claims Servicing Agreements			July 1, 2011
Corporate/Other/Eliminations [Member]
Revenues from external sources	0	(5.4)	0	(5.4)
Intersegment revenues	(3.0)	(13.0)	(5.9)	(25.1)
Segment pretax income (loss)	$ (3.2)	$ (12.3)	$ (191.5)	$ (26.8)

XML



Financing Arrangements

6 Months Ended

Jun. 30, 2011

Financing Arrangements

Financing Arrangements

6.    FINANCING ARRANGEMENTS

Termination of Amortizing Financing Facility

On May 26, 2010, we terminated our five-year non-interest bearing, $175 million amortizing financing facility with a non-U.S. lender that we entered into on December 19, 2007 by exercising our option to call the facility. In connection with the call, we recorded a $3.5 million pretax early debt extinguishment charge in the quarter ended June 30, 2010.

Senior Notes

In 2007 we issued $400 million in an aggregate principal amount of 6.375% Senior Notes due 2017 (Senior Notes). The indenture governing the Senior Notes limits our ability to incur certain liens, or consolidate, merge or sell all or substantially all of our assets. In the event of the occurrence of both (1) a change of control of Health Net, Inc. and (2) a below investment grade rating by any two of Fitch, Inc., Moody's Investors Service, Inc. and Standard & Poor's Ratings Services within a specified period, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes plus accrued and unpaid interest to the date of repurchase. As of June 30, 2011, no default or event of default had occurred under the indenture governing the Senior Notes.

The Senior Notes may be redeemed in whole at any time or in part from time to time, prior to maturity at our option, at a redemption price equal to the greater of:

• 100% of the principal amount of the Senior Notes then outstanding to be redeemed; or

• the sum of the present values of the remaining scheduled payments of principal and interest on the Senior Notes to be redeemed (not including any portion of such payments of interest accrued to the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the applicable treasury rate plus 30 basis points

plus, in each case, accrued and unpaid interest on the principal amount being redeemed to the redemption date.

Each of the following will be an Event of Default under the indenture governing the Senior Notes:

• failure to pay interest for 30 days after the date payment is due and payable; provided that an extension of an interest payment period by us in accordance with the terms of the Senior Notes shall not constitute a failure to pay interest;

• failure to pay principal or premium, if any, on any note when due, either at maturity, upon any redemption, by declaration or otherwise;

• failure to perform any other covenant or agreement in the notes or indenture for a period of 60 days after notice that performance was required;

• (A) our failure or the failure of any of our subsidiaries to pay indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, at the later of final maturity and the expiration of any related applicable grace period and such defaulted payment shall not have been made, waived or extended within 30 days after notice or (B) acceleration of the maturity of indebtedness for money we borrowed or any of our subsidiaries borrowed in an aggregate principal amount of at least $50 million, if that acceleration results from a default under the instrument giving rise to or securing such indebtedness for money borrowed and such indebtedness has not been discharged in full or such acceleration has not been rescinded or annulled within 30 days after notice; or

• events in bankruptcy, insolvency or reorganization of our Company.

Our Senior Notes payable balances were $398.8 million as of June 30, 2011 and $398.7 million as of and December 31, 2010, respectively.

Revolving Credit Facility

We have a $900 million five-year revolving credit facility with Bank of America, N.A. as Administrative Agent, Swingline Lender, and L/C Issuer, and the other lenders party thereto. As of June 30, 2011, $185.0 million was outstanding under our revolving credit facility and the maximum amount available for borrowing under the revolving credit facility was $654.8 million (see "—Letters of Credit" below). The revolving credit facility matures on June 25, 2012. Accordingly, the balance outstanding of $185.0 million as of June 30, 2011 is classified as a current liability.

Amounts outstanding under our revolving credit facility will bear interest, at our option, at (a) the base rate, which is a rate per annum equal to the greater of (i) the federal funds rate plus one-half of one percent and (ii) Bank of America's prime rate (as such term is defined in the facility), (b) a competitive bid rate solicited from the syndicate of banks, or (c) the British Bankers Association LIBOR rate (as such term is defined in the facility), plus an applicable margin, which is initially 70 basis points per annum and is subject to adjustment according to our credit ratings, as specified in the facility.

Our revolving credit facility includes, among other customary terms and conditions, limitations (subject to specified exclusions) on our and our subsidiaries' ability to incur debt; create liens; engage in certain mergers, consolidations and acquisitions; sell or transfer assets; enter into agreements which restrict the ability to pay dividends or make or repay loans or advances; make investments, loans, and advances; engage in transactions with affiliates; and make dividends. In addition, we are required to maintain a specified consolidated leverage ratio and consolidated fixed charge coverage ratio throughout the term of the revolving credit facility.

Our revolving credit facility contains customary events of default, including nonpayment of principal or other amounts when due; breach of covenants; inaccuracy of representations and warranties; cross-default and/or cross-acceleration to other indebtedness of the Company or our subsidiaries in excess of $50 million; certain ERISA-related events; noncompliance by us or any of our subsidiaries with any material term or provision of the HMO Regulations or Insurance Regulations (as each such term is defined in the facility); certain voluntary and involuntary bankruptcy events; inability to pay debts; undischarged, uninsured judgments greater than $50 million against us and/or our subsidiaries; actual or asserted invalidity of any loan document; and a change of control. If an event of default occurs and is continuing under the revolving credit facility, the lenders thereunder may, among other things, terminate their obligations under the facility and require us to repay all amounts owed thereunder.

Letters of Credit

We can obtain letters of credit in an aggregate amount of $400 million under our revolving credit facility. The maximum amount available for borrowing under our revolving credit facility is reduced by the dollar amount of any outstanding letters of credit. As of June 30, 2011 and December 31, 2010, we had outstanding letters of credit of $60.2 million and $249.1 million, respectively, resulting in a maximum amount available for borrowing under the revolving credit facility of $654.8 million and $650.9 million, respectively.  During the three months ended June 30, 2011, approximately $88.1 million in outstanding letters of credit were released in connection with our satisfaction of the entirety of the AmCareco litigation judgment (see Note 8 for more information on the AmCareco ruling).  As of June 30, 2011 and December 31, 2010, no amounts had been drawn on any of these letters of credit.

XML



Consolidated Statements of Stockholders' Equity (Parenthetical) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Consolidated Statements of Stockholders' Equity
Change in unrealized gain on investments, tax impact	$ 735	$ 10,007

XML



Significant Accounting Policies

6 Months Ended

Jun. 30, 2011

Significant Accounting Policies

Significant Accounting Policies

2.    SIGNIFICANT ACCOUNTING POLICIES

 Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with maturity of three months or less when purchased. We had checks outstanding, net of deposits, of $37.1 million as of June 30, 2011 and $45.9 million as of December 31, 2010. These amounts were classified as accounts payable and other liabilities in the consolidated balance sheets, and the changes in these amounts have been reflected in the line item net decrease in checks outstanding, net of deposits within the cash flows from financing activities in the consolidated statements of cash flows.

Investments

Investments classified as available-for-sale, which consist primarily of debt securities, are stated at fair value. Unrealized gains and losses are excluded from earnings and reported as other comprehensive income, net of income tax effects. The cost of investments sold is determined in accordance with the specific identification method, and realized gains and losses are included in net investment income. The Company analyzes all debt investments that have unrealized losses for impairment consideration and assesses the intent to sell such securities. If such intent exists, impaired securities are considered other-than-temporarily impaired. Management also assesses if the Company may be required to sell the debt investments prior to the recovery of amortized cost, which may also trigger an impairment charge. If securities are considered other-than-temporarily impaired based on intent or ability, management assesses whether the amortized costs of the securities can be recovered. If management anticipates recovering an amount less than its amortized cost, an impairment charge is calculated based on the expected discounted cash flows of the securities. Any deficit between the amortized cost and the expected cash flows is recorded through earnings as a charge. All other temporary impairment changes are recorded through other comprehensive income. During the three and six months ended June 30, 2011 and 2010, we did not recognize any losses from other-than-temporary impairments. See Note 4 to our consolidated financial statements for additional information regarding our investments.

Fair Value of Financial Instruments

The estimated fair value amounts of cash equivalents, investments available-for-sale, premiums and other receivables, notes receivable and notes payable have been determined by using available market information and appropriate valuation methodologies. The carrying amounts of cash equivalents approximate fair value due to the short maturity of those instruments. Fair values for debt and equity securities are generally based upon quoted market prices. Where quoted market prices were not readily available, fair values were estimated using valuation methodologies based on available and observable market information. Such valuation methodologies include reviewing the value ascribed to the most recent financing, comparing the security with securities of publicly traded companies in a similar line of business, and reviewing the underlying financial performance including estimating discounted cash flows. The carrying value of premiums and other receivables, long-term notes receivable and nonmarketable securities approximates the fair value of such financial instruments. The fair value of notes payable is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt with the same remaining maturities. The fair value of our fixed rate borrowings was $414.0 million and $401.2 million as of June 30, 2011 and December 31, 2010, respectively. The fair value of our variable rate borrowings under our revolving credit facility was $185.0 million as of June 30, 2011, which was equal to the carrying value because the interest rates paid on these borrowings were based on prevailing market rates. There were no borrowings outstanding under our revolving credit facility as of December 31, 2010. See Note 6 for additional information regarding our financing arrangements.

Concentrations of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments and premiums receivable. All cash equivalents and investments are managed within established guidelines, which provide us diversity among issuers. Concentrations of credit risk with respect to premiums receivable are limited due to the large number of payers comprising our customer base. The federal government is the primary customer of our Government Contracts segment (Government Contracts), with premiums and fees associated with this customer and, to a much lesser extent, state and local government contracts accounting for 100% of our Government Contracts revenue. In addition, the federal government is a significant customer of our Western Region Operations segment (Western Region Operations) as a result of our contracts with the Centers for Medicare & Medicaid Services (CMS) for coverage of Medicare-eligible individuals.

Comprehensive Income

Comprehensive income includes all changes in stockholders' equity (except those arising from transactions with stockholders) and includes net income, net unrealized appreciation (depreciation) after tax on investments available-for-sale, and prior service cost and net loss related to our defined benefit pension plan.

Accumulated other comprehensive income are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in millions)
Investments:
Unrealized (losses) gains on investments available-for-sale as of April 1 and January 1	$	(1.5	)	$	3.5		$	5.3		$	1.0
Net change in unrealized gains on investments available-for-sale		17.0			16.3			18.2			23.3
Reclassification of unrealized gains to earnings		(9.5	)		(2.6	)		(17.5	)		(7.1	)
Unrealized gains on investments available for sale as of June 30		6.0			17.2			6.0			17.2
Defined benefit pension plans:
Prior service cost and net loss amortization as of April 1 and January 1		(4.7	)		(0.9	)		(4.8	)		(0.9	)
Net change in prior service cost and net loss amortization		0.1			0.1			0.2			0.1
Prior service cost and net loss amortization as of June 30		(4.6	)		(0.8	)		(4.6	)		(0.8	)
Accumulated other comprehensive income	$	1.4		$	16.4		$	1.4		$	16.4

Earnings Per Share

Basic earnings per share excludes dilution and reflects net income divided by the weighted average shares of common stock outstanding during the periods presented. Diluted earnings per share is based upon the weighted average shares of common stock and dilutive common stock equivalents (this reflects the potential dilution that could occur if stock options were exercised and restricted stock units (RSUs) and performance share units (PSUs) were vested) outstanding during the periods presented.

Common stock equivalents arising from dilutive stock options, RSUs and PSUs are computed using the treasury stock method. For the three months ended June 30, 2011, 1,507,000 shares of dilutive common stock equivalents outstanding. For the six months ended June 30, 2011, 1,530,000 shares were excluded from the computation of loss per share due to their anti-dilutive effect. There were 791,000 and 929,000 shares of dilutive common stock equivalents outstanding for the three and six months ended June 30, 2010, respectively.

Options, RSUs and PSUs to purchase an aggregate of 1,328,000 shares of common stock, during the three months ended June 30, 2011, and 2,712,000 and 2,700,000, during the three and six months ended June 30, 2010, respectively, were considered anti-dilutive and were not included in the computation of diluted earnings per share. Outstanding options expire at various times through April 2019.

In March 2010, our Board of Directors authorized a $300 million stock repurchase program (2010 stock repurchase program). We completed our 2010 stock repurchase program in April, 2011. In May 2011, our Board of Directors authorized a new stock repurchase program for the repurchase of up to $300 million of our outstanding common stock (2011 stock repurchase program). The remaining authorization under our 2011 stock repurchase program as of June 30, 2011 was $272.9 million. See Note 5 for more information regarding our 2010 and 2011 stock repurchase programs.

Goodwill and Other Intangible Assets

The carrying amount of goodwill by reporting unit is as follows:

	Western Region Operations		Total
	(Dollars in millions)
Balance as of June 30, 2011 and December 31, 2010	$	605.9	$	605.9

The intangible assets that continue to be subject to amortization using the straight-line method over their estimated lives are as follows:

	Gross Carrying Amount		Accumulated Amortization			Net Balance		Weighted Average Life (in years)
	(Dollars in millions)
As of June 30, 2011:
Provider networks	$	40.5	$	(33.1	)	$	7.4		19.4
Customer relationships and other		29.5		(14.5	)		15.0		11.1
	$	70.0	$	(47.6	)	$	22.4
As of December 31, 2010:
Provider networks	$	40.5	$	(32.6	)	$	7.9		19.4
Customer relationships and other		29.5		(13.2	)		16.3		11.1
	$	70.0	$	(45.8	)	$	24.2

We performed our annual impairment test on our goodwill and other intangible assets as of June 30, 2011 for our Western Region Operations reporting unit, and no impairment was identified. We also re-evaluated the useful lives of our other intangible assets and determined that the current estimated useful lives were properly reflected.

During the three months ended June 30, 2010, we performed our annual impairment test and determined that the implied value of the Northeast Operations reporting unit's goodwill was zero. As a result, we recorded an impairment charge of $6 million for the total carrying value of the Northeast Operations' goodwill during the three months ended June 30, 2010. Estimated annual pretax amortization expense for other intangible assets for the current year and each of the next four years ending December 31 is as follows (dollars in millions):

Year	Amount
2011	$	3.5
2012		3.4
2013		3.4
2014		2.8
2015		2.6

Restricted Assets

We and our consolidated subsidiaries are required to set aside certain funds which may only be used for certain purposes pursuant to state regulatory requirements. We have discretion as to whether we invest such funds in cash and cash equivalents or other investments. As of June 30, 2011 and December 31, 2010, the restricted cash and cash equivalents balances totaled $0.3 million and $0.4 million, respectively, and are included in other noncurrent assets. Investment securities held by trustees or agencies were $25.7 million and $25.8 million as of June 30, 2011 and December 31, 2010, respectively, and are included in investments available-for-sale.

Subsequent Accounting for the Northeast Sale

On December 11, 2009, we completed the sale (the Northeast Sale) of all of the outstanding shares of capital stock of our health plan subsidiaries that were domiciled in Connecticut, New Jersey, New York and Bermuda (Acquired Companies) that had conducted businesses in our Northeast Operations segment (see Note 3) to UnitedHealth Group Incorporated (United). The sale was made pursuant to a Stock Purchase Agreement (Stock Purchase Agreement), dated as of July 20, 2009, by and among the Company, Health Net of the Northeast, Inc., Oxford Health Plans, LLC (Buyer) and, solely for the purposes of guaranteeing Buyer's obligations thereunder, United. At the closing of the Northeast Sale, affiliates of United also acquired membership renewal rights for certain commercial health care business conducted by our subsidiary, Health Net Life Insurance Company (Health Net Life) in the states of Connecticut and New Jersey (the Transitioning HNL Members). We were required to continue to serve the members of the Acquired Companies under United Administrative Services Agreements we entered into with United and certain of its affiliates (the United Administrative Services Agreements) until all members are either transitioned to a legacy United entity or non-renewed, which occurred on July 1, 2011. As part of the Northeast Sale, we retained certain financial responsibilities for the profits and losses of the Acquired Companies, subject to specified adjustments, for the period beginning on the closing date and ending on the earlier of the second anniversary of the closing date and the date that the last United Administrative Services Agreement was terminated. Accordingly, subsequent to the Northeast Sale, our Northeast Operations reportable segment (Northeast Operations) includes the operations of the businesses that provided administrative services pursuant to the United Administrative Services Agreements prior to the termination of the United Administrative Services Agreements on July 1, 2011, as well as the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Subsequent accounting for the Northeast Sale is reported as part of our Northeast Operations reportable segment (see Note 3).

Under the United Administrative Services Agreements, we provided claims processing, customer services, medical management, provider network access and other administrative services to United and certain of its affiliates. We recognized the revenue that we earned from providing these administrative services in the period these services were provided, and we reported such revenue in the line item, Northeast administrative services fees and other income, in our consolidated statements of operations. Also included in Northeast administrative services fees and other income was the amortization of the value of services provided under the United Administrative Services Agreements. In connection with the Northeast Sale, the United Administrative Services Agreements were fair valued at $48 million and recorded as deferred revenue. The deferred revenue was amortized and recorded as Northeast administrative services fees and other income using a level of effort approach. During the three months ended June 30, 2011 and 2010, $0.5 million and $24.6 million, respectively, and during the six months ended June 30, 2011 and 2010, $2.7 million and $27.1 million, respectively, were amortized from deferred revenue and recorded as Northeast administrative services fees and other income.

In addition, we were entitled to 50% of the profits or losses associated with the Acquired Companies' Medicare business for the year ended December 31, 2010 (subject to a cap of $10 million of profit or loss), and in the first quarter of 2011, we received $7 million related to our share of the profit associated with the Acquired Companies' Medicare business. The Medicare business was transferred to a United affiliate on January 1, 2011. As part of the Northeast Sale, we also retained certain financial responsibilities for the Acquired Companies, subject to specified adjustments for the period beginning on the closing date of the transaction and ending on the date that the last United Administrative Services Agreement was terminated. Accordingly, the Northeast administrative services fees and other income included a quarterly net payment (QNP) paid to United in accordance with the terms of the Stock Purchase Agreement. The QNP is a defined term in the Stock Purchase Agreement and represented the net profit or loss from the wind-down of the Acquired Companies, as adjusted in accordance with the Stock Purchase Agreement. We reported expenses we incurred in providing these administrative services as a separate line item, Northeast administrative services expenses, in our consolidated statements of operations.

         Under the Stock Purchase Agreement, United is required to pay us additional consideration for the value of the Transitioning HNL Members and the members of the Acquired Companies that transitioned to other United products based upon a formula set forth in the Stock Purchase Agreement to the extent such amounts exceed the initial minimum payment of $60 million that United made to us at closing (referred to as contingent membership renewals). This membership transition was completed on July 1, 2011. In connection with contingent membership renewals, we recorded as an adjustment to the loss on sale of the Northeast health plan subsidiaries $6.3 million and $41.1 million in the three and six months ended June 30, 2011, respectively, and $8.2 million in the three and six months ended June 30, 2010. As of June 30, 2011, $41.3 million was due from United in connection with contingent membership renewals.

        With the termination of the United Administrative Services Agreements on July 1, 2011, we have estimated and recorded the final QNP of $19.7 million in the second quarter of 2011. This estimated amount is subject to review by United, and the final QNP after such a review may be materially different than the amount recorded. At this time, we expect to complete the QNP review process with United by December 31, 2011. Upon the termination of the United Administrative Services Agreements, we entered into Claims Servicing Agreements with United and certain of its affiliates pursuant to which we will continue to adjudicate run out claims and perform limited other administrative services. The Claims Servicing Agreements will be in effect until the last run out claim under the applicable Claims Servicing Agreement has been adjudicated. 

T-3 TRICARE Contract

On April 1, 2011, we began delivering administrative services under the new Managed Care Support Contract (T-3) for the TRICARE North Region. The T-3 contract was awarded to us on May 13, 2010. We were the managed care contractor for the United States Department of Defense's (DoD) previous TRICARE contract in the North Region, which ended on March 31, 2011.

The T-3 contract has five one-year option periods; however, on March 15, 2011, the DoD exercised option period 2 (without exercising option period 1), due to a delay of approximately one year in the government's initial award of the T-3 contract. Accordingly, option period 2 commenced on April 1, 2011, and if all remaining option periods are exercised, the T-3 contract would conclude on March 31, 2015.

We provide various types of administrative services under the contract, including: provider network management, referral management, medical management, disease management, enrollment, customer service, clinical support service, and claims processing. We also provide assistance in the transition into and out of the T-3 contract. These services are structured similar to administrative services only (ASO) arrangements with fees received in the form of cost plus fixed price, and fixed unit price, and contingent fees and payments based on various incentives and penalties.

In accordance with GAAP, we evaluate, at the inception of the contract and as services are delivered, all deliverables in the service arrangement to determine whether they represent separate units of accounting. The delivered items are considered separate units of accounting if the delivered items have value to the customer on a standalone basis (i.e., they are sold separately by any vendor) and no general right of return exists relative to the delivered item. While we identified two separate units of accounting within the T-3 contract, no determination of estimated selling price was performed because both units of accounting are performed ratably over the option periods and, accordingly, the same methodology of revenue recognition applies to both units of accounting.

We recognize revenue related to administrative services on a straight line basis over the option period, when the fees become fixed and determinable.

The contract includes various performance-based incentives and penalties. For each of the incentives or penalties, we adjust revenue accordingly based on the amount that we have earned or incurred at each interim date and are legally entitled to in the event of a contract termination.

The transition-in process for the T-3 contract began in the second quarter of 2010. As of June 30, 2011, revenue in the amount of $52.5 million related to the transition-in activities has been recognized as an upfront fee, and amortized over the four-year customer relationship period on a straight-line basis. We have also deferred $43.8 million of costs related to the transition-in activities as of June 30, 2011. These deferred transition-in costs began amortizing on April 1, 2011 on a straight-line basis with the related deferred revenue over the customer relationship period. Fulfillment costs associated with the T-3 contract are expensed as incurred.

Revenues and expenses associated with the T-3 contract are reported as part of Government Contracts revenues and Government Contracts expenses in the consolidated statements of operations and included in the Government Contracts reportable segment.

The TRICARE members are served by our network and out-of-network providers in accordance with the T-3 contract. We pay health care costs related to these services to the providers and are later reimbursed by the DoD for such payments. Under the terms of the T-3 contract, we are not the primary obligor for health care services and accordingly, we do not include health care costs and related reimbursements in our consolidated statement of operations. Health care costs for the T-3 contract that are paid and reimbursable amounted to $421.6 million for the three and six months ended June 30, 2011.

Recently Issued Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-05, Comprehensive Income (Topic 220), Presentation of Comprehensive Income. The amendments in this update affect all entities that report items of other comprehensive income (OCI). Under the new guidance, the entities will no longer be allowed to present OCI in the statement of stockholders' equity. The entities are required to report components of comprehensive income in either a continuous statement of comprehensive income or two separate but consecutive statements. Under either method, entities must display adjustments for items that are reclassified from OCI to net income in both net income and OCI. Reclassification adjustments between OCI and net income have to be presented separately on the face of the financial statements. The amendments in this update do not change the items that must be reported in OCI or when an item of OCI must be reclassified to net income. Also, this ASU does not change the current option for entities to present components of OCI gross or net of the effect of income taxes as long as such tax effects are presented in the statement in which OCI is presented, or disclosed in the notes to the financial statements. This ASU does not affect how earnings per share is calculated or presented. The amendments in this update should be applied retrospectively and will become effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We do not expect the adoption of ASU No. 2011-05 to have a material effect on our financial condition or results of operations.

In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820), Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U. S. GAAP and IFRSs. The amendments in this ASU result in common fair value measurement and disclosure requirements in GAAP and International Financial Reporting Standards (IFRSs). Consequently, the amendments change the wording used to describe many of the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements. The FASB does not intend for these amendments to result in a change of application for many of the requirements in ASC 820, Fair Value Measurements and Disclosures. There are new disclosures requirements in this update including a disclosure of quantitative information about the unobservable inputs used for all Level 3 value measurements, a qualitative discussion about the sensitivity of recurring Level 3 measurements to changes in the unobservable inputs disclosed, and a description of the company's valuation processes. There are also additional disclosure requirements such as disclosure of any transfers between Levels 1 and 2 (not just significant transfers), information about when the current use of a non-financial asset measured at fair value differs from its highest and best use, and the hierarchy classification for items whose fair value is not recorded on the balance sheet but is disclosed in the notes to financial statements. ASU No. 2011-04 is effective for periods beginning after December 15, 2011. We do not expect the adoption of ASU No. 2011-04 to have a material impact on our financial condition or results of operations.

In July 2011, the FASB issued ASU No. 2011-06, Other Expenses (Topic 720), Fees Paid to the Federal Government by Health Insurers (a consensus of the FASB Emerging Task Force). This update affects reporting entities that are subject to the fee imposed on health insurers mandated by the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act (the Acts). The Acts impose an annual fee on health insurers for each calendar year beginning on or after January 1, 2014. This fee is not tax deductible and allocated to the individual health insurers based on the ratio of the amount of net premiums to the amount of health insurance for any U.S. health risk. This ASU addresses the recognition and classification of the entity's share of this imposed fee. The liability for the fee should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using a straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. The amendments in this update are effective for calendar years beginning after December 31, 2013, when the fee initially becomes effective. We will evaluate the impact of this update on our consolidated financial statements.

XML



Financing Arrangements (Termination of Amortizing Financing Facility) (Details) (USD $)	3 Months Ended		6 Months Ended		0 Months Ended	3 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	May 26, 2010 Short-term Debt [Member]	Jun. 30, 2010 Short-term Debt [Member]
Amortizing financing facility					$ 175,000,000
Early debt extinguishment charge	$ 0	$ (3,532,000)	$ 0	$ (3,532,000)		$ (3,500,000)

XML



Significant Accounting Policies (Estimated Annual Pretax Amortization Expense for Other Intangible Assets) (Details) (USD $) In Millions	6 Months Ended
	Jun. 30, 2011
Significant Accounting Policies
2011	$ 3.5
2012	3.4
2013	3.4
2014	2.8
2015	$ 2.6

XML



Segment Information

6 Months Ended

Jun. 30, 2011

Segment Information

Segment Information

3.    SEGMENT INFORMATION

Our Western Region Operations reportable segment includes the operations of our commercial, Medicare and Medicaid health plans, our health and life insurance companies, and our behavioral health and pharmaceutical services subsidiaries. These operations are conducted primarily in California, Arizona, Oregon and Washington. Our Government Contracts reportable segment includes government-sponsored managed care and administrative services plans through the TRICARE program and other health care-related government contracts. For the three and six months ended June 30, 2011, our Northeast Operations reportable segment included the operations of our businesses that provided administrative services to United and its affiliates pursuant to the United Administrative Services Agreements prior to their termination on July 1, 2011 and the operations of Health Net Life in Connecticut and New Jersey prior to the renewal dates of the Transitioning HNL Members. Beginning July 1, 2011, our Northeast Operations reportable segment will include the operations of our businesses that are adjudicating run out claims and providing limited other administrative services to United and its affiliates pursuant to the Claims Servicing Agreements.

As a result of the Northeast Sale, we operate the Northeast business in a manner that is different than the rest of our health plans. For additional information on the Northeast Sale, the United Administrative Services Agreements and the Claims Servicing Agreements, see Note 2. The rest of our health plans are operated as continuing core health plans.

We evaluate performance and allocate resources based on segment pretax income. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 2 to the consolidated financial statements included in our Form 10-K, except that intersegment transactions are not eliminated.

We also have a Corporate/Other segment that is not a business operating segment. It is added to our reportable segments to provide a reconciliation to our consolidated results. The Corporate/Other segment includes costs that are excluded from the calculation of segment pretax income because they are not managed within the segments and are not directly identified with a particular operating segment (for example, see Note 8 for the charge included in Corporate/Other in the six months ended June 30, 2011 related to the decision rendered by the Louisiana Supreme Court in the AmCareco litigation). Accordingly, these costs are not included in the performance evaluation of the reportable segments by our chief operating decision maker. In addition, certain charges, including those related to our operations strategy and corporate overhead cost reduction efforts, as well as asset impairments, are reported as part of Corporate/Other.

Our segment information is as follows:

	Western Region Operations		Government Contracts		Northeast Operations			Corporate/ Other/ Eliminations			Total
	(Dollars in millions)
Three Months Ended June 30, 2011
Revenues from external sources	$	2,593.6	$	171.0	$	11.3		$	0		$	2,775.9
Intersegment revenues		3.0		0		0			(3.0	)		0
Segment pretax income (loss)	$	72.5	$	40.2	$	(21.0	)	$	(3.2	)	$	88.5
Three Months Ended June 30, 2010
Revenues from external sources	$	2,507.9	$	851.9	$	82.6		$	(5.4	)	$	3,437.0
Intersegment revenues		13.0		0		0			(13.0	)		0
Segment pretax income (loss)	$	58.1	$	41.5	$	(9.4	)	$	(12.3	)		77.9
Six Months Ended June 30, 2011
Revenues from external sources	$	5,230.4	$	1,046.1	$	25.9		$	0		$	6,302.4
Intersegment revenues		5.9		0		0			(5.9	)		0
Segment pretax income (loss)	$	109.0	$	98.0	$	(25.9	)	$	(191.5	)	$	(10.4	)
Six Months Ended June 30, 2010
Revenues from external sources	$	5,038.6	$	1,661.4	$	158.5		$	(5.4	)	$	6,853.1
Intersegment revenues		25.1		0		0			(25.1	)		0
Segment pretax income (loss)	$	98.8	$	79.5	$	(47.0	)	$	(26.8	)	$	104.5

Our health plan services premium revenue by line of business is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
	(Dollars in millions)
Commercial premium revenue	$	1,481.4	$	1,411.0	$	2,971.1	$	2,823.2
Medicare premium revenue		734.4		770.7		1,526.5		1,557.6
Medicaid premium revenue		350.6		302.6		679.2		605.8
Total Western Region Operations health plan services premiums		2,566.4		2,484.3		5,176.8		4,986.6
Total Northeast Operations health plan services premiums		0.3		23.0		2.3		48.2
Total health plans services premiums	$	2,566.7	$	2,507.3	$	5,179.1	$	5,034.8

XML



Financing Arrangements (Revolving Credit Facility and Letters of Credit) (Details) (USD $)	3 Months Ended				6 Months Ended
	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2011 Letter of Credit [Member]	Dec. 31, 2010 Letter of Credit [Member]	Jun. 30, 2011 Line of Credit [Member]	Dec. 31, 2010 Line of Credit [Member]
Revolving credit facility expiration date, years					five
Revolving credit facility outstanding balance	$ 185,000,000	$ 0			$ 185,000,000
Maximum amount available for borrowing under the revolving credit facility					900,000,000
Revolving credit facility, remaining capacity					654,800,000	650,900,000
Applicable margin basis points					70
Outstanding letters of credit			60,200,000	249,100,000
Amount drawn on letters of credit	0	0
Line of credit default limit					50
Revolving credit facility, current capacity			400,000,000
Release of letters of credit	$ 88,100,000

XML



Significant Accounting Policies (Accumulated Other Comprehensive (Loss) Income) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Significant Accounting Policies
Unrealized gains (losses) on investments available-for-sale	$ (1,500,000)	$ 3,500,000	$ 5,300,000	$ 1,000,000
Net change in unrealized gains on investments available-for-sale	17,000,000	16,300,000	18,200,000	23,300,000
Reclassification of unrealized gains to earnings	(9,500,000)	(2,600,000)	(17,500,000)	(7,100,000)
Unrealized gains (losses) on investments available for sale	6,000,000	17,200,000	6,000,000	17,200,000
Prior service cost and net loss amortization	(4,700,000)	(900,000)	(4,800,000)	(900,000)
Net change in prior service cost and net loss amortization	100,000	100,000	200,000	100,000
Prior service cost and net loss amortization	(4,600,000)	(800,000)	(4,600,000)	(800,000)
Accumulated other comprehensive income (loss)	$ 1,380,000	$ 16,400,000	$ 1,380,000	$ 16,400,000	$ 487,000

XML



Segment Information (Premium Revenue by Line of Business) (Details) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Health plan services premiums	$ 2,566,719	$ 2,507,318	$ 5,179,103	$ 5,034,825
Commercial Premium Revenue [Member]
Health plan services premiums	1,481,400	1,411,000	2,971,100	2,823,200
Medicare Premium Revenue [Member]
Health plan services premiums	734,400	770,700	1,526,500	1,557,600
Medicaid Premium Revenue [Member]
Health plan services premiums	350,600	302,600	679,200	605,800
Western Region Operations Health Plan Services Premiums [Member]
Health plan services premiums	2,566,400	2,484,300	5,176,800	4,986,600
Northeast Operations Health Plan Services Premiums [Member]
Health plan services premiums	$ 300	$ 23,000	$ 2,300	$ 48,200

XML



Financing Arrangements (Senior Notes) (Details) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2011	Dec. 31, 2007	Dec. 31, 2010
Senior notes amount	$ 398,788,000		$ 398,685,000
Debt instrument, interest rate, stated percentage		6.375%
Debt instrument, maturity date		Dec. 31, 2017
Description of repurchase terms.	101
Default occurred under the indenture governing the senior notes	0
Description of call feature	100
Treasury rate basis points	30
Senior notes	398,800,000		398,700,000
Failure to Pay Indebtedness [Member] | 6.375% Senior Notes [Member]
Line of credit default limit	50
Acceleration of Maturity of Indebtedness [Member] | 6.375% Senior Notes [Member]
Minimum borrowed aggregate principal amount	50,000,000
6.375% Senior Notes [Member]
Senior notes amount		400,000,000

XML



Significant Accounting Policies (Estimated Lives of Intangible Assets) (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended	12 Months Ended
	Jun. 30, 2011 years	Dec. 31, 2010 years
Gross Carrying Amount	$ 70.0	$ 70.0
Accumulated Amortization	(47.6)	(45.8)
Balance	22.4	24.2
Provider Networks [Member]
Gross Carrying Amount	40.5	40.5
Accumulated Amortization	(33.1)	(32.6)
Balance	7.4	7.9
Weighted Average Life (in years)	19.4	19.4
Customer Relationships and Other [Member]
Gross Carrying Amount	29.5	29.5
Accumulated Amortization	(14.5)	(13.2)
Balance	$ 15.0	$ 16.3
Weighted Average Life (in years)	11.1	11.1

XML



Subsequent Event

6 Months Ended

Jun. 30, 2011

Subsequent Event

Subsequent Event

11.    SUBSEQUENT EVENT

In November 2010, CMS imposed sanctions against us suspending the marketing to and enrollment of new members into all of our Medicare Advantage and stand-alone Prescription Drug Plan (PDP) products. These sanctions related to our compliance with certain Medicare rules and regulations. On August 1, 2011, CMS lifted its marketing and enrollment sanctions against us. We have resumed marketing of our Medicare Advantage and stand-alone PDP products and are enrolling beneficiaries with effective dates beginning September 1, 2011. We will participate in the upcoming annual enrollment period, which begins October 15, 2011 for January 1, 2012 enrollment. CMS continues to prohibit our stand-alone PDP products from receiving auto-assignment of low income subsidy (LIS) eligible Medicare beneficiaries under CMS' LIS auto-assignment process. However, LIS members can make their own choice to enroll in our products during the upcoming annual enrollment period, or in the month they become eligible for PDP coverage.

XML



Investments

6 Months Ended

Jun. 30, 2011

Investments

Investments

4.    INVESTMENTS

Investments classified as available-for-sale, which consist primarily of debt securities, are stated at fair value. Unrealized gains and losses are excluded from earnings and reported as other comprehensive income, net of income tax effects. The cost of investments sold is determined in accordance with the specific identification method, and realized gains and losses are included in net investment income. We periodically assess our available-for-sale investments for other-than-temporary impairment. Any such other-than-temporary impairment loss is recognized as a realized loss, which is recorded through earnings, if related to credit losses.

There were no investments available-for-sale-noncurrent as of June 30, 2011. As of December 31, 2010, we classified $8.8 million as investments available-for-sale-noncurrent because we believed it would take longer than a year for such impaired securities to recover. All available-for-sale-noncurrent investments were sold in the three months ended June 30, 2011.

As of June 30, 2011 and December 31, 2010, the amortized cost, gross unrealized holding gains and losses, and fair value of our current investments available-for-sale and our investments available-for-sale-noncurrent, after giving effect to other-than-temporary impairments, were as follows:

	June 30, 2011
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	667.7	$	4.5	$	(1.3	)	$	670.9
U.S. government and agencies		88.3		0.2		0.0			88.5
Obligations of states and other political subdivisions		479.0		5.9		(1.1	)		483.8
Corporate debt securities		331.6		2.2		(1.0	)		332.8
Other securities		0.0		0.1		0.0			0.1
	$	1,566.6	$	12.9	$	(3.4	)	$	1,576.1

	December 31, 2010
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	642.3	$	8.1	$	(2.2	)	$	648.2
U.S. government and agencies		103.6		0.1		(0.4	)		103.3
Obligations of states and other political subdivisions		533.2		2.1		(8.1	)		527.2
Corporate debt securities		374.5		11.8		(1.8	)		384.5
Other securities		0.0		0.0		0.0			0.0
	$	1,653.6	$	22.1	$	(12.5	)	$	1,663.2
Noncurrent:
Obligations of states and other political subdivisions	$	10.5	$	0.0	$	(1.7	)	$	8.8

As of June 30, 2011, the contractual maturities of our current investments available-for-sale were as follows:

	Amortized Cost		Estimated Fair Value
	(Dollars in millions)
Due in one year or less	$	45.5	$	45.9
Due after one year through five years		502.3		506.2
Due after five years through ten years		256.7		258.2
Due after ten years		94.4		94.8
Asset-backed securities		667.7		670.9
Other securities		0.0		0.1
Total current investments available-for-sale	$	1,566.6	$	1,576.1

 Proceeds from sales of investments available-for-sale during the three and six months ended June 30, 2011 were $799.3 million and $1,197.8 million, respectively. Gross realized gains and losses totaled $16.3 million and $1.7 million, respectively, for the three months ended June 30, 2011, and $29.3 million and $2.4 million, respectively, for the six months ended June 30, 2011. Proceeds from sales of investments available-for-sale during the three and six months ended June 30, 2010 were $215.9 million and $660.1 million, respectively. Gross realized gains and losses totaled $4.1 million and $0.1 million, respectively, for the three months ended June 30, 2010, and $12.5 million and $1.6 million, respectively, for the six months ended June 30, 2010.

           The following table shows our current investments' fair values and gross unrealized losses for individual securities that have been in a continuous loss position at June 30, 2011:

	Less than 12 Months					12 Months or More				Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	246.6	$	(1.3	)	$	0.0	$	0.0	$	246.6	$	(1.3	)
U.S. government and agencies		4.0		0.0			0.0		0.0		4.0		0.0
Obligations of states and other political subdivisions		93.9		(1.1	)		0.3		0.0		94.2		(1.1	)
Corporate debt securities		129.0		(1.0	)		0.0		0.0		129.0		(1.0	)
Other securities		0.0		0.0			0.0		0.0		0.0		0.0
	$	473.5	$	(3.4	)	$	0.3	$	0.0	$	473.8	$	(3.4	)

The following table shows the number of individual securities included in our current investments that have been in a continuous loss position at June 30, 2011:

	Less than 12 Months		12 Months or More		Total
Asset-backed securities		54		0		54
U.S. government and agencies		1		0		1
Obligations of states and other political subdivisions		50		1		51
Corporate debt securities		75		0		75
Other securities		0		0		0
		180		1		181

The following table shows our current investments' fair values and gross unrealized losses for individual securities that have been in a continuous loss position at December 31, 2010:

	Less than 12 Months					12 Months or More					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	188.2	$	(2.2	)	$	0.2	$	0.0		$	188.4	$	(2.2	)
U.S. government and agencies		65.1		(0.4	)		0.0		0.0			65.1		(0.4	)
Obligations of states and other political subdivisions		372.7		(8.0	)		1.8		(0.1	)		374.5		(8.1	)
Corporate debt securities		97.9		(1.8	)		0.0		0.0			97.9		(1.8	)
Other securities		0.0		0.0			0.0		0.0			0.0		0.0
	$	723.9	$	(12.4	)	$	2.0	$	(0.1	)	$	725.9	$	(12.5	)

The following table shows our noncurrent investments' fair values and gross unrealized losses for individual securities that have been in a continuous loss position at December 31, 2010:

	Less than 12 Months				12 Months or More					Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Obligations of states and other political subdivisions	$	0.0	$	0.0	$	8.8	$	(1.7	)	$	8.8	$	(1.7	)

The above referenced investments are interest-yielding debt securities of varying maturities. We have determined that the unrealized loss position for these securities is primarily due to market volatility. Generally, in a rising interest rate environment, the estimated fair value of fixed income securities would be expected to decrease; conversely, in a decreasing interest rate environment, the estimated fair value of fixed income securities would be expected to increase. These securities may also be negatively impacted by illiquidity in the market.

XML



Segment Information (Tables)

6 Months Ended

Jun. 30, 2011

Segment Information

Segment Information

	Western Region Operations		Government Contracts		Northeast Operations			Corporate/ Other/ Eliminations			Total
	(Dollars in millions)
Three Months Ended June 30, 2011
Revenues from external sources	$	2,593.6	$	171.0	$	11.3		$	0		$	2,775.9
Intersegment revenues		3.0		0		0			(3.0	)		0
Segment pretax income (loss)	$	72.5	$	40.2	$	(21.0	)	$	(3.2	)	$	88.5
Three Months Ended June 30, 2010
Revenues from external sources	$	2,507.9	$	851.9	$	82.6		$	(5.4	)	$	3,437.0
Intersegment revenues		13.0		0		0			(13.0	)		0
Segment pretax income (loss)	$	58.1	$	41.5	$	(9.4	)	$	(12.3	)		77.9
Six Months Ended June 30, 2011
Revenues from external sources	$	5,230.4	$	1,046.1	$	25.9		$	0		$	6,302.4
Intersegment revenues		5.9		0		0			(5.9	)		0
Segment pretax income (loss)	$	109.0	$	98.0	$	(25.9	)	$	(191.5	)	$	(10.4	)
Six Months Ended June 30, 2010
Revenues from external sources	$	5,038.6	$	1,661.4	$	158.5		$	(5.4	)	$	6,853.1
Intersegment revenues		25.1		0		0			(25.1	)		0
Segment pretax income (loss)	$	98.8	$	79.5	$	(47.0	)	$	(26.8	)	$	104.5

Premium Revenue by Line of Business

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
	(Dollars in millions)
Commercial premium revenue	$	1,481.4	$	1,411.0	$	2,971.1	$	2,823.2
Medicare premium revenue		734.4		770.7		1,526.5		1,557.6
Medicaid premium revenue		350.6		302.6		679.2		605.8
Total Western Region Operations health plan services premiums		2,566.4		2,484.3		5,176.8		4,986.6
Total Northeast Operations health plan services premiums		0.3		23.0		2.3		48.2
Total health plans services premiums	$	2,566.7	$	2,507.3	$	5,179.1	$	5,034.8

XML



Stock Repurchase Program (Details) (USD $)	1 Months Ended		6 Months Ended		0 Months Ended	3 Months Ended	6 Months Ended	0 Months Ended	3 Months Ended	6 Months Ended
	May 31, 2011	Mar. 31, 2010	Jun. 30, 2011	Jun. 30, 2010	May 04, 2011 2011 Stock Repurchase Program [Member]	Jun. 30, 2011 2011 Stock Repurchase Program [Member]	Jun. 30, 2011 2011 Stock Repurchase Program [Member]	Mar. 18, 2010 2010 Stock Repurchase Program [Member]	Jun. 30, 2011 2010 Stock Repurchase Program [Member]	Jun. 30, 2011 2010 Stock Repurchase Program [Member]
Treasury Stock Shares Acquired						870,000			1,400,000	4,900,000
Aggregate consideration paid for common stock									$ 10,800,000
Cumulative Treasury Stock acquired, value									300,000,000	300,000,000
Treasury Stock Value Acquired Cost Method			199,220,000	158,444,000		27,100,000			45,200,000	149,800,000
Stock repurchase program authorized amount	300,000,000	300,000,000			300,000,000			300,000,000
Stock repurchase program remaining authorized repurchase amount			$ 272,900,000				$ 272,900,000
Average price of repurchased stock per share										$ 27.80

XML



Significant Accounting Policies (Carrying Amount of Goodwill) (Details) (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
Balance as of June 30, 2011 and December 31, 2010	$ 605,886	$ 605,886
Western Region Operations Health Plan Services Premiums [Member]
Balance as of June 30, 2011 and December 31, 2010	$ 605,900

XML



Consolidated Statements of Stockholders' Equity (USD $) In Thousands, except Share data	Common Stock [Member]	Additional Paid-In Capital [Member]	Common Stock Held in Treasury [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]	Total
Balance at Dec. 31, 2009	$ 154	$ 1,190,203	$ (1,389,722)	$ 1,895,096	$ 52	$ 1,695,783
Balance, shares at Dec. 31, 2009	144,175,000		(41,020,000)
Comprehensive (loss) income:
Net income (loss)				61,156		61,156
Change in unrealized gain on investments, net of tax impact					16,196	16,196
Defined benefit pension plans:
Prior service cost and net loss					131	131
Total comprehensive income (loss)						77,483
Exercise of stock options and vesting of restricted stock units, shares	782,000
Exercise of stock options and vesting of restricted stock units	(9)	1,055				1,046
Share-based compensation expense		23,121				23,121
Tax benefit (detriment) related to equity compensation plans		(5,249)				(5,249)
Repurchases of common stock, shares			(6,514,000)
Repurchases of common stock			(158,444)			(158,444)
Balance at Jun. 30, 2010	145	1,209,130	(1,548,166)	1,956,252	16,379	1,633,740
Balance, shares at Jun. 30, 2010	144,957,000		(47,534,000)
Balance at Dec. 31, 2010	145	1,221,301	(1,626,856)	2,099,339	487	1,694,416
Balance, shares at Dec. 31, 2010	145,121,000		(50,474,000)
Comprehensive (loss) income:
Net income (loss)				(49,895)		(49,895)
Change in unrealized gain on investments, net of tax impact					701	701
Defined benefit pension plans:
Prior service cost and net loss					192	192
Total comprehensive income (loss)						(49,002)
Exercise of stock options and vesting of restricted stock units, shares	1,586,000
Exercise of stock options and vesting of restricted stock units	2	26,979				26,981
Share-based compensation expense		15,295				15,295
Tax benefit (detriment) related to equity compensation plans		1,486				1,486
Repurchases of common stock, shares			(6,528,000)
Repurchases of common stock			(199,220)			(199,220)
Balance at Jun. 30, 2011	$ 147	$ 1,265,061	$ (1,826,076)	$ 2,049,444	$ 1,380	$ 1,489,956
Balance, shares at Jun. 30, 2011	146,707,000		(57,002,000)

XML



Investments (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2011

Dec. 31, 2010

Investments

Fair Value of Investments Available-for-Sale

	June 30, 2011
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	667.7	$	4.5	$	(1.3	)	$	670.9
U.S. government and agencies		88.3		0.2		0.0			88.5
Obligations of states and other political subdivisions		479.0		5.9		(1.1	)		483.8
Corporate debt securities		331.6		2.2		(1.0	)		332.8
Other securities		0.0		0.1		0.0			0.1
	$	1,566.6	$	12.9	$	(3.4	)	$	1,576.1

	December 31, 2010
	Amortized Cost		Gross Unrealized Holding Gains		Gross Unrealized Holding Losses			Carrying Value
	(Dollars in millions)
Current:
Asset-backed securities	$	642.3	$	8.1	$	(2.2	)	$	648.2
U.S. government and agencies		103.6		0.1		(0.4	)		103.3
Obligations of states and other political subdivisions		533.2		2.1		(8.1	)		527.2
Corporate debt securities		374.5		11.8		(1.8	)		384.5
Other securities		0.0		0.0		0.0			0.0
	$	1,653.6	$	22.1	$	(12.5	)	$	1,663.2
Noncurrent:
Obligations of states and other political subdivisions	$	10.5	$	0.0	$	(1.7	)	$	8.8

Available for Sale Current and Noncurrent Investments Classified by Contractual Maturity Date

	Amortized Cost		Estimated Fair Value
	(Dollars in millions)
Due in one year or less	$	45.5	$	45.9
Due after one year through five years		502.3		506.2
Due after five years through ten years		256.7		258.2
Due after ten years		94.4		94.8
Asset-backed securities		667.7		670.9
Other securities		0.0		0.1
Total current investments available-for-sale	$	1,566.6	$	1,576.1

Unrealized Loss Position for Current & Noncurrent Investments

	Less than 12 Months					12 Months or More				Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	246.6	$	(1.3	)	$	0.0	$	0.0	$	246.6	$	(1.3	)
U.S. government and agencies		4.0		0.0			0.0		0.0		4.0		0.0
Obligations of states and other political subdivisions		93.9		(1.1	)		0.3		0.0		94.2		(1.1	)
Corporate debt securities		129.0		(1.0	)		0.0		0.0		129.0		(1.0	)
Other securities		0.0		0.0			0.0		0.0		0.0		0.0
	$	473.5	$	(3.4	)	$	0.3	$	0.0	$	473.8	$	(3.4	)

	Less than 12 Months					12 Months or More					Total
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Asset-backed securities	$	188.2	$	(2.2	)	$	0.2	$	0.0		$	188.4	$	(2.2	)
U.S. government and agencies		65.1		(0.4	)		0.0		0.0			65.1		(0.4	)
Obligations of states and other political subdivisions		372.7		(8.0	)		1.8		(0.1	)		374.5		(8.1	)
Corporate debt securities		97.9		(1.8	)		0.0		0.0			97.9		(1.8	)
Other securities		0.0		0.0			0.0		0.0			0.0		0.0
	$	723.9	$	(12.4	)	$	2.0	$	(0.1	)	$	725.9	$	(12.5	)

	Less than 12 Months				12 Months or More					Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
	(Dollars in millions)
Obligations of states and other political subdivisions	$	0.0	$	0.0	$	8.8	$	(1.7	)	$	8.8	$	(1.7	)

Number of Securities Included In Loss Position of Current and Noncurrent Investments

	Less than 12 Months		12 Months or More		Total
Asset-backed securities		54		0		54
U.S. government and agencies		1		0		1
Obligations of states and other political subdivisions		50		1		51
Corporate debt securities		75		0		75
Other securities		0		0		0
		180		1		181

XML



Fair Value Measurements (Changes in the Balances of Level 3 Financial Assets) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Beginning balance			$ 605,886,000
Impairment related to Northeast Operations	0	(6,000,000)	0	(6,000,000)
Ending balance	605,886,000		605,886,000
Fair Value, Measurements, Recurring [Member]
Beginning balance on April 1 and January 1	9,900,000	10,000,000	9,900,000	10,000,000
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Realized in net income	0	0	0	0
Unrealized in accumulated other comprehensive income	0	0	0	0
Purchases	800,000	0	800,000	0
Sales	0	0	0	0
Issuances	0	0	0	0
Settlements	0	0	0	0
Ending balance	10,700,000	10,000,000	10,700,000	10,000,000
Change in unrealized gains (losses) included in net income related to assets still held	$ 0	$ 0	$ 0	$ 0

XML



Credit Quality of Financing Receivables (Tables)

6 Months Ended

Jun. 30, 2011

Credit Quality of Financing Receivables

Schedule of Financing Receivables

	June 30, 2011		December 31, 2010
Amounts due for contingent membership renewals	$	41.3	$	33.8
Loans to health care providers		7.9		13.6

XML



Consolidated Statements of Cash Flows (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (49,895)	$ 61,156
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Amortization and depreciation	17,781	17,129
Adjustment to loss on sale of business	(41,137)	(8,171)
Share-based compensation expense	15,295	23,121
Deferred income taxes	36,806	3,378
Excess tax benefit on share-based compensation	(1,277)	(473)
Asset impairment charges	0	6,000
Net realized (gain) loss on investments	(26,951)	(10,881)
Other changes	6,781	(9,768)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Premiums receivable and unearned premiums	(47,555)	(53,416)
Other current assets, receivables and noncurrent assets	(22,892)	9,435
Amounts receivable/payable under government contracts	(88,058)	(5,540)
Reserves for claims and other settlements	(41,300)	(16,776)
Accounts payable and other liabilities	(53,398)	95,950
Net cash (used in) provided by operating activities	(295,800)	111,144
CASH FLOWS FROM INVESTING ACTIVITIES:
Sales of investments	1,197,801	660,070
Maturities of investments	117,897	108,958
Purchases of investments	(1,210,617)	(835,625)
Sales of property and equipment	0	19
Purchases of property and equipment	(21,012)	(9,009)
Purchase price adjustment on sale of Northeast Health Plans	41,036	(8,415)
(Purchases) sales of restricted investments and other	(12,267)	4,464
Net cash provided by (used in) investing activities	112,838	(79,538)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options and employee stock purchases	11,796	1,046
Excess tax benefit on share-based compensation	1,277	473
Repurchases of common stock	(189,889)	(173,494)
Borrowings under revolving credit facility	467,500	100,000
Repayment of borrowings under financing arrangements	(282,500)	(216,771)
Net decrease in checks outstanding, net of deposits	(8,857)	0
Net cash used in financing activities	(673)	(288,746)
Net decrease in cash and cash equivalents	(183,635)	(257,140)
Cash and cash equivalents, beginning of year	350,138	682,803
Cash and cash equivalents, end of period	166,503	425,663
SUPPLEMENTAL CASH FLOWS DISCLOSURE:
Interest paid	15,285	14,620
Income taxes paid	$ 27,809	$ 49,279

XML



Credit Quality of Financing Receivables

6 Months Ended

Jun. 30, 2011

Credit Quality of Financing Receivables

Credit Quality of Financing Receivables

9.    CREDIT QUALITY OF FINANCING RECEIVABLES

As of June 30, 2011 and December 31, 2010, our financing receivables consisted of the following (amounts in millions):

	June 30, 2011		December 31, 2010
Amounts due for contingent membership renewals	$	41.3	$	33.8
Loans to health care providers		7.9		13.6

Amounts due for contingent membership renewals arose from the Northeast Sale (see Note 2). United is required to pay us additional consideration for the value of the Transitioning HNL Members and the members of the Acquired Companies that transitioned to other United products based on a formula set forth in the Stock Purchase Agreement to the extent such amounts exceeded the initial minimum payment of $60 million that United made to us at closing. This membership transition was completed on July 1, 2011. The receivable amount accrued as of December 31, 2010 was received in March 2011. The receivable amount as of June 30, 2011 is due in September 2011. Loans to health care providers are made from time to time to provide funding to certain health care providers and are generally due within twelve months from the time of the loan.

These financing receivables are considered past due if the required principal payments have not been received as of the date such payments were due. We do not accrue interest on these financing receivables, and interest income is recognized only to the extent any such cash payments are received. We had no past due financing receivables as of June 30, 2011 and December 31, 2010. Financing receivables are considered impaired when, based on current information and events, it is probable we will be unable to collect all amounts due in accordance with the original contractual terms of the agreement, including scheduled principal payments. Impairment is evaluated in total for smaller-balance receivables of a similar nature and on an individual receivable basis for other larger receivables. If a receivable is impaired, a specific valuation allowance is established. Impaired receivables, or portions thereof, are charged off when deemed uncollectible. We had no impaired receivables as of June 30, 2011 and December 31, 2010.

As part of the on-going monitoring of the credit quality of our financing receivables, we track and monitor certain credit quality indicators such as the counterparties' credit rating and financial condition, including their capital strength, amount of leverage, and stability of earnings and growth. The counterparty for the amounts due for contingent membership renewals is investment grade and in strong financial condition. We believe that the counterparties for the loans to health care providers are of strong financial condition.

The allowance for possible bad debt is a reserve established through a bad debt provision charged to general and administrative expense, which represents our best estimate of probable losses that have been incurred within the existing receivables. The allowance, in our judgment, is necessary to reserve for estimated bad debt and risks inherent in the receivables. Our allowance for bad debt methodology is based on historical loss experience by type of credit and internal risk assessment, with adjustments for current events and conditions. The allowance for bad debt was not material as of June 30, 2011 and December 31, 2010.

XML



Investments (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Investments
Investments available-for-sale-noncurrent	$ 0		$ 0		$ 8,756,000
Proceeds from sales of investments available-for-sale	799,300,000	215,900,000	1,197,801,000	660,070,000
Gross realized gains	16,300,000	4,100,000	29,300,000	12,500,000
Gross realized losses	$ 1,700,000	$ 100,000	$ 2,400,000	$ 1,600,000

XML



Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2011

Significant Accounting Policies

Accumulated Other Comprehensive (Loss) Income

	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
	(Dollars in millions)
Investments:
Unrealized (losses) gains on investments available-for-sale as of April 1 and January 1	$	(1.5	)	$	3.5		$	5.3		$	1.0
Net change in unrealized gains on investments available-for-sale		17.0			16.3			18.2			23.3
Reclassification of unrealized gains to earnings		(9.5	)		(2.6	)		(17.5	)		(7.1	)
Unrealized gains on investments available for sale as of June 30		6.0			17.2			6.0			17.2
Defined benefit pension plans:
Prior service cost and net loss amortization as of April 1 and January 1		(4.7	)		(0.9	)		(4.8	)		(0.9	)
Net change in prior service cost and net loss amortization		0.1			0.1			0.2			0.1
Prior service cost and net loss amortization as of June 30		(4.6	)		(0.8	)		(4.6	)		(0.8	)
Accumulated other comprehensive income	$	1.4		$	16.4		$	1.4		$	16.4

Carrying Amount of Goodwill

	Western Region Operations		Total
	(Dollars in millions)
Balance as of June 30, 2011 and December 31, 2010	$	605.9	$	605.9

Schedule of Intangible Assets

	Gross Carrying Amount		Accumulated Amortization			Net Balance		Weighted Average Life (in years)
	(Dollars in millions)
As of June 30, 2011:
Provider networks	$	40.5	$	(33.1	)	$	7.4		19.4
Customer relationships and other		29.5		(14.5	)		15.0		11.1
	$	70.0	$	(47.6	)	$	22.4
As of December 31, 2010:
Provider networks	$	40.5	$	(32.6	)	$	7.9		19.4
Customer relationships and other		29.5		(13.2	)		16.3		11.1
	$	70.0	$	(45.8	)	$	24.2

Estimated Annual Pretax Amortization Expense for Other Intangible Assets

Year	Amount
2011	$	3.5
2012		3.4
2013		3.4
2014		2.8
2015		2.6

XML



Consolidated Statements of Operations (USD $) In Thousands, except Per Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues
Health plan services premiums	$ 2,566,719	$ 2,507,318	$ 5,179,103	$ 5,034,825
Government contracts	171,015	851,939	1,046,142	1,661,398
Net investment income	25,091	16,567	48,926	36,489
Administrative services fees and other income	2,084	1,837	4,805	10,693
Northeast administrative services fees and other	11,021	59,301	23,470	109,661
Total revenues	2,775,930	3,436,962	6,302,446	6,853,066
Expenses
Health plan services (excluding depreciation and amortization)	2,231,278	2,163,191	4,513,612	4,374,447
Government contracts	130,828	811,386	952,980	1,583,288
General and administrative	219,029	237,378	645,390	484,474
Selling	57,571	56,574	118,262	115,405
Depreciation and amortization	8,953	8,466	17,781	17,129
Interest	8,238	8,761	15,858	18,645
Northeast administrative services expenses	37,825	71,951	90,080	153,829
Adjustment to loss on sale of Northeast health plan subsidiaries	(6,283)	(8,171)	(41,137)	(8,171)
Asset impairment	0	6,000	0	6,000
Early debt extinguishment charge	0	3,532	0	3,532
Total expenses	2,687,439	3,359,068	6,312,826	6,748,578
Income (loss) from operations before income taxes	88,491	77,894	(10,380)	104,488
Income tax provision	30,191	32,828	39,515	43,332
Net income (loss)	$ 58,300	$ 45,066	$ (49,895)	$ 61,156
Net income (loss) per share:
Basic	$ 0.64	$ 0.46	$ (0.54)	$ 0.61
Diluted	$ 0.63	$ 0.45	$ (0.54)	$ 0.61
Weighted average shares outstanding:
Basic	90,539	98,896	91,907	99,965
Diluted	92,046	99,687	91,907	100,894

XML



Investments (Available for Sale Current and Noncurrent Investments Classified by Contractual Maturity Date) (Details) (USD $) In Thousands	Jun. 30, 2011
Investments
Due in one year or less, amortized cost	$ 45,500
Due after one year through five years, amortized cost	502,300
Due after five years through ten years, amortized cost	256,700
Due after ten years, amortized cost	94,400
Asset-backed securities, amortized cost	667,700
Other securities, amortized cost	0
Total current investments available-for-sale, amortized cost	1,566,600
Due in one year or less, estimated fair value	45,900
Due after one year through five years, estimated fair value	506,200
Due after five years through ten years, estimated fair value	258,200
Due after ten years, estimated fair value	94,800
Asset-backed securities, estimated fair value	670,900
Other securities, estimated fair value	100
Total current investments available-for-sale, estimated fair value	$ 1,576,100

XML



Legal Proceedings (Narrative) (Details) (USD $) In Millions, except Per Share data	3 Months Ended	6 Months Ended					3 Months Ended
	Jun. 30, 2011	Jun. 30, 2011	Jun. 30, 2005	Dec. 30, 2008 AmCare-LA [Member]	Nov. 04, 2005 AmCare-LA [Member]	Nov. 04, 2005 AmCare-OK [Member]	Mar. 31, 2011 AmCare Co [Member]
Legal verdict			$ 117.4	$ 2.0
Compensatory damages			52.4		9.5	17.0
Punitive damages			65.0
Compensatory damages reduced	36.7	36.7
Punitive damages reduced	45.5	45.5
Legal Judgment Charge							177.2
Litigation Charge Amount Net Of Tax							157.9
Amount paid to satisfy judgment	$ 181.3
Decreased in net income per diluted share		$ 1.72

XML



Credit Quality of Financing Receivables (Schedule of Financing Receivables) (Details) (USD $) In Millions			6 Months Ended
	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2011 Contingent Membership Renewal [Member]	Jun. 30, 2011 Northeast Operations Segment [Member]
Membership transition date				July 1, 2011
Amounts due for contingent membership renewals	$ 41.3	$ 33.8
Loans to health care providers	7.9	13.6
Past due financing receivables		0
Impaired receivables		0
Initial payment for membership transferred			$ 60

XML



Investments (Unrealized Loss Position for Current & Noncurrent Investments) (Details) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Asset-backed Securities [Member] | Current [Member]
Less than 12 Months, Fair Value	$ 246.6	$ 188.2
Less than 12 Months, Unrealized Losses	(1.3)	(2.2)
12 Months or More, Fair Value	0	0.2
12 Months or More, Unrealized Losses	0	0
Total, Fair Value	246.6	188.4
Total, Unrealized Losses	(1.3)	(2.2)
U.S. Government and Agencies [Member] | Current [Member]
Less than 12 Months, Fair Value	4.0	65.1
Less than 12 Months, Unrealized Losses	0	(0.4)
12 Months or More, Fair Value	0	0
12 Months or More, Unrealized Losses	0	0
Total, Fair Value	4.0	65.1
Total, Unrealized Losses	0	(0.4)
Corporate Debt Securities [Member] | Current [Member]
Less than 12 Months, Fair Value	129.0	97.9
Less than 12 Months, Unrealized Losses	(1.0)	(1.8)
12 Months or More, Fair Value	0	0
12 Months or More, Unrealized Losses	0	0
Total, Fair Value	129.0	97.9
Total, Unrealized Losses	(1.0)	(1.8)
Obligations of States and Other Political Subdivisions [Member] | Current [Member]
Less than 12 Months, Fair Value	93.9	372.7
Less than 12 Months, Unrealized Losses	(1.1)	(8.0)
12 Months or More, Fair Value	0.3	1.8
12 Months or More, Unrealized Losses	0	(0.1)
Total, Fair Value	94.2	374.5
Total, Unrealized Losses	(1.1)	(8.1)
Current [Member]
Less than 12 Months, Fair Value	473.5	723.9
Less than 12 Months, Unrealized Losses	(3.4)	(12.4)
12 Months or More, Fair Value	0.3	2.0
12 Months or More, Unrealized Losses	0	(0.1)
Total, Fair Value	473.8	725.9
Total, Unrealized Losses	(3.4)	(12.5)
Other Securities [Member] | Current [Member]
Less than 12 Months, Fair Value	0	0
Less than 12 Months, Unrealized Losses	0	0
12 Months or More, Fair Value	0	0
12 Months or More, Unrealized Losses	0	0
Total, Fair Value	0	0
Total, Unrealized Losses	0	0
Obligations of States and Other Political Subdivisions [Member] | Noncurrent [Member]
Less than 12 Months, Fair Value		0
Less than 12 Months, Unrealized Losses		0
12 Months or More, Fair Value		8.8
12 Months or More, Unrealized Losses		(1.7)
Total, Fair Value		8.8
Total, Unrealized Losses		$ (1.7)